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Summary 
The Report on the Drug Situation in Austria commissioned by the European Monitoring Cen-
tre for Drugs and Drug Addiction and the Federal Ministry for Social Security and Genera-
tions appears annually and addresses the subject of illegal drugs. It gives an overview of cur-
rent developments regarding the political and legal framework, the epidemiological situation 
and demand reduction interventions in the reporting period 2000/01. Every year specific key 
issues are highlighted; this year poly-drug use, successful treatment and drug use in prisons 
have been selected for detailed presentation. 
What are the changes that have occurred regarding the legal,  
political and organisational framework? 
In the reporting period the drug policy framework was further developed at the provincial 
level. The trend towards integrative and comprehensive approaches to legal and illegal nar-
cotic substances has continued. In Burgenland an addiction coordinator was nominated. Sty-
ria appointed an addiction coordinator in the provincial capital of Graz, and in autumn a drug 
coordinator will start her activities at the provincial level. The Provincial Government of Carin-
thia unanimously adopted the new drug plan in May, which serves as a framework plan on 
addiction prevention and drug assistance for the period between 2001 and 2005. Burgenland 
started to draw up a drug plan and Upper Austria prepared an addiction plan. The drug plan 
of Vorarlberg will be revised in the next few months as a reaction to changes in the drug situ-
ation. Lower Austria, Salzburg and Vienna are implementing their drug plans or addiction 
plans. 
At the federal level a number of the plans in the field of drug policy described in the report of 
last year were implemented, after they had been adapted on the basis of responses by ex-
perts and opinions that had been requested. In April 2001 the Narcotic Substances Limit 
Quantities Decree reducing the limit quantity of heroin from five to three grams entered into 
force. In June 2001 the Narcotic Substances Act was also amended. Among other regula-
tions the maximum punishment for leaders of drug gangs was increased to life imprisonment. 
The past few months also saw a discussion of obligatory drug tests for drivers, which were 
announced by the government and met with criticism on the part of experts. 
What are the characteristics of the drug situation in Austria? 
The present data and estimates by experts indicate certain changes and new trends with re-
gard to the drug situation, and especially patterns of use. Drug consumers in Austria still tend 
towards poly-drug use, but the substances primarily consumed in this context seem to have 
changed, especially in the group of young addicts or problem drug users. While for the past 
decade opiates, and especially heroin, have played a central role in the context of poly-drug 
use involving a variety of substances (including in particular alcohol and benzodiazepines), 
now there are indications that stimulating substances, mostly amphetamines (speed) and co-
caine, are becoming more important. 
This trend does not point to a quantitative aggravation of the drug problem, however. The 
number of drug addicts is estimated to be stable in most areas. Only rural areas and regions 
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less strongly affected so far have registered an increase, which is a sign that the levelling-out 
process of regional differences has continued. Regarding the established drug scene the av-
erage age of users has risen noticeably, and many older drug addicts suffer from health 
problems that are often very serious (cf. below). Now for the first time various data showing 
the rising relevance of psychiatric co-morbidity among drug addicts has also been available. 
In 2000 the number of drug-related deaths, totalling 227, has markedly risen compared to 
previous years (1999: 174). The number of lethal poly-drug intoxications has again grown 
considerably, and experts attribute this rise to the increasing relevance of high-risk patterns 
of poly-drug use. 
Only few new data on drug experience in the general population has been available. The ba-
sic patterns have not changed: cannabis continues to be the drug used most frequently. Up 
to one third of the respondents indicate that they have used cannabis at least once in life. 
The second-most important substance is ecstasy, which up to 5% of the young people have 
experience of. Use of other substances is found considerably less often, even with regard to 
experimental use. A trend showing in some provinces is that biogenic drugs (psychoactive 
mushrooms, plants etc.) are becoming more and more popular, especially among young 
people. 
Which health policy measures have been taken to tackle the drug 
problem? 
The trend towards a diversification of health policy measures has continued. This is apparent 
especially in those provinces that did not have a highly diversified structure of drug help ser-
vices before but have started to provide additional kinds of services. This especially applies 
to outreach work and old services as well as measures aimed at socially reintegrating drug 
addicts. However, relevant developments have taken place in the established drug help sec-
tor as well. For instance there is a recent trend towards an increased diversification of inpa-
tient therapy options: as a response to a wider range of, and change in, drug symptoms that 
have been observed diversified, flexible treatment programmes were developed. 
The present health policy measures especially focus on the target group of youths in danger 
of becoming addicted. This includes outreach work and drug-related services for young peo-
ple in the context of secondary prevention services, which are becoming more and more 
firmly established. Integrating approaches aimed at avoiding a stigmatisation of the young 
people concerned play a prominent role in this regard. Another relevant future target group 
identified by experts is long-term addicts of rising average age. These addicts often have 
massive health problems and some of them need permanent nursing but at present ade-
quate services providing concentrated forms of care for these clients are lacking. 
Quality assurance of drug help services continues to play an increasingly important role. This 
is also reflected in a large number of corresponding research projects and evaluation studies. 
In addition guidelines for many fields or aspects of drug work have been drawn up. Education 
and training schemes for persons working in drug-related occupations are also significant in 
this context. Furthermore a large number of drug centres have started internal discussions of 
quality assurance measures. 
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Key issue: Poly-drug use 
Poly-drug use means that a drug user consumes several (illicit) substances simultaneously 
or in succession. In Austria there are two different groups of multiple drug users. The first 
one primarily includes young people intensively experimenting with many different sub-
stances. However, this does not usually lead to drug dependence and is restricted to a cer-
tain phase in life. On the other hand, poly-drug use has been a predominant pattern of con-
sumption among addicts of the drug scene in Austria for many years. Poly-drug use and 
combining various substances seems to be a pattern that has become more frequent in this 
group in the last few years, especially with regard to the range of substances consumed. 
While the ‘Vienna blend’ of alcohol, pills and opiates was typical in the past and opiates 
dominated, now in addition cocaine and amphetamines are also used more and more often. 
At least in part this change is due to the fact that these substances have become more easily 
available at lower prices. 
Multiple drug use by addicts leads to grave health problems and negative social conse-
quences. Combinations of different substances are more difficult to control for the users and 
thus more dangerous than the consumption of one single drug. The risk involved is also 
shown by the fact that the number of drug-related deaths caused by poly-drug intoxication 
has risen considerably. Multiple drug use is a specific challenge for the drug help structures 
as well. For instance withdrawal treatment of poly-drug users is often difficult. However, as a 
rule the health policy instruments available in Austria are open to all drug users, and as poly-
drug use is very frequent the drug help centres have also focused on this pattern of use. 
Key issue: Successful treatment 
In Austria two central approaches to treatment are followed, depending on the aims of ther-
apy with regard to patterns of use of the clients concerned. The goal of substitution treatment 
is a controlled and legal use of substances (viz. the substitution substance prescribed), while 
detoxification treatment is aimed at the clients’ abstinence from (illicit) drug use. However, a 
change in consumption patterns is only one of many different objectives. The activities of the 
drug help centres also focus on social reintegration of their clients and improvements regard-
ing their health and the legal situation they are in as well as their psychological and physical 
well-being, among other aspects. The manifold aims pursued by the treatment centres may 
be summed up in the term improvement of clients’ quality of life. So the success of treatment 
should be regarded from this angle and cannot be primarily judged from the patterns of use 
of the clients. 
In the last few years a rising number of evaluations have been made in the field of treatment 
in Austria, which serve as a basis for assessing whether therapy has been successful, i.e. 
whether the goals defined could be met. However only a few isolated results are available so 
far and therefore no general statements as to the success of addiction-related treatment in 
Austria can be made. Based on the evaluations completed so far one may conclude that the 
treatment programmes covered have successfully improved clients’ quality of life. The social 
reintegration of clients was facilitated in many cases, delinquency was reduced and regard-
ing drug use either abstinence or stabilisation could be achieved. This significantly contrib-
utes to the improvement of the clients’ life quality and helps to prevent negative social and 
health consequences of drug use. 
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Key issue: Drug users in prison 
According to available data and estimates by experts the share of drug users or drug addicts 
in prisoners is between 20% and 50% in Austria. This high share is explained by the fact that 
many criminal offences are connected with drug addiction. However, a number of inmates 
start to take drugs after imprisonment only. In most cases many different substances are 
used in prisons, depending on which drug is available at the moment. High-risk behaviour 
such as needle sharing is assessed to be considerably more common in prison than outside. 
Therefore experience of imprisonment is considered a major risk factor with regard to HIV 
and hepatitis infections. Drugs are smuggled into prisons in many ways and this cannot be 
completely prevented even by strict controls. 
As drug use plays an important role in prison various health policy measures were estab-
lished in this field. Drug-free zones were created to provide protected areas where prisoners 
do not get into contact with drugs. Admission to these zones is voluntary, and in most cases 
this approach is based on a combination of control (urinalyses) and granting of additional 
rights (visits, leave from detention). Substitution treatment must be possible for addicts in all 
prisons. Methadone is prescribed most frequently, but recently other substances have also 
been used to some extent. The prison of Vienna/Favoriten has specialised in abstinence-
oriented treatment, but a few other prisons also provide specific services in this field. Infec-
tion prophylaxis is another focus of drug-related activities. In addition to information folders 
and take-care sets prisoners get when they are examined at the beginning of imprisonment, 
condoms and disinfectants should also be available in all prisons. Often external drug cen-
tres are also involved in the treatment of drug addicts in prisons. What is still insufficient is 
relevant services for women. Here improvements are planned for the future. 
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Introduction 
This is the sixth time that the REITOX Focal Point at the Austrian Health Institute (ÖBIG) 
presents the annual Report on the Drug Situation commissioned by the European Monitoring 
Centre for Drugs and Drug Addiction (EMCDDA) and the Austrian Federal Ministry for Social 
Security and Generations (FMSSG).  
The Report on the Drug Situation serves both as an overview of the situation in the field of il-
licit drugs in Austria and as one of the national contributions describing the drug situation in 
the European Union. Reports of its kind are submitted by the REITOX Focal Points in all EU 
Member States according to a structure defined by the EMCDDA. These reports form the 
central basis of the EMCDDA‘s Annual report on the state of the drugs problem in the Euro-
pean Union (EMCDDA 2000). 
This year’s report follows the structure of last year. The first three parts deal with current de-
velopments and trends concerning the drug policy framework, the epidemiological situation 
and the health policy measures aiming at demand reduction. These parts refer to the report-
ing period from summer 2000 to summer 2001 while the routine statistics refer to the year 
2000. As they are based on the previous reports (most recent report: ÖBIG 2000a), they 
have been kept concise deliberately. Part 4 contains a detailed presentation of selected key 
issues, which in the present report include poly-drug use, successful treatment and drug use 
in prisons. The annex gives a number of tables, figures and maps with detailed information 
and data as well as an overview of major sources of information and drug monitoring sys-
tems in Austria. 
This report is based on many different data and information transmitted to ÖBIG by various 
experts in the field of drugs. In this respect, the reports on the drug situation in the individual 
Austrian provinces drawn up by the Drug Coordinators were especially significant. In addition 
a number of experts provided background information on, as well as feedback to, individual 
chapters of this report (cf. Key Issues). We would like to express our gratitude for their coop-
eration. 
We are especially indebted to the members of the advisory working group of the REITOX 
Focal Point Austria, Mr. Peter Hacker (Drug Coordinator of the City of Vienna), Ms. Elfriede 
Fitz (FMSSG), Mr. Alexander Jentzsch (FMSSG), Ms. Brigitte Magistris (FMSSG), Ms. Helga 
Oberarzbacher (Drug Coordinator of the Province of the Tyrol), Mr. Robert Scharinger 
(FMSSG), Ms. Johanna Schopper (FMSSG) and Mr. Wolfgang Werdenich (FMJ), whose 
comments on and complements to the present report have been most helpful. 
  
 
   
 
 
 
Part 1 
National Strategies:  
Institutional and Legal 
Frameworks
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1 Developments in Drug Policy and Responses  
1.1 Political framework in the drug field 
The trend of the past few years to further develop the drug policy framework at the provin-
cial level has been continued in the reporting period. In Burgenland a Drug Coordinator was 
appointed in October 2000 so this post, which has been vacant for some time, has been 
filled. Different to past times the new Drug Coordinator is employed in a full-time capacity. 
She works in the Health Department of the Provincial Government and her activities cover 
not only illicit drugs but any form of addiction. One of her current tasks is to draw up a drug 
plan for the province of Burgenland in line with the drug policy principles outlined by the prov-
inces (cf. ÖBIG 2000a). In autumn 2001 a Drug Coordinator for Styria will be appointed, fill-
ing a staff position in the Health Department of the Provincial Government. So now all prov-
inces have Drug Coordinators or Addiction Coordinators (cf. also Figure 1.1). In Styria an 
Addiction Coordinator responsible for addiction and drug affairs in the urban area of the pro-
vincial capital of Graz was hired. In line with the prevailing trend towards comprehensive ap-
proaches to the problem of addiction the competences of the Drug Coordinator of the Tyrol 
were expanded as of May 2001 to include alcohol as well, and her position is now called Ad-
diction Coordinator. 
At the end of May the new drug plan of Carinthia was unanimously adopted by the Provincial 
Government of Carinthia. It is a paper that lays down psychosocial principles providing a 
framework plan on addiction prevention and drug help for the period from 2001 to 2005 (cf. 
Chapter 8.1). A drug plan is also being prepared in Upper Austria. Based on a series of indi-
vidual plans already available, it is drawn up in cooperation with external experts and will be 
finished in the course of 2002. Vorarlberg plans to revise the existing drug plan to take into 
account changes regarding the drug situation (cf. results of the Vorarlberg drug report in 
Chapter 2), with the main emphasis placed on secondary prevention. 
In the reporting period Salzburg, Lower Austria and Vienna focused on implementing their 
drug plans or addiction plans, respectively. In Salzburg a central issue was the preparation of 
a framework plan aimed at preventing addiction (cf. Chapter 8.1). Lower Austria launched a 
comprehensive project involving many experts in the field of practical addiction work to pre-
pare a proposal for implementing the measures described in the Lower Austria addiction plan 
(cf. also Chapter 9). In Vienna the Vienna Social Fund (VSF) was established, which was a 
decisive step to meet the goal defined in the Vienna drug plan of 1999, namely that the or-
ganisational structure should be improved so that new or changed functions may be fulfilled. 
The VSF unites the Vienna Drug Coordinators and the individual departments of the City of 
Vienna responsible for drug issues so far, in a structure outside the administration of Vienna. 
The VSF has 43 permanent positions and an annual budget of approx. ATS 142m (approx. 
EUR 10.3m; cf. also Chapter 1.4). A tendency towards privatisation also shows in Lower 
Austria, where the addiction and drug counselling centres formerly run by the Province have 
been taken over by private organisations. 
In the Tyrol the organisational framework has been advanced to promote further regionalisa-
tion: district groups concerned with professional networking and cooperation structures at the 
regional level have been appointed. 
Institutions + Organisations Coordinating Bodies
National administration (Federal Ministries*)
Provincial administration (Provincial Governments)
Burgen-
land
FMF FMESC FMD FMTIT FMFA
Addiction Prevention Units
Addiction
Prevention
Coord. Body
VIVID kontakt&co SUPRO ISP
Spezialisierte Einrichtungen
DRDR DCDRAR ACDR + DC
Akzente
Salzburg
DR DC DRDR AC
Drug Forum
Provincial Conference
of Drug Coordinators
Meetings of the heads of
Addiction Prevention Units
AR = Addiction representative
AC = Addiction coordinator
DR = Drug representative
DC = Drug coordinator
= part of the Provincial Administration
= external institution or expert
Carinthia LowerAustria
Upper
Austria Salzburg
Styria Tyrol Vor-arlberg Vienna
FMJ
Treatment Care Counselling Reintegration Harm Reduction . . .
FMAFEW
AC
FMSSG FMI . . .
Addiction
Prevention
Unit
Federal Drug Coordination
Source: ÖBIG
* see List of abbreviations
Figure 1.1: Organisational structure of the drug sector in Austria (overview)
Institute
for Addiction
Prevention
ACDC DC
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Relevant activities at the federal level in the reporting period include the implementation by 
the government of plans to change the drug policy frameworks described in last year’s report 
(cf. ÖBIG 2000a). This primarily refers to amendments of the Narcotic Substances Act (NSA) 
and the Narcotic Substances Limit Quantities Decree (cf. Chapter 1.2), which have already 
entered into force. This was preceded by - often highly controversial - discussions and rejec-
tion of these plans by a large number of drug experts. In addition to the drug experts judges 
of juvenile courts also voiced distinct reservations about the government’s plans. What was 
especially criticised with regard to amendments of the NSA was the plan to increase the term 
of imprisonment for drug trafficking. After the official examination of the draft and before a fi-
nal decision was made some aspects of the plans were amended or qualified. For example, 
the original plan included an increase of the minimum term of imprisonment for violations of 
Art. 28(4) of the NSA (production, import, export or putting into circulation of large quantities 
of narcotic drugs under aggravating circumstances) from one year to three years. This provi-
sion was withdrawn after experts had pointed to negative consequences of such an amend-
ment, especially the problem that the principle of therapy instead of punishment would be 
massively restricted because suspension of prison sentences is possible only if the sentence 
imposed does not exceed three years (Art. 39 of the NSA). 
In spring 2001 the Federal Government presented a resolution concerning measures to 
combat drugs in road traffic, which met with protest especially because one of the measures 
included obligatory drug tests for drivers. Numerous experts pointed out that such tests did 
not provide reliable information on whether a person was fit to drive. In this situation the Fed-
eral Drug Coordination organised an expert hearing in April 2001 and in May the Vienna So-
cial Fund, in cooperation with ARBÖ, a drivers’ association, held a symposium on illicit drugs 
and pharmaceuticals in road traffic. The national and international experts who took part in 
these events voiced strong doubts whether drug tests for drivers actually made sense. As the 
opposition in parliament did not back this bill it did not achieve the two-thirds majority re-
quired in this case because a constitutional act was involved. So eventually the controversial 
issue of obligatory drug tests was not included in the amended Road Traffic Act. 
Regarding the organisational framework, at the federal level no relevant changes occurred in 
the reporting period. 
1.2 Policy implementation, legal framework and 
prosecution 
A number of plans on the part of the Federal Government regarding changes of the legal 
framework were discussed last year and implemented in the reporting period. On 8 April 
2001 the amended Narcotic Substances Limit Quantities Decree entered into force (pub-
lished in BGBl. II No. 145/2001), reducing the limit quantity for heroin from five to three 
grams (if a person is found to possess drugs exceeding the limit quantity it is regarded as a 
large quantify of drug, which has specific legal consequences; for more detail cf. ÖBIG 
2000a). At the same time 4-MTA, included as a new substance under control covered by the 
Narcotic Substances Act, was also taken into account in the amended Decree. 
On 1 June 2001 the amended Narcotic Substances Act entered into force (published in 
BGBl. I No. 51/2001). The maximum punishment for leaders of drug gangs (Art. 28(5) of the 
Developments in Drug Policy 
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NSA) was increased from 20 years to life imprisonment. Now Art. 29 of the NSA, which regu-
lates punishment for public propaganda encouraging drug abuse, explicitly includes the 
Internet. However, to take into account a wish expressed by many experts, the explanatory 
notes to the Act specifically mention that this shall not apply to any counselling and preven-
tion activities on the Internet. 
Other developments regarding the legal situation do not concern drug laws in particular but 
have indirect effects on the field of drugs. For instance under the amended Juvenile Court 
Act of 1 July 2001 the age of maturity was changed from 19 years to 18. As a result the 
Criminal Code for adults now also applies to 18-year olds as a rule, which has specific reper-
cussions on NSA cases, where the share of young delinquents is high. However a number of 
special regulations for criminal proceedings involving young adult offenders were also 
adopted. 
The expert opinion on use of cannabis for medical purposes, which was mentioned in the re-
port of last year, has been completed and draws the conclusion that it is sensible according 
to international scientific publications to prescribe THC preparations in cases of clearly de-
fined indications. Although use of cannabis for medical purposes is admissible under the ex-
isting laws in Austria already, no corresponding pharmaceutical drug has been officially re-
gistered so far (cf. ÖBIG 2000a). In April 2001 the district court of Wels, Upper Austria, deliv-
ered an interesting judgement in the context of hashish use for medical purposes: a person 
accused of growing cannabis plants was acquitted because it was for his own use. He 
smoked hashish to relieve symptoms such as nausea and loss of weight resulting from of his 
AIDS infection. In the oral statement the court gave the explanation that the superior legal in-
terest of a life worth living should override the inferior legal interest of the Austrian Criminal 
Code. 
Regarding law enforcement Upper Austria saw an increasing number of reports to the police 
for violations of the NSA involving large groups of youths or young adults (40 to 60 persons 
in many instances) and as many members had used drugs for long periods before being re-
ported, the cumulative quantity of drugs consumed in this period seemed to be extremely 
high. This caused excitement in the municipalities concerned (cf. Chapter 1.3) so two of them 
started specific crisis management intervention programmes. However on taking a closer 
look it turned out that even the central persons accused of passing on drugs had hardly han-
dled large amounts of drugs (see above) and thus had not committed felonies. 
1.3 Developments in public attitudes and responses 
Public attitudes were investigated in a number of surveys conducted in Vienna and Upper 
Austria. In February 2001 the general population survey carried out at regular intervals was 
repeated in Vienna, based on a sample of 600 persons of 16 or older. The results are similar 
to those of the past year in many respects (cf. also ÖBIG 2000a) and confirm that compre-
hensive, balanced drug policy approaches focusing on health and social policy measures are 
clearly, and more and more widely, accepted (cf. Feistritzer 2001 and Figure 1.2). 
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Figure 1.2: Attitudes to drug policy measures in the population of Vienna, comparison 1995-2001  
(approval of measure; percent) 
 
1 The results of this question are comparisons to the years 1997 and 2001, as this question was not included before. 
Source: Feistritzer 2001 
As the survey was conducted during the electoral campaign for the provincial parliament (cf. 
below) corresponding questions were included in the survey. One third of the respondents 
indicated that they had already noticed recent electoral posters dealing with the issue of 
drugs. 62% thought that drugs were no appropriate issue to be raised in an electoral cam-
paign, while one third thought it was right to do so (Feistritzer 2001). 
In the context of the pilot study Rapid Situation Assessment conducted in Upper Austria a re-
presentative sample of approx. 1,000 persons over 15 were interviewed (cf. also Chapter 2) 
and confronted with a set of different statements on drug policy and other themes. Accep-
tance of preventive and therapeutical interventions was high in this sample as well (65% and 
50% respectively), but unlike in Vienna repressive interventions met with the highest degree 
of approval (more severe punishment for drug dealers: 70%). Depenalising measures (no 
punishment for hashish use: 19%) and legalisation (selling hashish in pharmacies: 17%) did 
not meet with as much acceptance as in Vienna (cf. market 2000). 
Legalisation of cannabis was also discussed by the general public and political actors, espe-
cially in connection with corresponding plans in Switzerland. In the beginning of June 2001 a 
march in favour of cannabis legalisation was organised in Vienna, and measures to this ef-
fect were also advocated by representatives of the Green Party. The government parties, 
however, rejected steps towards legalisation or expanded depenalisation measures. 
Drug issues have played a pronounced role in public discussion throughout the reporting pe-
riod as the general debate of different drug policy approaches started in the previous year 
20
46
81
6
13
27
67
28
64
79
6
29
20
70
0 10 20 30 40 50 60 70 80 90
Establishment of users' rooms where
addicts may consume heroin bought
in the black market
Providing sterile syringes for addicts
Establishment of additional
treatment centres for drug addicts
Complete liberalisation or
legalisation of drug use and drug
trafficking
Liberalisation/legalisation of drug
use only for hashish, e.g. authorised
hashish cafes
Prison sentence for drug use
In favour of general prohibition of
narcotic drugs but against regarding
addicts as criminals
1
1
1
2001
1995
Developments in Drug Policy 
 10 
has been continued (cf. ÖBIG 2000a). In addition to amendments of the Narcotic Substances 
Act (cf. Chapter 1.2) the issue drug tests for drivers was prominent in the media (cf. Chapter 
1.1). Controversial positions showed most strongly before the provincial elections in this pe-
riod (Styria: autumn 2000; Vienna: spring 2001), as drugs were a central campaign issue in 
particular of the Freedom Party. A number of provinces (especially Salzburg and Upper Aus-
tria) also report an increasing polarisation in the public discussion of drug problems at the 
provincial level. In Upper Austria, for example, reports to the police were made against entire 
groups of persons (cf. Chapter 1.2), which met with immediate interest on the part of the me-
dia and led to intensive discussions, also in terms of political party policy, in the municipali-
ties concerned. 
1.4 Budget and funding arrangements 
No new data and information on budget and funding with regard to drugs are available. How-
ever, the results of the study presented in the report of last year, according to which about 
two thirds of the relevant expenditure is used for law enforcement (police, courts) still seem 
to hold (Bruckner und Zederbauer 2000). 
No information has yet been available regarding the effects on drug help centres of the 
budgetary economies mentioned in last year’s report. However for the time being no further 
economies affecting health policy measures at the federal level are expected. A problem dis-
cussed for several years that still remains to be solved is the so-called negative conflict of 
competences between federal and provincial governments regarding cost coverage for alter-
natives to punishment if the pertinent cost is not taken over by the social insurance funds. 
Under the NSA the Federal Government shall be subsidiary liable for cost coverage (Art. 
41(1) of the NSA), if a number of prerequisites are met. But as some of the provincial welfare 
assistance laws also include subsidiary cost coverage provisions this is a deadlock situation. 
The Ministry of Justice has now issued a decree (703.015/58-II 2/2000) stipulating criteria for 
assessing the question of subsidiary cost coverage by the Federal Government. Based on 
this decree individual agreements with selected drug centres may be concluded but what is 
still lacking is a general solution regarding the social affairs departments of the provinces. 
When the Vienna Social Fund was established (cf. Chapter 1.1) one goal was to simplify 
funding procedures for drug help centres by integrating individual financing systems and re-
sources. While in the past four different municipal departments provided various types of 
support for drug help centres and facilities (subsidies, cost sharing, service agreements, 
staff), now any kind of financial support is centrally handled by the VSF. For 2001 the VSF 
has a budget of more than ATS 142m (approx. EUR 10.3m), ATS 107m (approx. EUR 7.8m) 
of which are spent for financial support and projects. More than half of this sum (53%) goes 
to outpatient services, 28% to inpatient services and 16% to specific projects. The rest (3%) 
is accounted for by prevention and information work as well as studies, but it should also be 
mentioned that the VSF carries out many of these activities in the context its own services 
and projects, which are not financed by external funds. For instance, the Institute of Drug 
Prevention and the Diagnoses Institute are located at the FSW headquarters, which also in-
cludes an information and documentation staff unit in charge of monitoring and quality assur-
ance. 
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2 Prevalence, Patterns and Developments 
in Drug Use 
2.1 Main developments and emerging trends 
Only one recent regional survey on drug experience in the population is available (cf. Chap-
ter 2.2), indicating rather high results regarding lifetime experience of illegal drugs compared 
to previous studies. This concerns not only cannabis but also cocaine and ecstasy, although 
these drugs are only used experimentally in most cases. Another aspect worth mentioning is 
that use of cannabis is more often indicated, not only by youths and young adults but also 
older respondents. This does not necessarily mean that experience of drugs has risen but 
rather that the social awareness of cannabis has changed and respondents more readily 
admit cannabis experience. A new consumption trend showing in a few provinces is that bio-
genic drugs (e.g. mushrooms, cacti, Solanaceae; cf. Chapter 2.2) are becoming more and 
more popular in particular among young people. 
The available data and information on problem drug use apparently indicate a reorientation 
regarding patterns of drug use, or an already existing reorientation has begun to show now. 
Surveys among drug users and reports of drug experience reveal a change in the sub-
stances used - albeit in the context of poly-drug use, which still prevails (cf. Chapter 11). The 
provinces of Vorarlberg, Styria and Upper Austria report a more prominent role of ampheta-
mines while opiates are becoming less important in some cases. In the Tyrol, as well as in 
Vienna, there is a trend towards use of morphines and other opiates, which have already 
overtaken heroin. Benzodiazepines and alcohol also play a central role as far as problem 
drug use is concerned (cf. also Chapters 3.2 and 11). 
The rising relevance of amphetamines and cocaine could be connected with changing social 
frameworks. Use of stimulants (speed) seems to be a better way of responding to stress, 
high speed and pressure, which have become typical of modern life. Extended sociological 
analyses of possible connections between overall social developments and patterns of use 
would be needed to obtain further insight, which would be relevant especially for prevention 
work. 
2.2 Drug use in the population 
Regarding experience of illicit drugs in the population the results of a regional population sur-
vey are available for the reporting period. In addition other provinces have provided comple-
menting reports based on estimates by experts. 
The pilot project Rapid Situation Assessment (RSA) conducted in Upper Austria also in-
cludes a representative survey of the population over 15, covering both legal and illegal sub-
stances as well as a number of questions about health awareness and (drug policy) stand-
points (cf. Chapter 1.3). Experience of illicit drug use is indicated rather often compared to 
previous surveys of the general population. 21% of the respondents indicate that they have 
tried cannabis at least once, compared to only 11% found in the survey conducted in Vienna 
the year before (cf. Table A1 of Annex B). Lifetime experience of ecstasy and cocaine is also
Prevalence, Patterns and Developments of Drug Use 
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rather high (4% for either substance) as the results do not refer to young people only but to 
the general population. However, the relevant percentages are markedly lower for experi-
ence of use in the past year or month - results of more than 1% are found in the case of can-
nabis only. 
More detailed analyses can only be made for cannabis as the percentages of all other drugs 
tend to be too low for further statistical analyses to yield reliable results. In this survey ex-
perience of cannabis use is found twice as often among men (28%) than women (14%). The 
most frequent indications of drug experience are found among the age groups between 15 
and 24 (28%) as well as between 30 and 39 (32%), but the results for almost all other age 
groups are also rather high, averaging approx. 20% (25 to 29 years: 22%; 40 to 49 years: 
20%; 50-59 years: 19%). Noticeably lower percentages are only found in the oldest group 
(60 and older): 5%. Experience of legal substances is as follows: 99% of the respondents in-
dicated use of alcohol in general, 95% consumption of alcohol in the past year and 34% on 
three days or more of the past week. 58% said they smoked tobacco at least occasionally, 
while 10% indicated that they were heavy smokers (cf. market 2000). 
In addition to the survey of the general public, experts (i.e. the staff of addiction counselling 
centres, young people trained as peers, prevention coordinators at schools) were also inter-
viewed about their subjective opinions on trends regarding drugs and addiction in Upper Aus-
tria. While it was in particular drug counsellors who thought that the problem of illicit drug ad-
diction was on the rise, the majority of the coordinators stated that the situation had not 
changed, and regarding the peers interviewed, approximately one half said the drug situation 
was aggravating while the other half thought it had remained the same. However, when 
asked which addiction problem prevailed among young people, in particular legal substances 
were indicated (smoking: approx. 90%; alcohol: approx. 75%), while illicit drugs were men-
tioned only in rare instances (RSA-Endbericht 2001). 
Some provinces, for instance Lower Austria and Styria, report that estimates by experts and 
practical experience point to an increase of spare-time and weekend use of illicit drugs. 
However these statements cannot be tested scientifically as a corresponding data base is 
lacking. In addition there are indications of an increased use of biogenic drugs (psychoactive 
mushrooms or plants etc.). This has become apparent because of cases of psychoses result-
ing from use of such ‘natural drugs’, and occasional instances of overdoses. 
In the reporting period synthetic drugs that had hardly been significant in Austria before (e.g. 
ice, metamphetamine, PMA) were found in a few cases (cf. Chapter 5). However, the avail-
able information in this context does not suggest that these substances play an important 
role as to drug consumption. There still does not seem to be a wide range of synthetic drugs 
used. Consumption is basically restricted to ecstasy and amphetamines (speed). According 
to experts other substances such as GHB or ketamine are used in rare instances only. In the 
context of drug tests PMA and PMMA were found repeatedly but had always been sold as 
ecstasy (cf. Chapter 5). 
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2.3 Problem drug users 
No new data based on scientific studies are available with regard to the prevalence of prob-
lem drug use, i.e. frequent consumption of hard drugs (especially opiates and cocaine), 
which often entails dependence and health problems as well as social and legal conse-
quences (cf. Chapters 3 and 4). The prevalence estimate of the number of problem opiate 
users presented last year (cf. ÖBIG 2000a) will be updated in autumn 2001 to cover the pe-
riod from 1996 to 2000. 
However, a number of regional studies and data provide information on trends with regard to 
problem drug use or characteristic features of users of hard drugs. A few provinces report 
developments that indicate a change, albeit a slow one. A few years ago Vorarlberg started 
to interview drug users of outpatient and inpatient centres as well as imprisoned drug users 
to obtain information on patterns of use. The Vorarlberg drug report (Boss et al. 2001) gives 
a comparison of the corresponding results from 1995 (50 persons interviewed) and 2000 (77 
respondents), which show a noticeable reduction of opiate use paralleled by a rise in cocaine 
and especially amphetamine consumption. Heroin use was nearly halved between 1995 
(86% of the respondents indicating heroin consumption) and 2000 (44%). By the year 2000 
heroin had been overtaken by amphetamines (65%), which only 4% of the respondents of 
1995 had used . Cocaine was indicated as primary drug more often than five years before, 
and as in the past about half of the respondents used ecstasy. Consumption of poppers has 
markedly increased (from 0% to 16%). The age of first drug use has not changed and is be-
tween 20 and 22 years on an average for most substances (amphetamines, cocaine, heroin). 
While central motives for starting to take drugs were peer pressure and psychosocial prob-
lems five years before, in 2000 more fun, intensified spare-time feelings and excessive stress 
were mentioned as additional reasons. 
Styria reports a strong rise in substitution clients (Berthold, personal information) represent-
ing a new group of consumers: socially integrated youths or young adults who have taken 
heroin and amphetamines for a longer period already and make use of the opposed effects 
of the two substances. In most cases they smoke heroin for quite some time before they start 
injecting. Afterwards these young people seem to seek help rather soon. The increase regis-
tered in this specific group of drug users may in part be explained by an increased drug sup-
ply while prices are falling. The rising numbers of substitution patients also seem to be due to 
the fact that the drug scene has complete confidence in the attending doctor so the youths 
are willing to turn to drug help agencies at an early stage already. To corroborate this im-
pression the situation has to be observed over a longer period and additional data must be 
collected. 
In recent years the Erlenhof treatment centre in Upper Austria (cf. also Chapter 9.3) has no-
ticed a wider range of drug symptoms among their clients. While in the past heroin used to 
be the primary drug in almost all cases the corresponding share of opiates has fallen to 
around 60% since 1998, and amphetamines and benzodiazepines are on the rise, often 
combined with hashish and/or alcohol (Therapiestation Erlenhof 2001). 
These trends are hardly underpinned however by interviews of 89 clients of the low-threshold 
centre Komfüdro in the Tyrol, carried out in summer and autumn 2000 in the context of a 
European study dealing with the evaluation of the health room supply for drug users in three 
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European cities (cf. Zurhold et al. 2001). Asked which substances they had used in the past 
24 hours the clients indicated opiates most frequently, followed by benzodiazepines (63%), 
cannabis (59%) and alcohol (44%). Approximately 25% of the respondents had used cocaine 
and only 10% indicated amphetamines. What is interesting in this context is that regarding 
opiates the substance mentioned most frequently was not heroin (35%) but morphine/other 
opiates (68%). This is in line with the findings of Vienna, where morphine pills and cocaine 
have gained in importance for poly-drug users (cf. ÖBIG 2000a). Another striking aspect 
concerns surprising gender-related differences. The percentages of women indicating drug 
use in the past 24 hours were generally higher ten those of men, and for almost all sub-
stances, which indicates more intensive poly-drug use. In addition the share of intravenous 
drug use is considerably higher among women (80%) than men (53 %). On the other hand 
women never indicated that they regularly shared syringes or injecting equipment compared 
to 6% of the men. 80% of the respondents said they never shared syringes. 
In Vienna the prevailing patterns of use differ according to local street scene. In some areas 
intravenous use of morphine pills as well as sleeping pills or tranquillisers is most frequent 
while other local street scenes prefer heroin and cocaine, or both substances combined as 
speedballs. As a rule IDU prevails, but some groups have been found to take drugs by chi-
nesing, a practice rather uncommon in Vienna before (VWS 2001b). The rising relevance of 
cocaine in the street scene is a challenge for drug help agencies as due to the stimulating ef-
fect of the drug it is difficult to integrate the users in a treatment setting (VWS 2001a; cf. also 
Chapter 9.2). 
Generally speaking there is no doubt that poly-drug use has continued to play a central role 
(for more details cf. Chapter 11), although the situation with regard to preferred substances 
seem to be changing at least in some areas. However, these developments do not necessar-
ily mean that the drug situation has aggravated as far as quantities are concerned. The tradi-
tional drug problem areas report unchanged numbers of drug addicts (cf. e.g. Boss et al. 
2001), while in regions hardly affected so far a quantitative rise seems to have occurred. Still, 
this does not apply to, or has not become apparent in, all regions. For instance, Salzburg re-
ports that the situation has not changed and that cocaine and designer drugs still play a mi-
nor role only (3% and 6%, respectively) among drug users turning to drug counselling cen-
tres. 
On the other hand there are further indications that the share of older persons in the estab-
lished drug scene tends to rise. Since its foundation 10 years ago the low-threshold centre 
Ganslwirt (cf. also Chapter 9.2) has seen an increase of the share of clients over 30 from 
28% in 1991 to 60% in 2000 (VWS 2001a). This is also in keeping with rising average ages 
regarding drug-related deaths (cf. Chapter 3.2) and information from other drug help agen-
cies. For instance the Vienna hospital connection service CONTACT sees an increasing 
number of older drug addicts and this group seems to grow further, constituting a new target 
group of health care interventions that has not been focused on before (cf. Chapters 8.2 and 
9.2). 
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3 Health Consequences 
3.1 Drug treatment demand 
As there is no uniform client documentation system, only few data of limited interpretative 
value is yet available in the field of treatment. In 200/01 the working group convoked by the 
FMSSG in spring 1999 to establish a uniform documentation and reporting system has con-
tinued its activities. Recently the pilot version of a client questionnaire has been drawn up 
and sent out to several treatment and care centres, which use it in the context of a test run. 
Client data covering the whole of Austria will not be available before 2003, however. 
The pilot study Documentation and reporting system of drug help centres in Austria (ÖBIG 
2001) was concluded in spring 2001. The primary goal of this study was to obtain information 
on drug help structures in Austria, (regional) availability of services and facilities as well as 
staff structures. In the context of this project aggregate client data was also gathered. There 
are certain reservations however regarding the quality of client data: due to its aggregate 
character the type of treatment or assistance (e.g. examinations according to the Narcotic 
Substances Act, counselling or long-term assistance/treatment) cannot be specified. Double 
counts of clients cannot be excluded either. 
57 out of a total number of 126 outpatient drug help centres contacted provided data on 
drug use of clients in 1999, broken down by gender (cf. Figure 2.1) 
Figure 3.1: Number of clients documented in the statistics of 57 outpatient drug help centres in 
Austria, by gender and (drug) problem, in 1999 
 
Source: ÖBIG 2001 - survey by ÖBIG (May to September 2000) 
In view of this data one may safely assume that the largest share of clients receiving treat-
ment or assistance because of drug problems comprises (poly-drug) users of opiates. Re-
garding inpatient drug help services (for this area data from 8 out of 34 centres contacted is 
available) the share of (poly-drug) users of opiates is even higher (84%). Exclusive use of 
hashish/hallucinogens alone accounts for 2%; problems only concerning alcohol for 2%; and 
poly-drug use excluding opiates for 11%. Both in the outpatient and in the inpatient centres 
there are twice as many male clients as women. 
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Unfortunately this data does not permit a verification of the trends reported by a few centres, 
viz. the share of clients with opiate problems is declining while the number of persons using 
amphetamines and benzodiazepines is on the rise (cf. Chapters 2.1 and 11). This is mainly 
due to the fact that drug use patterns cannot be broken down accordingly in the statistics 
sheet (amphetamines and benzodiazepines are not explicitly named). The plan to implement 
a uniform client documentation system with a more detailed collection of drug use data (prob-
lem of primary drug) will considerably facilitate an observation of such trends. 
National monitoring of substitution treatment is performed by the FMSSG and based on 
the reports of attending doctors. Although not all cases are reported or reports often come in 
late (cf. ÖBIG 1999), some broad insights may nevertheless be gained as to quantitative de-
velopments and characteristics of clients. The increasing acceptance of, and resort to, this 
form of treatment is reflected in the annually rising number of reports concerning persons 
currently undergoing substitution treatment as well as the rising number of clients going in for 
substitution treatment for the first time (cf. Figure 3.2). 
Figure 3.2: Development of annual registrations of persons currently undergoing substitution treatment 
in Austria from 1990 to 2000, by first treatments and continued treatments 
 
Note: Continued treatments are treatments started before the respective year or repeated treatments of persons having under-
gone substitution treatment before. First treatments are treatments of persons who have never been undergoing substitu-
tion treatment before. 
Sources: FMSSG (BMSG, Abt. VIII/B/12), calculations by ÖBIG 
The high shares of persons over thirty in the group of persons reported as currently undergo-
ing substitution treatment in 2000 indicates that most of them are long-term drug addicts. The 
gender distribution of patients reported is balanced more or less in the group under 20, while 
the older age groups have a markedly higher proportion of men than women (25-34 years: 
ratio 2:1; over 34: 3:1; cf. Figure 3.3). Those 822 persons undergoing substitution treatment 
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for the first time in 2000 were 29.1 years old on an average; the average age of the women 
in this group was younger (28.1 years) compared to the male patients (29.6 years). 
Figure 3.3: Persons currently registered for substitution treatment in Austria by age and gender, 
in 2000 
 
 
Note: The difference to the total sum results from cases where age and gender were not included in the database. 
Sources: FMSSG (BMSG, Abt. VIII/B/12), calculations by ÖBIG 
3.2 Drug-related mortality 
After stable numbers of drug-related deaths in the past few years 2000 saw a marked in-
crease, as 227 drug-related casualties were registered (cf. Figure 3.4 and Table A2 of Annex 
B). 
In 2000 the cases of persons dying as a direct consequence of drug use were analysed on 
the basis of the EBDD groups for the first time, i.e. retrospectively for the time from 1991 to 
2000. For each year the definitions of narcotic drugs of the NSA were used (see also Annex 
A). 
2000 saw a continuation of the trend of the last few years, namely a decrease of intoxications 
by opiates paralleled by a rise in poly-drug intoxications including opiates. A detailed analysis 
of the total number of 167 intoxications according to substance involved shows that approxi-
mately two thirds of the cases concern opiates combined with other drugs. 22% had used al-
cohol in addition to one or several illicit drugs, 26% had consumed psychoactive medicines 
and another 26% had combined one or several illicit drugs with alcohol and psychoactive 
medicines (cf. Tables A5 and A6 of Annex B). 
The causes of death of persons dying as an indirect consequence of drug use have been 
broken down in Table A2 of Annex B. 
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Figure 3.4: Number of drug fatalities in Austria by cause of death from 1991 to 2000 
 
 
Note: The question whether to include intoxications solely involving psychoactive pharmaceutical products is still under discus-
sion so the statistics for 2000 do not take into account these cases (n=2; see also Annex A). 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
The share of female drug fatalities, which was 28% in 1999 and thus almost twice as high as 
in previous years, fell to 19% in 2000, which is in line with the long-term average. 
The average age of those persons dying as a direct or indirect consequence of drug use has 
risen over the years. While it was 27.7 for persons dying as a direct consequence of drugs in 
1991, the average age of this group has risen to 30.1 years by 2001. Persons dying as an 
indirect consequence of drug use in 1991 were 32.2 years old on an average but 33.3 years 
in 2000. More than half of the drug victims of 2000 (53%) were over 29 (cf. Figure 3.5). 
The number of drug-related deaths has developed differently in the individu al provinces. 
Only Upper Austria, Styria and Vienna report rather high increases compared to the previous 
year (cf. Table A6 in the Annex). On the other hand, the number of cases is low in statistical 
terms and there have been strong fluctuations in individual provinces in the course of time, 
which has to be taken into account before these regional differences are interpreted. 
It is a matter of discussion whether the rise in drug-related deaths in 2000 may be interpreted 
as a quantitative increase of the drug problem in general. One argument against this inter-
pretation is the strong increase direct drug related deaths in the age group over 34 (1998: 36 
persons; 1999: 47 cases; 2000: 57 cases), i.e. persons likely to have taken drugs for pro-
longed periods. 
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Figure 3.5: Age distribution of drug fatalities in Austria from 1990 to 2000 
 
 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
A plausible explanation of the rising number of drug-related deaths in 2000 given by experts 
is that this is mainly due to an increase of intoxications resulting from a mix of different drugs, 
alcohol and/or psychoactive medicines. In other fields of drug monitoring there are also indi-
cations of a rise in high-risk patterns of poly-drug use where the effects of different sub-
stances may be potentiating and can hardly be controlled (cf. Chapters 2.3 and 11). In the 
context of syringe checks in Vienna another risk factor was found: drugs with additions or 
contaminating substances unknown to the drug users that may pose health hazards 
(Haltmayer et al. 2001 - cf. also Chapters 11 and 5).  
3.3 Drug-related infectious diseases 
The situation regarding infectious diseases, which is especially relevant because of the in-
fection risk involved in intravenous drug use, may only be estimated on the basis of a few 
small samples from treatment centres and low-threshold services (cf. ÖBIG 2000a). The 
available data again indicates a stable HIV prevalence rate at a low level (between 0% and 
5%). The hepatitis prevalence rates however continue to be very high (hepatitis C: 48% to 
71%, hepatitis B: 25 % to 47 %). 
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Table 3.1: Data on hepatitis B, hepatitis C and HIV infection rates, in 2000 
Source of data HB rate HC rate HIV rate 
Short-term therapy department Lukasfeld 25% (32) 48% (25) 0% (27) 
Long-term therapy department of Anton Proksch Institute 45% (66) 71% (65) 0% (66) 
Low-threshold centre Ganslwirt 47% (57) 61% (88) 5% (81) 
Drug fatalities (intoxications) not available not available 4% (167) 
Sources: Riedl, F. personal information, API 2001, Haltmayer, H. personal information, FMSSG (BMSG, 
Abt. VIII/B/12) 
According to experts tuberculosis infections are hardly relevant in the context of drug-related 
infectious diseases in Austria (only isolated cases). 
Regarding psychiatric co-morbidity recent data has been available. A longitudinal study 
completed in 2001 (cf. Chapter 12) involving 100 patients of the withdrawal department of the 
Anton Proksch Institute has shown that at the start of treatment (1993/94) the majority of the 
population examined had psychological or psychiatric problems in addition to their addiction 
disease. 73% said they had thought of suicide in the last month before therapy. Personality 
disorders diagnosed according to DSM III-R were found in 45% of the cases, and 24% of the 
patients suffered from multiple personality disorders. The most frequent diagnoses were bor-
derline disorders (23%) and antisocial personality disorders (21%). An interesting aspect is 
that the borderline prevalence rate was significantly higher among women (44%) than men 
(16%). Patients suffering from psychiatric diseases, especially multiple personality disorders, 
turned out to give up treatment more often than other patients (Wirth 2001).  
90% out of a total number of 59 patients admitted to the long-term therapy department of the 
Anton Proksch Institute at Mödling, Lower Austria, suffered from personality disorders. 17% 
of the clients were treated with pharmaceuticals for three months because of severe depres-
sions, and the case histories of 26% listed grand mal seizures in the context of withdrawal or 
pathological EEG results as well as long-term prescription of epilepsy medication (API 2001). 
The annual report of dialog, a Vienna-based association, also mentions psychiatric co-morbi-
dity and that existing depressive and anxiety conditions are not identified in many instances 
because opiates have strong effects on the related symptoms and if they do become mani-
fest later they are attributed to withdrawal (dialog 2001). 
A few drug assistance services report a rising trend over the years regarding numbers of pa-
tients with psychiatric co-morbidity (e.g. Therapiestation Erlenhof 2001). 
Data on the general state of health has been obtained from 89 consumers of hard drugs 
(primarily IDUs) of the open drug scene at Innsbruck (cf. Chapter 2.3). Only 28% of the pa-
tients said that they had not had health problems in the last 30 days. The rest of the respon-
dents indicated the following problems: liver diseases/hepatitis (52%), stays in hospital 
(17%), problems related to HIV/AIDS (10%), overdoses (10%), abscesses (9%), grave 
emergencies (6%), or other diseases and handicaps (11%). When asked for a subjective 
opinion of their state of health only 33% said it was very good or fairly good. 48% responded 
Health Consequences 
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that it was partly good and partly bad, 14% indicated it was rather bad and 5% thought it was 
very bad (Zurhold et al. 2001). 
20% of the aforementioned group of 59 patients at the Anton Proksch institute also had skin 
diseases (e.g. herpes zoster, mycosis, condyloma or candidiasis). 
The rising age of drug users is another challenge regarding their general state of health 
(e.g. VWS 2001b, dialog 2001, Boss et al. 2001), as it involves a rise in long-term conse-
quences of drug use, which often means need for nursing services (cf. Chapter 8.2). 
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4 Social and Legal Correlates and Consequences 
4.1 Social problems 
The central social consequences of problem drug use have not changed in the reporting pe-
riod: unstable accommodation and unemployment, and consequently no opportunity to earn 
a legal income and eventually high debts. 
When 89 clients of the low-threshold centre Komfüdro in the Tyrol were interviewed (Zurhold 
et al. 2001; cf. also Chapter 2.3) their social situation was also surveyed. About 20% of the 
respondents indicated unstable accommodation, and more than 50% were out of work. 
Women had stable partnerships more often (60% v. 38%) and lived as singles less often 
than men (26% v. 41%). 
The Vienna Social Projects Association, the largest provider of low-threshold drug services 
(cf. also Chapter 9.2), has obtained recent information on social problems related to drug 
use. As many addicts are homeless Ganslwirt’s sleeping facility usually cannot meet the cor-
responding demand (VWS 2001a). Partners, work and accommodation are central issues 
clients raise in the context of counselling and assistance services, and it is especially women 
who also indicate problems regarding violence and prostitution (VWS 2001b). On the occa-
sion of the 10th anniversary of the Vienna Social Projects Association a book on perspec-
tives of drug work and drug policy was published, where the central problem of social mar-
ginalisation and discrimination of drug users and addicts is also discussed. Drug users tend 
to be stigmatised and consequently often lose their jobs and meet with obstacles when they 
try to obtain social welfare, which thus encourages negative careers (Schinnerl 2001). A diffi-
cult problem is that drug users usually cannot find legal jobs, which would not only satisfy 
material needs but also provide everyday structures and encourage self-assurance as well 
as a feeling of usefulness. Having a job is a central prerequisite for long-term addicts so that 
they may put down roots again (Bacher 2001; cf. also Chapter 9.4).  
4.2 Drug offences and drug-related crimes 
In 2000 18,125 reports for violations of the Narcotic Substances Act (NSA) were registered, 
which is a slight rise compared to preceding years (1999: 17,597 reports; cf. also Table A8 of 
Annex B). A total of 17,568 reports refer to narcotic drugs, the rest concerns psychotropic 
substances. With regard to types of report (cf. Figure 4.1), reports for misdemeanours (pos-
session and small-scale trafficking of drugs as regulated under Art. 27 of the NSA) have 
again increased, while reports for felonies (large-scale trafficking and commercial trafficking 
as regulated under Art. 28 of the NSA) have gone down. 
Social and Legal Correlates and Consequences 
 25
Figure 4.1: Development of reports to the police for violations of the Narcotic Drugs Act/Narcotic 
Substances Act by misdemeanours and felonies in Austria from 1991 to 2000 
 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. In order to facilitate comparison, 
for the period from 1998 to 2000 only reports concerning narcotic drugs are considered. The difference to the total number 
of reports results from reports that cannot be allocated. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
Regarding substances involved, in 2000 the number of reports to the police concerning can-
nabis did not rise further for the first time in several years. Reports in connection with opiates 
have continued to go down (slightly), while reports of ecstasy offences have markedly risen 
(cf. Figure 4.2). This year a separate representation of amphetamines has been possible for 
the first time since 1997; the relevant figures have not markedly changed since then (cf. Ta-
ble A10 of Annex B). Great differences regarding substances involved (cf. Table A11 of An-
nex B) have again been found in the individual provinces. In Vienna the proportion of reports 
in connection with opiates is comparatively high, while the majority of reports in all other pro-
vinces concern cannabis. 
As explained in previous years, the data concerning reports to the police only allows for very 
limited conclusions to be drawn as to the development of consumption and misuse of illegal 
drugs, because they primarily reflect the intensity and focus of police activities in this field. 
Compared to over 18,000 reports to the police in 2000, 2,052 arrests in connection with nar-
cotic drug investigations were registered (1999: 1,864), but for the latter no details (type of 
offence, substance involved, etc.) are available.  
 
3,878
5,779
8,327
10,420
13,834
15,006
14,283
15,090
15,779
1,880
2,415
2,250
2,459
2,712
2,198
1,956
1,789
10,163
2,162
1,400
0
2,000
4,000
6,000
8,000
10,000
12,000
14,000
16,000
18,000
20,000
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Year
R
ep
or
ts
Felonies
Misdimeanours
Social and Legal Correlates and Consequences 
 26 
Figure 4.2: Development of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by drug type from 1991 to 2000 
 
 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
The year 2000 saw 3,240 convictions for violations of the Narcotic Substances Act (leading 
offence; cf. Note to Table A12 of Annex B), which is a slight decline (1999: 3,359 convic-
tions). On the other hand the share of drug-related convictions in the total number of convic-
tions (7.8%) has reached a new peak (1991: 2%; 1999: 5.4%). The high proportion of misde-
meanours (2,245 cases; violation of Art. 27 of the NSA - possession and small-scale traffick-
ing) compared to felonies (993 cases; violation of Art. 28 of the NSA - trafficking; cf. Table 
A12 of Annex B) has further grown. About 60% of all persons convicted were punished with 
imprisonment; approximately one half of these sentences was suspended and one half not. 
Young people tend to be sentenced to imprisonment less often (cf. Table A14 of Annex B). 
Complementary to the data on convictions, information concerning the temporary (provi-
sional) withdrawal of reports to the police (Art. 35 of the NSA) and dismissal of proceedings 
(Art. 37 of the NSA) is also relevant. These legal alternatives to criminal prosecution (cf. also 
Chapter 9.6) were made use of in 8,098 cases in 2000, which is a considerable increase 
compared to past years (cf. Figure 4.3). 
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Figure 4.3: Development and application of statutory alternatives to punishment in Austria from 1994 
to 2000 
 
 
 
 
Art. 35 of the NSA = temporary withdrawal of the report to the police by the public prosecutor 
Art. 35(4) of the NSA = temporary withdrawal of the report to the police in the case of small amounts of cannabis for personal 
use 
Art. 37 of the NSA = temporary dismissal of proceedings by the court 
Note: The Narcotic Drugs Act was replaced by the Narcotic Substances Act on 1 January 1998. A specification of the kind of 
alternative to punishment can be given for the period since 1998 only. 
Source:FMSSG (BMSG, Abt. VIII/B/12) 
Again no data on crimes committed for the purpose of drug acquisition or other drug-related 
crimes is available. For details regarding prevalence of drug use in prison see Chapter 13. 
4.3 Social and economic costs of drug consumption 
Apart from the studies presented last year (cf. ÖBIG 2000a) no studies or data on social and 
economic costs of drug consumption in Austria are available. 
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5 Drug Markets 
According to the Federal Ministry of the Interior (FMI) the trends concerning the situation of 
organised narcotic drug trafficking remained basically unchanged in 2000 (Bundesministe-
rium für Inneres 2001). As in the preceding year FMI data indicates an increase of ecstasy 
trafficking and consumption and a further spreading of this problem to small-scale events and 
discos. Furthermore, an increase in smuggling, trafficking and use of amphetamines was re-
gistered. For the first time in Austria 450g of ice, a metamphetamine, was also found. 
Regarding the development of seizures in the past four years there has been a decline in 
heroin and LSD seizures. Cocaine and ecstasy show a falling trend initially, followed by a 
slight rise, and cannabis seizures have remained unchanged (cf. Table A16 of Annex B and 
Figure 5.1). 
Figure 5.1: Number of seizures of narcotic drugs in Austria from 1991 to 2000 
 
 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
The amount of substances seized reflect these trends only to a limited extent, as individual 
seizures of exceptionally large quantities strongly influence the general picture (cf. Table A17 
of Annex B). For instance, the fact that rather large amounts of cannabis, heroin and ecstasy 
were seized is due to a small number of large-scale seizures (e.g.1,200 kg of marijuana at 
the border to Slovenia near Spielfeld and 104 kg of heroin at the airport of Vienna). 
When assessing the data on seizures and relating them to drug demand and supply one has 
to bear in mind that part of the drugs seized in the context of frontier checks are not intended 
for Austria (transit). Unfortunately the seizures by the police and customs authorities cannot 
be broken down accordingly. 
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
4,500
5,000
5,500
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000
Year
S
ei
zu
re
s
Cannabis
Heroin
LSD
Cocaine
Ecstasy
Drug Markets 
 29
The purity of substances consumed was analysed in a study conducted by the Ganslwirt 
drug counselling centre in cooperation with the Institute of Medical and Chemical Laboratory 
Diagnostics of the University of Vienna. The residues found in 753 syringes that had been re-
turned contained many different combinations of various substances in most cases. For in-
stance heroin (n = 130) was mixed with cocaine (58% of the cases), caffeine (52%), noscap-
ine (41%), papaverine (40%), codeine (32%), or noscapine plus papaverine (18%). The addi-
tives to cocaine (n = 212) were caffeine (30% of the cases), lidocaine (7%) and oxymeta-
zoline, trimethoprom and diphenhydramine (between 3 and 4% each). Based on these re-
sults the authors conclude that in addition to deliberate combinations of several substances 
(e.g. heroin and cocaine), the substances used intravenously contain many different addi-
tives, some of which are detrimental to health (Haltmayer et al. 2001). 
In 2000 the project ChEck iT!, which tests the purity and ingredients of substances bought 
as ecstasy or speed during rave parties, was present at five rave events, where a total of 453 
samples were handed in for testing. As has already been observed in the year before, the 
percentage of pills bought under the name of ecstasy and actually containing MDMA has 
tended to increase further (1998: 37%; 1999: 78%, 2000: 85%). The share of high dose ec-
stasy pills has dropped compared to the previous year (in 1999 18 out of 138 samples, or 
13%, contained more than 100 mg of MDMA; and in 2000, 8 out of 302 samples, or 3%). As 
in past years the situation regarding the ingredients of substances bought as speed has been 
more dramatic with regard to actual ingredients. Only 67% of ‘speed’ analysed by the ChEck 
iT! team turned out to contain amphetamine (cf. Table A18 of Annex B). 
As already mentioned in the report of last year in July 2000 PMA was found in pills sold as 
ecstasy for the first time in Austria. In that month a person in Lower Austria consumed PMA 
but thought it was ecstasy and died as a consequence. In the course of that year ChEck iT! 
found pills containing PMA at two other rave events but as the ravers were warned immedi-
ately serious consequences could be prevented. 
In 2000 it showed once again that pills with a variety of logos are distributed (316 pills with a 
total of 62 different logos). A fact underlining the high market dynamics is that only four logos 
were found at more than two raves. Even common logos do at all not stand for specific in-
gredients (VWS 2001e). 
No recent studies on drug prices have been drawn up in the reporting period, the only infor-
mation available comes from the low-threshold sector and the ChEck iT! project. According 
to these sources one gram of street heroin (of a purity between 8% and 16%) was sold for 
ATS 500 (EUR 36) in 2000; and ravers informed ChEck iT! that they paid an average of ATS 
146 (EUR 11) for one ecstasy tablet and ATS 315 (EUR 23) for one gram of speed (VWS 
2001e). 
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6 Trends per Drug 
Cannabis is the illegal substance that is by far most frequently used. About 20% of the re-
spondents of a recent consumption survey conducted among the general population in Up-
per Austria (cf. Chapter 2.2) said they had experience of cannabis use. In a few age groups 
the relevant percentage was considerably higher even and only the group over 60 accounted 
for a lower share. However, regular use of cannabis is much less frequent than experimental 
consumption. Again, indications of social or health problems in connection with cannabis use 
are rare. Cannabis is also the substance to which the majority of reports to the police and 
seizures refer. 
Synthetic drugs, above all ecstasy, are the second-most consumed illegal drugs after can-
nabis and especially popular among youths. 4% of the respondents in the above survey said 
they had experience of ecstasy, which is a high share in the general population. The trend 
regarding use of ecstasy is estimated to be stable by many experts, and is expected to rise 
further only in a few rural regions. However, an increase of amphetamine use is reported in 
many areas, especially in the context of poly-drug use (cf. Chapter 11). The number of re-
ports to the police in connection with amphetamines has not changed as against the most re-
cent figures of comparison from 1997, while reports involving ecstasy have risen markedly. 
Drug tests and seizures in the reporting period revealed a number of different synthetic sub-
stances such as PMA, PMMA, ice or yaba, some of which were sold as ecstasy. So far social 
and health problems have appeared primarily when synthetic drugs are consumed in the 
context of poly-drug patterns of use. 
In representative population surveys opiates have been found to be used by no more than 
one percent of the respondents, although opiates continue to be the most relevant group of 
substances with regard to problem drug use. However, a few provinces report a downward 
trend for opiates. In addition recent data from the Tyrol (cf. Chapter 2.3) confirm the experi-
ence of Vienna that morphine and other opiates have begun to play a more important role 
compared to heroin in the context of poly-drug use by addicts. Opiates are involved in almost 
all cases of drug-related intoxications, and the share of deaths resulting from poly-drug in-
toxications has risen further. The number of reports to the police in connection with opiates 
has continued to decrease. 
Until now experience of cocaine use has not been indicated by more than 1% or 2% of the 
population, although some sources report a rise in cocaine consumption. For instance a sur-
vey conducted in Upper Austria revealed a rather high share of cocaine experience, namely 
4%. Due to falling prices and easy availability, cocaine has become more relevant in the 
open drug scene, where injecting use as a component of poly-drug consumption is also fre-
quent. However, only very few fatalities have been registered where cocaine has played a 
relevant role. The number of reports to the police and seizures have not changed in the re-
porting period. Crack use has still not been of relevance in Austria so far. 
.
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As in the past poly-drug use (cf. Chapter 11) continues to be the prevalent pattern of use 
among Austrian drug addicts, and according to recent reports it is still rising. As described 
above, amphetamines, apart from cocaine and morphine pills, also have begun to play a 
more important role in the context of poly-drug use or multiple use of many different sub-
stances (such as heroin, benzodiazepines or alcohol). Most substances are injected, and in 
some cases they are consumed in a combined form. This is also reflected in the correspond-
ing health consequences: this year the number of deaths caused by poly-drug intoxication 
has risen again. In addition to combinations of various illegal substances alcohol is also 
found rather often. The group of poly-drug users also have relevant social problems such as 
unemployment, homelessness and high debts. 
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7 Discussion 
The available data on the epidemiological situation in Austria shows a number of relevant 
trends. There is various data and information by experts indicating increased use of stimulat-
ing substances (such as amphetamines and cocaine), while opiates seem to play a some-
what less important role. This especially applies to heroin, as a rising number of opiate ad-
dicts tend to take morphines and opiates other than heroin. Generally speaking, poly-drug 
use combining many different legal and illegal substances is on the rise. In addition to the 
substances mentioned, in particular benzodiazepines and alcohol are also used frequently. 
The trend towards combining different drugs is also reflected in the increase of drug-related 
deaths, most of which are due to poly-drug intoxication. The fact that the average age of per-
sons dying due to drug use has risen indicates that the recent increase of drug-related 
deaths has not been caused by a growing number of drug users but rather by a trend to-
wards high-risk drug use. Most of the traditional drug problem regions of the past report that 
the situation continues to be stable while other regions have observed an aggravation. This 
means that the levelling-out process has continued, i.e. regional differences are becoming 
less prominent. 
At first glance the existing data does not always seem to be consistent. However, this is due 
to the fact that data and information often refer to rather small and local samples or studies 
and are thus likely to cover different groups of drug users. The data provided by the Tyrol 
and Vienna come from the low-threshold sector, where opiates still appear to play a central 
role. Here the average age of clients tends to rise. On the other hand, it is primarily the group 
of younger persons who seem to be affected by the trend towards stimulating substances, 
which is in line with social developments. Amphetamines (speed) and cocaine are rather as-
sociated with pressure at work, high speed and success-oriented life-styles than sedative 
drugs such as opiates. 
These developments are challenges for drug policy in many respects. It has to be examined 
whether the kind of drug assistance currently provided is adequate for consumers of stimulat-
ing drugs or if it should be adapted or expanded. What is especially important in view of the 
rising number of drug-related deaths and other problematic factors is measures aimed at 
preventing high-risk patterns of use dangerous for the drug consumers. In addition the group 
of drug addicts that are growing older and may need nursing services is a target group insuf-
ficiently reached by health policy interventions so far. 
The Austrian monitoring system (cf. Annex A) still has a number of shortcomings. A central 
problem in this respect is the lack conclusive data on drug-specific treatment and care cen-
tres comparable at the national level. What is positive, however, is an abundance of local 
data and small-scale studies dealing with specific issues, which will provide important com-
plements to routine data. The new developments with regard to prevailing patterns of use will 
make it necessary to discuss prevalence estimates for amphetamines and cocaine in future. 
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8 Strategies in Demand Reduction at National Level 
8.1 Major strategies and activities  
Regarding the provincial level in the reporting period, a new drug plan for Carinthia has been 
adopted, and Burgenland as well as Upper Austria are in the process of drawing up drug 
plans. Vorarlberg and the Tyrol plan to revise the existing drug plans. Lower Austria, Salz-
burg, Styria and Vienna are implementing their drug or addiction plans (cf. Chapters 1.1 and 
9). 
The framework plan on addiction prevention and drug help adopted in Carinthia for the pe-
riod from 2001 to 2005 (Prehslauer et al. 2001) is a paper laying down fundamental psycho-
social positions. As in the rest of the provincial drug plans (ÖBIG 2000a) the relevant ap-
proach to primary prevention is based on a broad concept of addiction, and comprehensive 
strategies in line with the principle of health promotion play a prominent role. As a result the 
addiction prevention coordinators of the Provincial Government of Carinthia focus on health 
promotion at kindergartens and schools and have defined the overall goal that counselling 
and care for youths in danger of becoming addicted should not be provided by centres spe-
cialising in the treatment of drug patients but by a counselling and care network created in 
the context of youth welfare departments and aimed at early intervention. The framework 
plan of Carinthia explicitly states that peer group approaches are not regarded as helpful, 
while streetwork activities are considered to be highly effective and will thus be further devel-
oped. Regarding inpatient centres the framework plan refers to the psychiatry plan of Carin-
thia, in which an expansion of the existing facilities is demanded. 
The drug plan of Vorarlberg will be modified with regard to an intensification of secondary 
prevention measures, as a reaction to the new drug report of Vorarlberg (Boss et al. 2001), 
which points to changes in the drug situation (cf. Chapters 1.1 and 2.3). 
Salzburg has drawn up a framework plan of addiction prevention and an implementation 
model for substitution treatment (cf. Chapter 9.3). The framework plan defines technical 
standards of primary and secondary prevention and lays down binding cooperation struc-
tures of drug help centres. 
As already mentioned in the report of last year, quality standards for drug work continue to 
be a central issue. The guidelines for the announcement of drug facilities drawn up by Fed-
eral Ministry of Social Security and Generations also focus on quality assurance in terms of 
defined minimum standards and will be applied after the coordination process with the Prov-
inces has been completed (ÖBIG 2000b). The new philosophy statement of the Austrian Ad-
diction Prevention Units prepared in cooperation with all Addiction Prevention Units and the 
Ludwig Boltzmann Institute of Addiction Research (Uhl und Springer 2001) is also aimed at 
quality assurance and professionalisation of addiction prevention in Austria (cf. also Chapter 
10).  
The relevant organisational framework and funding conditions are described in Chapter 1. 
.
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8.2 Approaches and new developments 
The trends described in last year’s Report on the Drug Situation (ÖBIG 2000a) have contin-
ued as far as concrete demand reduction interventions are concerned. The expansion of 
secondary prevention still plays an important role, and youths in danger of addiction are a 
central target group of new treatment and care approaches. Special importance is attached 
to integrative aspects to help to prevent a stigmatisation of the young people concerned (cf. 
Chapters 8.1 and 9.4). 
The activities pursued in the field of demand reduction intervention have revealed new health 
policy requirements inadequately met so far. For instance more and more drug addicts suffer 
from severe psychological disturbances and the number of older drug addicts (over 40) who 
are often physically ill and some of them need nursing services is also rising (cf. also Chapter 
3.3) so new approaches are necessary. These clients need adequate treatment centres and 
assistance structures that have yet to be created. Future interventions will have to focus on 
new target groups such as immigrants and users of stimulating substances. While the former 
use the drug help system to a small extent only, the latter are difficult to include in existing 
treatment and care settings. 
The result of ÖBIG’s pilot study (ÖBIG 2001) confirm the high degree of specialisation and 
diversity of the drug help structure in Austria, especially with regard to available services, but 
also as to target groups, degree of specialisation and staff structure (cf. also Chapter 9.3). 
This study also shows that quality assurance plays a major role in the drug help system. 
The diversification in the field of drug help is further increasing. At present this especially 
concerns the inpatient sector (cf. Chapter 9.3), where the range of treatment options has 
been widened. Apart from the continued trend towards short-term treatment, a development 
oriented to more flexible treatment schemes shows, so specific needs and target groups may 
be attended to more easily. 
 .
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9 Intervention Areas 
In the following chapter examples of different measures taken in the field of demand reduc-
tion in Austria are presented. The list does not claim to be exhaustive. The central focus was 
placed on new activities as well as projects and measures for which evaluation results are 
available. More detailed descriptions of individual projects and demand reduction interven-
tions are found both in the reports of the last few years (ÖBIG 1997, 1998, 1999, 2000a) and 
in the EDDRA database of the EMCDDA (cf. list of Austrian EDDRA projects in the reference 
section). In addition maps have been included (cf. pp. 41 and 42) to provide an overview of 
the regional distribution of drug centres and drug help services. 
9.1 Primary prevention 
Prevention measures continue to be of central importance in Austria, with corresponding ac-
tivities taking place in the fields both of primary and increasingly often also secondary pre-
vention. The distinction between primary prevention1 and secondary prevention2 is regarded 
as fundamental and is based on the principles of prevention policy established in Austria. 
Preventive measures are usually implemented at the local or regional levels. In this context 
the Addiction Prevention Units of the individual provinces play a major role. 
Interventions focusing on infancy and families are organised in particular in kindergartens. 
In addition to specific kindergarten projects (e.g. in Burgenland, Styria or Vienna) special 
emphasis is placed on further training measures for multipliers (cf. EDDRA). As a result of a 
further training programme run by the Addiction Prevention Unit VIVID of Styria, 16 projects 
aimed at preventing addiction have already been implemented in Styrian kindergartens. The 
Addiction Prevention Unit of Lower Austria planned a focus of activities addressing parents 
and as a result a comprehensive parent education project (Shaping the Future) was carried 
out and scientifically monitored. It will be continued as a model project. In addition the Addic-
tion Prevention Institute of Upper Austria prepared a comprehensive parents’ manual on ad-
diction prevention within families. The framework plan of Carinthia also underlines the impor-
tance of health-promoting general conditions within families (cf. Chapter 8.1). 
 
 
 
 
1 The aim of primary prevention is to avoid the development of addiction among persons who do not 
belong to a specific at-risk group and who have not had addiction problems so far. The pertinent 
measures are often based on the concept of health promotion. Other relevant scientific approaches 
forming the basis of primary prevention include the concept of life skills and protective factors such 
as social learning. Primary prevention especially focuses on children and young people. 
2 Secondary prevention is oriented towards defined at-risk groups and persons who do have problems, 
but which have not become manifest to their full extent however. The target group of secondary pre-
vention in particular includes young people. 
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Schools continue to be the most important setting of prevention measures. The prevention 
of addiction has been defined as a general educational principle in the context of health pro-
motion at Austrian schools. A recent activity of the Federal Ministry of Education, Science 
and Culture in this field has been the preparation of specific teaching materials methodically 
and didactically adapted to the theme of joint learning and active addiction prevention at 
schools. These materials will be available in autumn 2001. In addition the GIVE service cen-
tre of health education has been established, which provides information on model projects 
and new initiatives and has just completed a set of information materials on addiction. 
Primary schools have been the centre of new initiatives in the field of addiction prevention at 
schools. For instance a number of Addiction Prevention Units participated in an international 
prevention programme for primary schools (Becoming Independent), which was scientifically 
monitored and evaluated. In addition 40 classes from Innsbruck are taking part in the EU co-
operation project Substance Use Prevention in Schools: Evaluation of the School Pro-
gramme Gläserne Schule. Several provinces started projects where theatre play is used as a 
tool of primary addiction prevention in primary and lower secondary schools. In addition there 
are many prevention projects at schools based on peer group education (cf. also EDDRA).  
As a result the Working Group for Addiction Prevention developed guidelines for peer educa-
tion in the field of primary prevention. Although this method is frequently applied in preven-
tion programmes in and outside schools it is a controversial issue among drug experts. For 
instance the framework plan of Carinthia explicitly excludes peer education approaches. Fur-
ther training continues to play an important role for prevention at schools. Upper Austria saw 
the implementation both of an academic course on addiction prevention organised by the 
Federal Teacher Training Academy (cf. Chapter 10) and also of an academic course for ad-
diction prevention coordinators at higher secondary schools. Apart from this the Addiction 
Prevention Units of several provinces organise further training schemes for teachers. The 
secondary prevention project for teachers, Step by Step, which has already been described 
in the report of 2000, will now be implemented at a nation-wide level. 
Youth programmes outside schools remain essential for prevention activities. The Aus-
trian Education Forum for Promotional and Preventive Youth Work, which plays a central role 
with regard to quality advancement and lobbying in all fields of prevention concerning youth 
work (addiction, AIDS, violence etc.), has continued its wide range of activities in the report-
ing year. A relevant new development is the Federal Act on the Promotion of Youth Educa-
tion and Youth Work outside Schools, which entered into force in January 2001. Under this 
Act specific concerns in the context of work with children and youths shall be supported, for 
instance prevention in youth-specific problem areas. Another initiative worth mentioning is 
the information flyer It’s up 2U for the target group of young people, a joint project of the Aus-
trian Drug Prevention Association co-funded by the Austrian Federal Ministry for Social Se-
curity and Generations. 
In addition to the large number of primary prevention projects for youths outside schools (cf. 
ÖBIG 1999 and 2000a), a special focus has been placed on secondary prevention pro-
grammes such as the JUPI international prevention programme for young people, developed 
in collaboration with the Addiction Prevention Unit SUPRO, in the context of the INTERREG 
II EU project. This programme aims at youth workers in relevant youth organisations as well 
as open youth work staff. Its goal is to provide addiction- and drug-relevant training for youth 
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workers so that they may identify dangerous developments of youths and respond ade-
quately. Also in the field of secondary prevention the Drug Prevention Institute of Upper Aus-
tria has implemented kontext: Think Tank Prevention aimed at facilitating responses to cur-
rent developments and trends at an early stage already. In addition outreach work in the field 
of secondary prevention in the form of mobile youth work/street work has been of increasing 
relevance (cf. Chapter 9.2). 
The project Living Together organised by the Vienna-based Institute of Drug Prevention is 
aimed at regional addiction prevention in the context of work with children and youths within 
and outside schools in urban areas and combines various intervention settings. Cooperation 
in networks and information for specific target groups forms the basis for implementing addic-
tion prevention in urban areas in a sustainable and efficient way. The relevant target groups 
include political decision makers, key persons of children and youth work within and outside 
schools as well as parents. The project, which was started in September 2000, is being sci-
entifically monitored and evaluated (cf. Chapter 10). 
Community programmes have played an increasingly important role in addiction preven-
tion. Under the framework plan of Carinthia prevention at the municipal level will be imple-
mented in the context of the Healthy Villages programme. In cooperation with the Addiction 
Prevention Unit VIVID the project Practical Prevention of Addiction in Communities (in the 
district of Fürstenfeld/Styria) was started in November 2000. The aim of this project is to train 
locals to become addiction prevention contacts who also acquire competences enabling 
them to initiate projects in the neighbourhood and to form networks with other interested 
groups. The Addiction Prevention Unit of Lower Austria is also concerned with community 
approaches to prevention, and in cooperation with the Health Forum of Lower Austria work-
ing groups and information events with decision-makers and Healthy Municipalities staff are 
organised. Other activities include the exhibition Addiction and Preventing Addiction for muni-
cipalities as well as a prevention training scheme for church employees. The Addiction Pre-
vention Institute of Upper Austria also implements various community-related projects and 
reports a rising demand in this field. 
No additional telephone help lines have been set up in Austria in the reporting period. One 
centre in the Tyrol plans to create a hotline (ÖBIG 2001). 
Mass media campaigns do not play a prominent role for prevention in Austria. SUPRO, the 
Vorarlberg Addiction Prevention Unit, launched the campaign Empower our Children by 
Sports, which included information and communication via different media (papers, TV) as 
one element of prevention. However, nation-wide mass media campaigns have not taken 
place in the reporting period. 
The relevance of new media, and in particular, the Internet, has continued to rise. The majo-
rity of the regional Addiction Prevention Units have created their own Web sites, which are 
used more and more often. For instance SUPRO, the Vorarlberg Addiction Prevention Unit, 
reports an average of 80 to 100 visitors of its Web site every day. In addition to the services 
described in the report of last year, the Addiction Prevention Institute of Upper Austria is 
worth mentioning. Its virtual city Cybertown (www.cybertown.at) includes an information
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house providing assistance with regard to addiction and prevention, and every week a chat 
hour addressing young people takes place. A drug help centre of the Tyrol also plans to start 
an Internet prevention forum. 
9.2 Reduction of drug-related harm 
Reducing drug-related harm comprises a wide range of interventions addressing drug users 
or drug addicts. Most of these measures are not primarily oriented towards abstinence; but 
their aim is rather to provide low-threshold assistance for drug addicts in their actual life 
situation and to reduce the risks and problematic consequences of drug consumption as far 
as possible. Therefore the corresponding measures are often referred to as accepting drug 
assistance, survival assistance or harm reduction. For an overview of the relevant centres in 
the individual provinces see the maps on pp. 45 and 46. 
Outreach work is an important service in this field. In Lower Austria the pilot project Event 
Consulting was started, where young persons in danger of addiction are offered information 
and help on the spot. The ChEck iT! project of the Vienna Social Projects Association, a very 
successful initiative, will be extended to the province of Burgenland, in cooperation with the 
Vienna Social Fund (VSF) and the Addiction Coordinators of Burgenland (cf. also Chapter 5). 
In 2000 the MDI...B project of the Tyrol was contacted by 954 young people between 16 and 
24, which subsequently led to 38 counselling talks. The two-year pilot stage was completed 
in April 2001, the project was further developed and its resources as to counselling hours, 
resources and staff were increased (Jugend-Projekt MDA basecamp). The drug counselling 
centres of the Vorarlberg-based foundation Maria Ebene also focus on secondary prevention 
events addressing youths and young adults in danger of becoming addicted. Since last year 
legal counselling has also been offered. 
Another kind of outreach service is provided by the CONTACT hospital connection service in 
Vienna. In 2000 a total number of 284 patients received help during 362 hospital visits in 
hospitals, which is about the same number of persons as in the year before. While the num-
ber of contacts during stays in hospitals has risen only slightly (by 4%) as against the previ-
ous year, the contacts maintained after stays in hospital have strongly increased (by approx. 
54%). The work of CONTACT revealed that the share of persons over 40 (cf. Chapters 2.3 
and 3.3) in the total number of first contacts (i.e. first contact after admission to hospital) was 
rising significantly (13% in 2000 compared to 9% in 1999 and 5% in 1998). As many of these 
persons are physically ill as well they face the same problems as physically handicapped 
persons and clients in need of nursing services: there are no adequate agencies to which 
CONTACT could refer their clients, so most of them stay in nursing departments, although 
their actual target group is persons over 60. Another new issue CONTACT was confronted 
with in 2000 is end-of-life care. At the beginning of May 2000 the pilot project Mobile Youth 
Work - Street Work opened offices in three towns in Lower Austria. It has been planned to 
establish this project in all districts, but the corresponding decision will not be made before 
the project evaluation has been completed by the end of 2002. 
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Map 9.1: Specialised offers for treatment, counselling of and assistance to drug patients
Prevention of infectious diseases - testing and vaccination
Outreach work (Streetwork, bus, connection-services, etc.)
Housing for former drug addicts - aftercare (HalfWayHouse, housing communities, etc.)
Housing for drug addicts (temporary sleeping facilities, etc.)
Occupation projects for drug addicts (low threshold)
Occupation projects for former drug addicts (aftercare, reintegration, etc.)
Prevention of infectious diseases - syringe exchange, -distribution
Outpatient psycho-therapy for drug addicts
Note:
The map provides an overview of selected drug-related offers, broken down by district. The map does not specify quantitative and qualitative aspects (i.e. opening hours or number and qualification of personnel, respective-
ly). The map differentiates by offer and not by facility (cf. Map 9.2), therefore a single facility can appear in several categories.
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2001
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Map 9.2: Specialised facilities for treatment, counselling of and assistance to drug patients
Inpatient facilities for short-term treatment
Inpatient facilities for physical withdrawal
Outpatient drug facilities and wards
Low threshold facilities
Counselling centres
Outpatient counselling centres (open less thean 15 hours/week)
Inpatient facilities for long-term treatment
Therapeutic facilities in prison
Note:
The map provides an overview of selected drug-related facilities, broken down by district. The map does not specify quantitative and qualitative aspects (i.e. opening hours or number of qualification of personnel, respective-
ly). However, a distinction was made in the field of counselling, which is frequently offered by general facilities covering a broader range of services (psycho-social counselling centres, addiction counselling centres, etc.)
though limited to a few hours a week. Specialised drug counselling organisations with limited opening hours have been listed seperately (see legend).
Source: ÖBIG - based on information by the Drug Coordinators and Drug Representatives as of August 2001.
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Almost all provinces plan to establish or further expand already existing low-threshold ser-
vices. At the end of November 2000 Upper Austria opened a contact point for drug addicts 
run by the association Substanz. The services provided by the contact point include ex-
change of syringes, medical and psychosocial counselling as well as streetwork activities. 
In Vienna the social medicine counselling centre Ganslwirt of the Vienna Social Projects As-
sociation celebrated its 10th anniversary in the autumn of 2000. In the course of one decade 
Ganslwirt has provided care and assistance to 2,700 persons. The day centre registered 
180,600 contacts, and the outpatient clinic 54,800 contacts. The sleeping facility reports 
35,400 overnight stays. 2,160,000 one-way syringes were distributed, 82% of which were re-
turned to be exchanged for new ones and to be disposed of. In the last few years, growing 
numbers of older patients have been registered in particular in the day centre and the sleep-
ing facility, which means that specific services for persons between 40 and 50 are needed 
(cf. also Chapters 2.3 and 3.3). The activities of Ganslwirt have also revealed that there is a 
lack of adequate services providing accommodation for homeless drug-users on the one 
hand (cf. also Chapter 4.1) and specific services for groups of clients for whom care services 
have to be intensified (e.g. patients additionally suffering from psychiatric diseases and ex-
cessive drug users) on the other. In 2000 Ganslwirt’s focus of activities was placed on safer 
used, prevention of hepatitis B and C infections as well as the group of immigrants (cf. also 
Chapter 9.6). Apart from this, plans for users’ rooms were prepared, with the goal to reduce 
the risk of infection connected with intravenous drug use and to minimise overdoses (VWS 
2001a). Several drug experts from Vienna and Vorarlberg, among other actors, demand that 
such services be provided in Austria, particularly in view of the rising number of drug-related 
deaths (cf. also Chapter 3.2). 
The prevention of infectious diseases continues to be a relevant focus of services aimed 
at harm reduction. In Salzburg, the Tyrol and Burgenland the AIDS Assistance Service plays 
an active part in this respect: It provides information leaflets, counselling and testing services 
and also syringe dispensing machines. In Salzburg, depending on the season, between 150 
and 250 packs are distributed in this way. In the last few years Vienna, the Tyrol and Vorarl-
berg have registered a strong increase of the number of syringes exchanged, while the num-
ber of syringes bought is declining (cf. also Figure 9.1). In the context of the syringe ex-
change programme 158,785 sterile injection sets were handed out in Vorarlberg in the year 
2000, which has been an increase by 370% from 1994 to 2000 (Boss et al. 2001). This rise is 
attributed to strong efforts on the part of drug assistance organisations in Vorarlberg on the 
one hand, but also to an increase of IDU among poly-drug users (cocaine) and substitution 
patients. Due to drug help activities between 1999 and 2000 the A and B inoculation rates 
among high-risk groups in Vorarlberg have risen considerably. Carinthia also plans to inten-
sify hepatitis B vaccination efforts for high-risk groups, and to establish and expand existing 
syringe exchange programmes (Prehslauer et al. 2001).  
The Superior Sanitary Council, following recommendations of a working group on hepatitis 
and drug use established in summer 2000 (ÖBIG 2000a) decided on preventive measures in 
this field. The decision states that combined vaccinations against hepatitis A and B are ad-
visable for all injecting drug users receiving care in existing drug help centres and that ser-
vices provided for these patients should also include close cooperation with specialists of in-
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ternal medicine. Regarding pilot studies investigating issues of serology, diagnosis and 
treatment no agreement has been reached so far. 
 
Figure 9.1: Number of syringes sold or exchanged in the context of the syringe distribution programme 
in the open drug scene in Vienna from 1993 to 2000 
Source: Vienna Social Projects Association 
9.3 Treatment 
By now Austria has reached almost full coverage regarding treatments and health care 
centres at national level (cf. p. 46), although there are pronounced differences as to size 
and specific focuses of individual centres. The necessary services are provided both by spe-
cialised agencies and in the framework of general health care (e.g. by psychiatric hospitals, 
psychosocial service centres etc.). At present further information on drug help structures with 
regard to target groups, diversity of services, availability and staff are being gathered in the 
context of a pilot project carried out by ÖBIG (ÖBIG 2001; cf. also Chapter 3.1). 
The corresponding research covers 83% out of a total number of 126 outpatient centres and 
13 inpatient departments. The latter represent the majority of the institutions specialising in 
care for illegal drug users. They provide a total of 25 treatment programmes: 5 withdrawal 
programmes with capacities for the simultaneous treatment of 91 patients; 6 short-term pro-
grammes (62 patients); 6 long-term programmes (319 patients) and 8 reintegration pro-
grammes (127 patients). 
The existing outpatient centres were classified according to kind of services as well as avail-
ability (hours per week when staff provides services clients with drug problems as well as 
their friends and relatives): 51% provide counselling/health care/treatment for 40 hours per 
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week or less; 36% offer these services for 40 hours per week or more; and 11% are low-
threshold centres or outreach services available for 40 hours a week or more. 
There are marked regional differences regarding the degree of specialisation of outpatient 
centres (cf. Figure 9.2). However, this primarily reflects specific regional needs as outpatient 
centres specialising in illicit drug problems make sense only in regions where there is a de-
mand for such services. 
Figure 9.2: Degree of specialisation of outpatient health care centres for drug patients in Austria by 
province in 2000 
Note: Branch offices of central organisations have been counted as separate centres 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, St = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna 
Source: ÖBIG 2001 - survey by ÖBIG (May to September 2000) 
The outpatient services covered here provide approximately 9,100 staff hours per week, and 
the inpatient departments, approximately 9,300 weekly hours, for illicit drug users and their 
friends and relatives). The range of professions found in these centres (cf. Figure 9.3) re-
flects the interdisciplinary orientation of drug help and the view that addiction is a diseases in 
a psychosocial context. 
The existing data indicates that the outpatient drug help services in Austria have capacities 
of approximately two staff hours per week for every 1,000 persons between 15 and 54 years. 
These capacities are considerably higher in Vienna, Vorarlberg and the Tyrol compared to 
the rest of the provinces, which is due to the fact that the former have been more strongly af-
fected by drug problems so far. 
Both the inpatient and the outpatient sectors provide wide ranges of different services (ÖBIG 
2001; cf. Tables A19 and A20 of Annex B). 
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Figure 9.3: Distribution of weekly work hours of professionals in inpatient and outpatient health care 
centres for drug patients in Austria in 2000 
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Source: ÖBIG 2001 - calculations by ÖBIG (May to September 2000) 
Regarding developments in this field the trend towards inpatient short-term treatment as well 
as outpatient treatment has continued, and a rising number of opiate addicts take part in 
substitution programmes (cf. e.g. Boss et al. 2001).  
In this connection the Erlenhof therapy centre of Upper Austria is worth mentioning. Erlenhof, 
which celebrated its 20th anniversary in May 2001, provides inpatient abstinence-oriented 
long-term treatment for patients addicted to illicit drugs or pharmaceutical products. In addi-
tion to the care elements of education and psychotherapy, an extensive aftercare programme 
is also included (cf. Chapter 9.4). Responding to a widening range of drug symptoms found 
in its clients Erlenhof has adapted the basic treatment approaches accordingly (cf. Chapters 
2.3 and 12.2). Now patients may also undergo step-by-step treatment. After a test stage of 
one month which includes detailed diagnosing and examinations, five treatment stages may 
be attended one by one or combined according to individual needs. After each stage the 
treatment process is discussed with the client in the context of a so-called indication confer-
ence. In the early summer of 2000 Erlenhof, in cooperation with the Wagner Jauregg neuro-
logical hospital of Upper Austria, founded an addiction group in the hospital, which aims at in-
creasing the referral rate of patients by means of motivation therapy within the first 24 hours 
after a patient has been admitted to detoxification treatment (Therapiestation Erlenhof 2001). 
The foundation Maria Ebene of Vorarlberg, which will celebrate its 25th anniversary in No-
vember 2001, has also reformed its inpatient treatment structure and will expand its outpa-
tient therapy services (Stiftung Maria Ebene 2001). 
In Styria funding has been granted for the drug department Walk About, which will integrate 
withdrawal treatment and short-term therapy in the context of a three-month compact treat-
ment programme (cf. ÖBIG 1998). A new building is needed for this purpose so the depart-
ment will be established in the course of the next two years. 
The general framework of substitution and maintenance programmes (cf. Chapter 3.1, 
and for more details, ÖBIG 1999) has not changed essentially. In Salzburg the Drug Coordi-
nators cooperated with the Provincial Sanitary Directorate to develop an implementation 
Pe
rc
en
ta
ge
s 
of
 p
ro
fe
ss
io
ns
 
Intervention Areas 
 47
model for substitution treatment, with the aim to decentralise substitution treatment by involv-
ing the general health-care system. This requires a framework guaranteeing the security and 
quality of treatment. So far a general outline of this model has been drawn up and may be 
implemented after the authorities and institutions concerned have agreed to it. Methadone 
still is the substitution substance most frequently prescribed, however the trend towards an 
increased use of other pharmaceuticals such as Substitol has continued. In 2000 more than 
half of the substitution patients in Vorarlberg (54%) were prescribed other substances. 
9.4 Aftercare and reintegration 
Interventions aimed at aftercare and reintegration of (former) drug addicts address both cli-
ents having undergone abstinence therapy and persons with manifest addictions, in order to 
achieve social stabilisation and reintegration. General aftercare measures (e.g. psychother-
apy or counselling by social workers) are provided by many drug help centres (cf. also Chap-
ter 9.3). In addition there are specific social reintegration services in the fields of education, 
occupation and housing (see also ÖBIG 1998, ÖBIG 1999, ÖBIG 2000a). 
By now many centres provide comprehensive aftercare packages combining education and 
training, occupation and housing, for instance the Erlenhof treatment centre, where aftercare 
includes a combination of training and work in the joinery, kitchen, farm and pottery work-
shop as well as a vocational orientation stage and group housing outside the centre (Thera-
piestation Erlenhof 2001). 
Education and training is possible both in the context of specialised programmes (e.g. 
Needles or Pins, Vienna Job Exchange; cf. ÖBIG 2000a and EDDRA) and as an element of 
inpatient treatment. To give an example, the treatment programme of Erlenhof in Upper Aus-
tria also includes a vocational orientation stage (cf. also Chapter 9.3). 
The socioeconomic project Fix und Fertig of the Vienna Social Projects Association (cf. ÖBIG 
1999 and 2000, EDDRA) was started in 1995 and offers employment on a daily basis or 
transition jobs for current drug users, former drug addicts and clients of substitution pro-
grammes. In 2000 and 2001 the staff of Fix und Fertig was increased considerably, so at pre-
sent 55 persons, including key positions, are employed. In 2000 increased efforts were made 
to refer clients to the local labour market. This was successful for 41% of the clients who had 
completed the care programme as planned in this year. The plans for 2001 include building 
an additional wing to house storage rooms for shipment and renovation work as well as 
structural changes (VWS 2001c). 
Early in 2001 an assisted housing strategy was drawn up in Lower Austria. Initially sched-
uled for May the start of the pilot project Housing Group Airbag at St. Pölten, Lower Austria, 
has been delayed a little however. The target group of this project is young people between 
14 and 18 living in the neighbourhood. 12 youths with or without addiction problems may be 
admitted. The goal that has been defined is to enable the youths to lead independent, self-
determined lives. Regarding drug use what is aimed at is stabilisation. After a pilot stage the 
project will be evaluated until the end of 2002. For this purpose a case history form has to be 
filled in when clients are admitted and the care process is documented. 
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The assisted housing project of the Vienna Social Projects Association (ÖBIG 2000a, Chap-
ter 11.4 and EDDRA) was comprehensively evaluated for the first time in 2000, with very 
positive results. As demand is high the capacities of the housing project will be increased to 
provide accommodation for 50 clients instead of 18 persons and together with Ganslwirt’s 
expanded sleeping facility it will form a new drug assistance centre. A plan for implementa-
tion has already been drawn up (VWS 2001d). 
The care centres and contact points in Upper Austria provide aftercare on the basis of 
agreements with housing platforms so clients may find accommodation in this context. In ad-
dition contacts have been established to the Public Employment Service and the reintegra-
tion services of pro mente Upper Austria in order to place clients in work. Grüner Kreis has 
started a home project including mobile aftercare services (Grüner Kreis 2001), addressing 
patients who, due to their addiction disease and psychiatric multimorbidity, need long-term 
assistance after undergoing inpatient treatment. 
9.5 Intervention in the Criminal Justice System 
The health-care services for imprisoned drug users or addicts in Austria are described in the 
chapter on drug use in prison (cf. Chapter 13). A recent booklet published by the Federal 
Ministry of Justice gives an overview of various activities in the field of drug-specific demand 
reduction for convicted prisoners and offenders in custody in the context of measures other 
than punishment (Bundesministerium für Justiz 2001).  
Medical care services for drug-addicted prisoners in the Vienna police prison are provided by 
staff of the dialog drug counselling centre, as described in last year’s report (cf. ÖBIG 2000a, 
dialog 2000 and dialog 2001). Apart from this the police prison of Linz cooperates with drug 
centres in Upper Austria, especially with regard to substitution treatment. 
The police have also continued their activities in the field of prevention. Here measures of 
quality assurance are found, for instance, in the guidelines for addiction prevention events 
held by police officers, drawn up by the Criminal Police Information Service of Vienna. In the 
beginning of 2001 these guidelines, which are based on the principles of prevention policy 
established in Austria (cf. ÖBIG 2000a), were adopted as a decree of the Federal Ministry of 
the Interior, after they had been extensively discussed in the context of a networking confer-
ence initiated by the Ministry of the Interior including authorities concerned with preventing 
addiction and delinquency of youths as well as prevention experts. In addition a current eva-
luation study by the Institute for the Sociology of Law and Criminal Sociology investigates the 
activities of the Criminal Police Information Service and the effects of its interventions (con-
sulting or general assistance) with regard to problems with legal and illegal drugs at schools. 
To improve the cooperation between the police force and drug experts two projects were run 
in Vienna and Upper Austria (cf. also ÖBIG 2000a). The Vienna project Quality assurance of 
work with drug addicts and in the field of addiction prevention, a joint initiative by drug assis-
tance centres and the police force of Vienna, was implemented between December 1999 
and June 2000. The central goal of this further training programme was interdisciplinary fur-
ther training and creation of a network comprising drug help services and those departments 
of the police force that deal with the issues of addiction and prevention. This project was eva-
luated by external experts. PräGend, a cooperation project between the Addiction Prevention 
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Institute and the federal rural police of Upper Austria, with the goal to improve the coopera-
tion between these two actors, was carried out between April 1999 and November 2000. It 
included further training events, regular exchange of information by means of a newsletter as 
well as regional meetings and concrete local collaboration and is regarded as a successful 
model project (Institut für Suchtprävention 2001). 
9.6 Specific targets and settings 
Regarding demand reduction more and more measures are aimed at specific target groups 
or areas. A number of these interventions will be described for illustration.  
Gender-specific interventions form an integral part of drug help activities in Austria, with 
the focus mostly placed on the creation of specific services for women (cf. ÖBIG 1999). For 
instance Erlenhof, in the context of its long-term treatment programme, organises special 
groups for women (cf. also Chapter 9.3), and there are projects in the field of outreach work 
also especially addressing women, e.g. Streetwork’s weekly women’s cafe at Karlsplatz in 
Vienna (VWS 2001b). 
In the last few years the children of addicts have become an increasingly important target 
group of drug-related interventions (cf. ÖBIG 1999). For cases where children are in danger 
of being neglected or otherwise affected, Upper Austria created the instrument of helpers’ 
conferences in cooperation with the clients concerned. In 2000 the Parents and Children 
House project of Grüner Kreis (cf. also Chapter 12.2 and EDDRA), which is being evaluated 
at present, has provided help for 25 children, most of them under 6 (Grüner Kreis 2001). 
The workplace has become increasingly significant as a prevention setting. However, most 
projects in this context focus on alcohol (e.g. Alcohol in the Workplace by SUPRO of Vorarl-
berg). Many initiatives in this field address trainees. The main purpose here is to provide op-
portunities for enterprises to deal with addiction problems, in order to prevent those con-
cerned from being marginalised and also to reduce the rate of youths not completing trainee-
ship. Lower Austria has implemented a number of projects in this field and has planned fur-
ther initiatives, which will also be evaluated. In Carinthia this area is a central aspect of the 
framework plan 2001-2005. 
Another project in this context is Health promotion and addiction prevention among trainees 
of the Austrian Federal Railways, jointly developed by the Austrian Federal Railways (ÖBB) 
and the Addiction Prevention Institute. Trainers, trainees, staff representatives and occupa-
tional physicians were trained in central areas of primary prevention, then subprojects were 
drawn up aimed at creating healthy working conditions and human relations. The subsequent 
evaluation of the project showed very favourable results. This project also included the pre-
paration of guidelines for handling addiction problems among trainees (dialog 2001). 
The Austrian Association of Experts Working on Drug Abuse (ÖVDF) started an initiative for 
the target group of youths of immigrant families. A booklet about the problem of addiction, 
primarily addressing parents, was translated into Turkish, Serbian, Bosnian, Hungarian, 
Croatian, English and Burgenland Croatian and will be available in autumn 2001. Experience 
made  in  the low-threshold  sector shows that immigrants are  underrepresented in the  drug 
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help centres. So Ganslwirt started to deal with this subject more intensively in 2000 (VWS 
2001a). 
The number of self-help groups for addicts continues to be small in Austria, and pertinent 
initiatives are primarily started by relatives of addicts. For instance, there are parent groups 
organised in the Federal Association of Groups of Parents of Person in Danger of Addiction 
and Drug Addicts. This association provides cost-free counselling and assistance in all fields 
of addiction prevention and supports evaluated projects, especially in public and private kin-
dergartens and primary schools. 
Alternatives to punishment are included the general drug assistance system. ÖBIG’s pilot 
study (ÖBIG 2001) has shown that approximately 60% of the outpatient centres and almost 
all inpatient short- and long-term treatment departments specifically address also clients who 
receive care and treatment in the context of alternatives to punishment (in line with the prin-
ciple of therapy instead of punishment). 
  51
10 Quality Assurance 
Quality assurance procedures continue to play an increasingly important role in the field of 
drug-specific demand reduction, and many projects are implemented. The guidelines for the 
announcement of drug centres under Art. 15 of the NSA (cf. Chapter 8.1) and the guidelines 
for addiction prevention by police officers (cf. Chapter 9.5) have already been mentioned. In 
addition the Austrian Working Group for Addiction Prevention has drawn up guidelines for 
peer education in primary prevention. Similar activities have also been started in many Aus-
trian provinces (cf. ÖBIG 2000a) and institutions. For instance, the Ludwig Boltzmann Insti-
tute of Addiction Research, in cooperation with the Addiction Prevention Units, has devel-
oped the new philosophy statement of the Austrian Addiction Prevention Units, which in-
cludes basic positions as to central issues and profiles of institutions as well as a definition of 
the tasks of the Units, basic strategies and guidelines for professionalisation (Uhl und 
Springer 2001). The Vienna Social Projects Association is also drawing up its philosophy 
statement. The current Total Quality Management Project of the Drugs Institute at the Otto 
Wagner Hospital of Vienna, based on the European quality management model of the 
EFQM, is another example of measures at institutional level. Initial results are available for 
the subjects of strategy, philosophy and client satisfaction. In addition the report on employee 
satisfaction has recently been completed (Dirscherl et al. 2000). 
Evaluation of projects and activities is another relevant measure of quality assurance and is 
becoming a standard instrument in the field of drug help. The data of ÖBIG’s pilot study 
shows that about 20% out of the total number of 105 registered outpatient centres carry out 
evaluation and research projects (ÖBIG 2001). The funds for evaluation studies are still lim-
ited however. The guidelines for the announcement of drug centres mentioned above also 
take cost aspects into account: although evaluation and monitoring are defined as important 
measures of quality assurance, in consideration of staff and financial capacities evaluation is 
not obligatory (ÖBIG 2000b). For projects receiving financial support by the Healthy Austria 
Fund evaluation continues to be obligatory, however, and it has shown that this funding in-
strument has been used more and more often. The evaluation of the further training pro-
gramme Quality assurance of work with drug addicts and in the field of addiction prevention 
(cf. Chapter 9.5) drawn up by an research institute outside the university system is one ex-
ample. The Vienna Job Exchange and its strategies and methods that have been developed 
and implemented for the purpose of occupational rehabilitation of addicted patients are also 
being evaluated externally. Another current evaluation analyses the activities of the Criminal 
Police Information Service and the effects of its interventions with regard to problems with le-
gal and illegal drugs at schools. As has already been described in the report of last year 
there is a trend towards cooperation with universities or affiliated research centres, which 
makes it possible to draw up evaluation studies in the context of (diploma) theses. Evaluation 
continues to be a central issue in the training of drug experts. The quality circle evaluation, 
started in the beginning of 2000 for the target group of drug experts, has been continued in 
the reporting period and the commitment of the participants has remained high. For further 
details regarding evaluation of drug treatment programmes please see the corresponding 
key issue chapter of this report (cf. Chapter 12.2). 
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In addition to evaluation studies various research projects are conducted in the field of de-
mand reduction (cf. Chapters 2.2 and 2.3). A project worth mentioning with regard to current 
monitoring studies is Living Together: Regional addiction prevention in the context of work 
with children and youths within and outside schools in urban areas. Apart from the research 
institutes traditionally specialising in addiction issues (cf. ÖBIG 2000a) the Interdisciplinary 
Addiction Research Unit at the University of Vienna will be established as an interfaculty re-
search unit designing and implementing new research strategies. 
Training for professionals constitutes another central aspect of quality assurance and has 
been expanded continuously in the last few years (cf. Chapters 9.1 and 9.5 as well as ÖBIG 
2000a). This is also confirmed by the results of ÖBIG’s recent pilot study according to which 
the vast majority of drug centres registered have regulations concerning further training of 
their staff (ÖBIG 2001). In the Tyrol, in cooperation with partners from South Tyrol, the uni-
versity course Professional work in the field of work with addicted patients has been re-
peated. The course is run in line with European standards in the field of education and train-
ing with regard to addiction. Participants may obtain an additional expert qualification in the 
fields of primary, secondary and tertiary prevention. The Federal Teacher Training Academy 
of Upper Austria established a training scheme on addiction prevention of approximately 200 
lessons, which provides comprehensive basic education in the field of prevention. The edu-
cational network Healthy Austria Fund, assisted by the Vorarlberg Addiction Prevention Unit 
SUPRO, is aimed at facilitating the work of practitioners in the field of health promotion and 
care as well as supporting their competences and resources (SUPRO 2001). Apart from the 
activities mentioned a large number of further training schemes, courses and conferences for 
drug experts exist which cannot be described in detail here. 
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11 Poly-drug use 
Poly-drug use is the consumption of several substances, either successively or at the same 
time. The more or less simultaneous use of different substances is also called mixed drug 
use. In Austria poly-drug use is the prevailing consumption pattern, which is encountered in 
drug addicts more frequently than the consumption of one substance alone, leading to multi-
ple dependencies. In the following section, poly-drug use denotes the multiple or mixed use 
of several (illegal) substances.  
11.1 Patterns and users groups 
In Austria, there are two relevant groups of poly-drug users: 
• Members of the first group are (young) drug users who experiment with various sub-
stances in their leisure time; they are not considered addicts and their drug consumption 
is mostly limited to a certain phase in their lives. 
• Members of the second groups are persons associated with the drug scene, who show a 
poly-drug use pattern in their dependence on drugs.  
These two groups differ fundamentally as to the type of substances they prefer and the envi-
ronment where drug consumption occurs. 
Data on the first group has been collected for several youth studies, which were however not 
representative. One example is the Vienna pilot project ChEck iT! which inquired among rav-
ers about their experience of drugs and their drug use patterns. Among the 346 respondents 
the consumption of various substances is frequently encountered. Young people who said 
they had consumed ecstasy at least once in their lives also indicated to have tried cannabis 
(97%), speed (92%) and LSD (70%). Speed users among the respondents also have a high 
prevalence for the above substances: 94% have tried cannabis at least once, for ecstasy and 
LSD the corresponding shares are 88% and 68%, respectively (Kriener et al. 1999).  
However, these substances are not always used simultaneously. The majority of respon-
dents indicated they never use a combination of ecstasy and cocaine, and rarely combine 
ecstasy and speed. The substances are bought from friends or acquainted dealers and pref-
erably used in the company of friends at raves and clubbings, in a setting that remains un-
changed over long periods of time (Kriener et al. 1999).  
Also within the framework of the EU project "Drug affinity among youths in the techno party 
scene in European metropolises" (Tossmann et al. 1999) data was collected at techno 
events in Austria, i. e. in Vienna and in the province of Vorarlberg, to obtain complementary 
evidence from a mainly rural area. For Vienna, the results of this study were in many ways 
comparable to that of the ChEck iT! project. The 489 respondents in Vorarlberg, on the other 
hand, generally indicated less experience of illegal drugs (cannabis: 59%, ecstasy: 32%, 
speed: 26%, hallucinants: 23%, cocaine: 16%) than the 505 respondents in Vienna. It may 
be assumed that half of all drug users in the techno party scene currently follow poly-drug 
use patterns. The most prevailing combinations all contain either cannabis or ecstasy; the
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main combination with ecstasy is cannabis and alcohol. Similar to hallucinants and opiates, 
cocaine plays a minor role in this group of drug users (Tossmann et al. 1999). 
Information on drug experiences in specific youth scenes is also documented by a study on 
the importance and use of psychoactive substances among Austrian youths (Springer et al. 
1999). Among the four groups that were examined in this study (ravers, fun sports activists, 
members of youth associations, control group), ravers were found to have the strongest ten-
dency to experiment with illegal drugs (e. g. cannabis: 82%, ecstasy: 64%, stimulants: 54%, 
cocaine: 42%, LSD: 40%, sedatives: 20%), followed by fun sports activists (cannabis: 76%, 
ecstasy: 10%, stimulants: 20%, cocaine: 22%, LSD: 24%, sedatives: 26%), while the other 
two groups are less inclined to take illegal drugs. From the indicated shares it may be con-
cluded that poly-drug use occurs also in this case. However, the shares for all illegal sub-
stances were much lower in all groups when asked to indicate illegal drug use within the past 
three months. For instance, cannabis use was only reported by 72% of the ravers and 60% 
of the fun sports activists; the corresponding share for ecstasy use is 42% and 4% respec-
tively, for stimulants, 41% and 2% respectively and for cocaine, 12% and 4% respectively. 
Members of the other two groups do not name ecstasy or cocaine at all in this context. This 
confirms the observation that poly-drug use is limited to certain phases in life. 
While cannabis users also smoke their joints at home by themselves, ecstasy, stimulants, 
cocaine, LSD and other drugs are consumed in the company of friends, particularly at rave 
parties, and stimulants are specifically used against tiredness in such settings. When asked 
why they were using drugs young people said drugs would get them in a good mood (canna-
bis, ecstasy), make them feel happy (ecstasy, LSD, cocaine, stimulants), improve their per-
formance (stimulants, cocaine) and expand their state of mind (LSD, ecstasy); (Springer et 
al. 1999).  
In this context it should again be pointed out very clearly that for the studies discussed 
above, a very specific youth sub-culture with a high drug affinity was examined and the stud-
ies do not claim to be representative in any way. In the total population of youths, experience 
of illegal drugs is encountered much less frequently (cf. Table A1 in Annex B). 
Data collected on the second group - members of the drug scene with a poly-drug use pat-
tern - in several interview studies with drug addicted persons and among the street scene 
show that mixed consumption is very pronounced in this setting. One example is the inter-
view study of the Vienna street scene commissioned by the Ludwig Boltzmann Institute for 
Addiction Research a few years ago (Uhl und Springer 1997), where during the first stage, 
52 "experts" (counsellors, opiate (ex-)addicts, members of the police) were interviewed and 
during the second stage, 150 drug users among the street scene were chosen as interview 
partners. The majority of respondents indicated a high degree of poly-drug use, i. e. they 
consume a broad range of psychotropic substances (opiates, cocaine, cannabis, sleeping 
pills and tranquillisers, amphetamines, designer drugs, alcohol). With regard to the different 
stages of a drug career it turned out that at the initial stage, cannabis (65%), alcohol (48%), 
tranquillisers (41%) and heroin (26%) play a major role. When the entire drug career is con-
sidered, a remarkably high indication of use of many substances becomes apparent (e. g. 
cannabis: 85%, heroin: 84%, tranquillisers: 71%, alcohol: 56% and cocaine: 52%). Pro-
nounced poly-drug use patterns are also indicated for the six previous weeks.  
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In a study of the Vienna hospital connection service CONTACT (Seidler 2000) half of the 90 
respondents indicated several substances when asked for their current main drug. 60% said 
they used hard drugs (52% morphines, 42% heroin, 22% cocaine, 22% benzodiazepines), 
13% consumed substitution medicine and 27% other substances. When asked for the hard 
drugs they had consumed within the past 24 hours, 42% named morphine tablets, 34% her-
oin, 24% methadone and said they had taken cocaine (61% intravenous use, 50% intrave-
nous use mixed with heroin - speedball). 
In a survey carried out among opiate users in the Vienna low threshold facility Ganslwirt and 
in the street scene in 1996, all of the 59 interviewed persons said they used several drugs. 
44% reported to use heroin every day; for methadone, everyday use was reported by 31%, 
for cannabis, by 21% and for cocaine and benzodiazepine by 15% respectively (Seidler 
1997). 
A study carried out by Caritas Innsbruck in 1999 shows that the majority of the target group 
for a health room (users’ room) in Innsbruck had used opiates for several years and habitu-
ally used several psychotropic substances at the same time. The prevalent mode of applica-
tion for morphine derivatives in this group was intravenous use (Caritas der Diözese Inns-
bruck 1999).  
The increase of poly-drug use in Vienna becomes apparent in the results of a retrospective 
survey done at the intensive care unit of the University Hospital of Psychiatry at the General 
Hospital in Vienna. In the period from 1989 to 1995, the number of poly-drug users among 
the patients admitted for withdrawal treatment was over 50%, while the corresponding figure 
for 1980/81 at the same unit was approximately 14% (Wagner et al. 1999). 
Similarly, the annual reports of activities of the association Grüner Kreis for the years 1996 
and 1997 demonstrate the high incidence of mixed drug use among its clients. Before ther-
apy was started, there was a high percentage indicating heroin use (approximately 50%), 
hashish (approximately 45%), tranquillisers (approximately 35%), cocaine (approximately 
35%), alcohol (approximately 40%) and opiate substitutes (approximately 35%). Different 
from adult poly-drug users, who preferred opiates and tended to use other drugs - mainly al-
cohol and cocaine - only on the side, young people seemed to favour amphetamines, LSD 
and ecstasy (Grüner Kreis 1997 and 1998; cf. also Chapter 2.3). 
A new development has been observed in the street scene, where cocaine has been intro-
duced because of its rapidly decreasing price and is used intravenously, often together with 
heroin (speedballs), to potentiate its effects. This pattern of use, where cocaine and heroin 
are injected simultaneously, is becoming more and more frequent. For Vienna, the estimated 
number of speedball users is 300 to 400 (Strobel & Silbermayr 1999; cf. also ÖBIG 2000a). 
In the province of Vorarlberg it was also observed that cocaine is used intravenously in a 
growing number of cases (Boss et al. 2001). 
For Vienna, data is available for various different scenes; on the illegal drugs market, the 
prevalent pattern of use is the so-called 'Vienna blend', a combination of alcohol and tablets, 
tranquillisers and sleeping pills, with amphetamines, hashish and hard drugs, if available on 
the illegal market (Brosch et al. 1993). 
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In the scene around Karlsplatz in the centre of Vienna, the most frequently used drugs are 
preparations containing morphine, sleeping pills and tranquillisers, with intravenous use as 
the prevalent pattern. At Südtiroler Platz the scene members mainly use heroin, cocaine or a 
mixture of both. Beside intravenous use, which is a frequent pattern for this scene, chinesing, 
which is rather uncommon in Vienna, has also been observed (VWS 2001b). 
11.2 Health and social consequences 
Poly-drug use, which is a frequent pattern among Austrian drug users, is accompanied by 
severe health and social problems. As to the individual discharge diagnoses for patients 
leaving the hospital after inpatient treatment, it was observed that the number of cases clas-
sified as "poly-drug users including morphine consumers" rose from 1,319 in 1995 to 1,768 in 
1999, which is a 32% increase; the annual share of men was slightly over two thirds. The 
number of admission for inpatient treatment on account of the diagnosis "poly-drug use ex-
cluding morphine" decreased from 608 in 1995 to 459 in 1999; here the annual share of men 
was around 60%. In comparison, the number of admission of patients diagnosed with "drug 
addiction/morphine" was 399 in 1995, reached a peak of 491 cases in 1997 and declined to 
351 in 1999 (calculations by ÖBIG). 
The share of poly-drug intoxication among the drug-related deaths caused by intoxication 
was 48% in 1995, experienced a continual rise and reached 90% in the year 2000; one-fifth 
were women. The problem of mixed consumption also becomes evident in cases of drug-re-
lated deaths among young users. In autopsy several psychotropic substances, or alcohol 
and/or psychoactive pharmaceuticals in addition to one or more psychotropic substances 
were found in 15 of 19 cases (cf. Chapter 3.2 and Table A5 in Annex B). 
In the course of the interview study mentioned in Chapter 11.1 that was carried out among 
opiate users in Vienna in 1996, heroin turned out to be the substance most frequently con-
tributing to overdoses, with 59%. However, only in 24% of the cases heroin was used exclu-
sively, while 35% of the overdose cases were caused by a mixture of heroin and other drugs, 
mostly benzodiazepines or cocaine (Seidler 1997).  
The treatment of poly-drug users poses specific problems. As a large number of patients of 
the drug outpatient department at the General Hospital of Vienna abuse several substances 
at the same time, it can be difficult to interpret reported and observed symptoms correctly. 
For example, in spite of receiving a sufficient dose of opiates patients in opiate maintenance 
therapy may suffer from withdrawal symptoms if they have also misused alcohol or benzodi-
azepines (Drogenambulanz 1999). 
Apart from the above information, no data relating to specific health consequences of poly-
drug use is available in Austria. However, since it can be assumed that most drug addicts are 
poly-drug users, the data and information on morbidity contained in Chapter 3.3 also applies 
to poly-drug consumers. 
According to the Vienna based counselling and care centre dialog, which opened in 1999, 
the share of persons showing both psychiatric symptoms and pronounced poly-drug use is 
remarkably high among their clients. This can partly be explained by the fact that patients of 
this type have a particularly great tendency to drop out of existing counselling services, pri-
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marily in established doctors' practices, but in some cases they are also specifically referred 
to dialog. In this context it should be mentioned that psychiatric symptoms and poly-drug use 
are often interlinked, as patients with personality disorders or chronic anxiety symptoms es-
pecially tend to resort to "self-treatment" with psychoactive substances (dialog 2001; cf. also 
Chapter 3.3).  
In the course of medical care for drug-addicted prisoners in the Vienna police prison it turned 
out that the majority of drug addicts who suffer from withdrawal symptoms during their prison 
term, have shown poly-drug use patterns (involving opiates, benzodiazepines, alcohol, co-
caine) and must receive corresponding treatment. In many cases these patients are in bad 
health, they have lived in unstable social circumstances and do not receive regular treatment 
or care. This is especially true of women, who are often illegal sex workers in order to pro-
cure drugs, which makes them a high-risk group regarding their health. In most cases they 
are not incorporated in the social insurance system, so they can neither seek medical help 
nor substitution treatment free of costs (dialog 2000, cf. also Chapter 13).  
In a catamnestic study carried out by the Anton Proksch Institute, 100 clients were examined 
with special regard to psychiatric co-morbidity (Wirth 2001; cf. also Chapter 12.2). Apart from 
problems connected to their alcohol and drug use the examined clients were also under 
great pressure in other spheres of life. Problems were connected in particular to family and 
social life, work and financial obligations, and the housing situation. More than half of the re-
spondents had incurred substantial debts. Further information on social problems connected 
to drug use are included in Chapter 4 and in the Report on the Drug Situation in Austria 2000 
(ÖBIG 2000a). 
 
11.3 Risk assessment and local market  
The combination of two or more psychotropic substances within a short period of time leads 
to severe physical and psychological stress conditions and increases the risk of dangerous 
incidents. The effects triggered by a combination of two or more substances are hard to as-
sess and usually do not correspond to the sum of the single effects of each substance added 
up. According to the substances involved, the effects can potentiate or reinforce each other, 
as in the case of speed combined with cocaine or GHB combined with alcohol, or they act on 
mind and body in two opposing ways, as in the case of cocaine and alcohol. Both phenom-
ena put the body in an extremely stressful condition. Combinations of downers with other 
downers or stimulants with other stimulants are particularly dangerous. For instance, amphe-
tamines and cocaine are often used to delay the effect of "coming down". But as a conse-
quence, the hangover is worsened and the risk to be exposed to deliriums and hallucinations 
is increased (http://www.CheckYourDrugs.at).  
While , stimulants and hallucinants are frequently used in the rave scene, poly-drug use in-
volving opiates is very common in the drug scene (cf. Chapter 11.1). The modes of admini-
stration correspond to the single drug use patterns that apply to the drugs involved (cf. Chap-
ter 5).  
In a study carried out by the Vienna Social Projects Association in cooperation with the uni-
versity of Vienna (Haltmayer et al. 2001), the residues in used syringes were chemically ana-
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lysed. The analysis of residues from 753 syringes yielded information as to the nature, distri-
bution and impurity of intravenously injected substances in Vienna. It was found that the in-
travenously consumed substances contained a variety of additives. For example, 58% of the 
heroin samples from the examined syringes were mixed with cocaine, and 52% with caffeine. 
Apart from deliberate combinations, injected substances were found to contain a number of 
additives (cf. Chapter 5) of which users are completely unaware, and some of these additives 
can have detrimental effects on the health of the users. Because of the nature of the black 
market users have no way to check the quality of the substances acquired for intravenous 
consumption (VWS 2001a). 
Data relating specifically to the market situation is scarce. For further details see Chapter 5.  
11.4 Specific approaches to the interventions 
In the same way as care and treatment, prevention in Austria follows a comprehensive ap-
proach which does not relate to specific substances. As a consequence of this approach, 
and in view of the fact that a great part of the Austrian drug addicts are poly-drug users, 
(nearly) all the drug help services and facilities are open to poly-drug users and attend to 
their specific needs. In the following section only a small number of individual examples out 
of the broad range of existing offers is selected for discussion. 
For the interventions to be effective it is necessary to distinguish between the two groups of 
users described in Chapter 11.1, young experimenting consumers and members of the drug 
scene applying poly-drug use. In this context it should be mentioned that poly-drug consump-
tion does not necessarily cause addiction. 
One of the services designed for the first users group is the ChEck iT! project, which has al-
ready been described in preceding sections. In this project substances are directly tested at 
rave parties, which is combined with other secondary prevention and harm-reducing meas-
ures. For the purpose of harm reduction ravers are expressly warned against poly-drug use 
and especially mixed consumption of various substances. According to the experts involved, 
in the future it would be appropriate to complement this secondary prevention measure for 
consumers of party drugs by a round-the-clock information and counselling service, where 
the ingredients of substances could be tested and contact to this consumer group could be 
established on a regular basis. 
In a number of provinces, services for youths in danger of becoming addicted have been set 
up (cf. Chapter 8.2 and 9.2), with a growing emphasis on outreach work and mobile drug and 
youth work (e. g. in parks, youth centres etc.). For this kind of services it is of great impor-
tance to offer highly attractive experiences in order to motivate youths to participate actively 
and thus to increase the chances of success (i. e. to achieve a high degree of satisfaction 
while minimising problematic social behaviour). In practice this means to communicate to 
kids the kick and the fun they will get out of taking part in the action, and to increase this ef-
fect by making them anticipate collective chances of success, taking into account the high 
group identification of young people (Wilfing 2001). 
As to the second group, apart from adequate therapeutical care, the measures in the field of 
social (re)integration, infection prevention and substitution treatment need to be expanded. In 
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response to the widening range of drug symptoms of its clients, the Erlenhof therapy centre 
(cf. Chapter 2.3) has reorganised and accordingly differentiated its treatment approaches 
(Therapiestation Erlenhof 2001, Chapter 9.3). 
As an example of the great relevance of social reintegration measures for longer-term stabil-
ity or abstinence from (illegal) drugs, the Vienna assisted housing project is worth mention-
ing. In this project assisted housing is provided for persons who are affected by social disin-
tegration and homelessness because of their (in most cases long career of multiple) drug 
use. In the period between 1996 and 2000, 39 clients left the assisted housing facility, in half 
of the cases with a successful outcome. Another 13% left prematurely, with a positive per-
spective. For 19 persons there is evidence of a change in consumption patterns. The number 
of abstinent clients was increased from three to seven, the number of persons who achieved 
substitution without parallel drug use rose from one to eleven (VWS 2001d, Chapter 9.4). 
This shows how increasing the stability of social factors can pave the way towards drug ab-
stinence. 
A new service of special relevance for poly-drug consumers suffering from addiction has re-
cently been created in Vienna. In order to close a supply gap with regard to crisis interven-
tion, a specific care service operating on weekends and holidays was opened. This service is 
designed for everyone in urgent need of help in connection with drugs. It is also open to sub-
stitution treatment clients in need of a substitution substance. Patients can call a telephone 
help line and are then referred to one of the three round-the-clock facilities, Ganslwirt, the 
drug outpatient department at the Otto Wagner Hospital, or the Doctors' Emergency Service 
(Der Standard 2001). 
11.5 Methodological issues 
In Austria, data relating specifically to poly-drug use is scarce. However, it has already been 
mentioned that existing data can be considered significant for poly-drug use, which is the 
prevailing consumption pattern. 
With the implementation of the harmonised key indicators set up by the EMCDDA, the data 
situation might substantially improve over the next few years. This is primarily true of the im-
plementation of the Treatment Demand Indicator by introducing a uniform client documenta-
tion system (cf. Chapter 3.1). However, what is still lacking is a way to account for poly-drug 
use; at present, one drug has to be identified as main drug. Regarding the key indicator 
Prevalence Estimates of Problem Drug Use considerations about the possibilities for estimat-
ing the prevalence of poly-drug use and problem drug use without opiates will be continued, 
because at present only estimates of problematic opiate use are available. As to the key in-
dicator Drug-related Deaths, the data analysis in Austria has already been changed in favour 
of a more detailed representation of intoxication indicating several substances involved (cf. 
Chapter 3.2). A discussion of measures to improve data quality, especially with regard to the 
gathering of detailed information on the substances involved and their combinations, is 
scheduled for autumn 2001. 
The gradual adaptation of hospital discharge diagnoses from ICD-9 to ICD-10 is also ex-
pected to have a positive effect on the data situation, as poly-drug use can be better classi-
fied according to the ICD-10 system.  
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12 Successful treatment3 
To determine the success of drug-related or addiction-specific treatment is rather complex for 
methodological reasons (cf. also Chapter 12.3). Even the concept of treatment is hard to de-
fine, so it is all the more difficult to decide whether a treatment measure has been successful. 
Against this background a pragmatic approach was chosen for the presentation of the follow-
ing Key Issue Chapter. In this context treatment comprises medical, psychological, psycho-
therapy and/or social work measures over a longer period of time based on an agreement 
between a client and a care institution with the aim of improving the individual drug or addic-
tion problem and the general life situation of the client. Whether these measures have been 
successful is determined according to the degree in which the set goals have been reached. 
It should be added that such goals should not only be defined for the individual client, but 
also at the level of institutions, where the general framework for therapy planning is provided. 
12.1 The approaches to the treatments and the related 
concepts of success 
In Austria a high degree of diversification of drug help measures was registered over the past 
decade. Also in the field of treatment a great variety of services and concepts have been de-
veloped regarding the target groups (e. g. specific services for drug-addicted mothers and 
their children), the care setting (inpatient/outpatient facilities, short-term/long-term therapy, 
care in prisons) and the objectives as to drug consumption (abstinence, controlled use, sub-
stitution). However, treatment services have hardly differentiated according to the drugs con-
sumed, with the exception of substitution treatment, which has only been possible for opiate 
users. But because of the common occurrence of poly-drug consumption patters (cf. Chapter 
11) among problem drug users in Austria it would be inappropriate to speak of substantially 
different target groups according to the drugs used.  
Before discussing the question of how to define success, we will outline the most relevant 
treatment approaches.  
In Austria, substitution treatment is the treatment of persons addicted to opiates, with a sub-
stitution substance. The duration of treatment is not limited. Apart from methadone a number 
of other pharmaceuticals are increasingly applied. According to the Substitution Decree, HIV-
infected addicts and pregnant women are defined as target groups, but the treatment is open 
to all users who have been addicted for more than a year and who have tried withdrawal or 
detoxification treatment, but failed. In Austria substitution treatment is provided primarily as 
an outpatient service; in addition to the drug help facilities, established doctors play a major 
role in this respect (for a detailed discussion cf. ÖBIG 1999).  
 
 
 
 
 
3 We are especially indebted to the members of the Quality Circle Evaluation, whose fruitful discussion 
of the concept of success in the context of drug help has been a valuable contribution to this Chap-
ter. 
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Contrary to substitution treatment, detoxification treatment is directly abstinence-oriented and 
aims at releasing the client from the bonds of the addictive substance by means of psycho-
logical, social and medical support and by replacing these bonds with objectives and habits 
that seem appropriate in the context of the client's biography. Detoxification treatment follows 
withdrawal treatment, which ends when physical withdrawal symptoms have ceased. Some 
services provide both stages of treatment in combination, in other cases they are offered 
separately. In Austria there is generally no restriction of the target group of detoxification 
treatment according to the drugs consumed, but the willingness of clients to be abstinent is a 
prerequisite for treatment. Detoxification treatment is offered by inpatient and outpatient 
facilities. In the inpatient sector in Austria, well-established long-term therapies with a 
duration of usually 12 to 24 months have been offered for decades. In the last decade, this 
offer has been complemented by a number of short-term therapy facilities providing 
treatments of usually six months duration. They are primarily aimed at (young) drug users 
with a short career of drug use who are socially integrated, and at addicts who have not been 
motivated to go in for long-term therapy. In the outpatient sector, there is a great number of 
therapy services which can be adapted to the individual needs of clients according to the 
specific setting (cf. also Chapter 9.3). 
These two treatment approaches only reflect two broad lines of orientation which become 
manifest in a variety of therapy strategies that differ according to the facility offering treat-
ment and cannot be discussed in detail here. In the context of certain target groups treatment 
approaches become more specific. One example is drug-addicted mothers (cf. ÖBIG 1999 
for a detailed discussion), for whom specific services are provided both for substitution treat-
ment and for detoxification treatment. Both types of treatment are also available to drug us-
ers in prison (cf. Chapter 13). 
The concept of success of treatment can be derived both from policy objectives and from 
the overall aims of drug help or the specific aims of individual facilities. In the provincial drug 
plans (cf. ÖBIG 2000a for a detailed discussion), which provide the framework for the plan-
ning of health policy measures at the provincial level, the reduction of health and social harm 
is defined as the overall objective of drug policy. To meet this objective, measures including 
prevention, therapy and accepting assistance have been devised. Based on the view of drug 
addiction as a disease in a psychosocial context, which has also been set down in the Nar-
cotic Substances Act, this approach calls for comprehensive and integrative measures taking 
into account the general context in which addiction occurs.  
These criteria of success are reflected at the level of drug help, as the specific aims of the 
various services offering treatment can all be summed up in the term "improving the quality 
of life" for clients. This includes a variety of aspects such as work, housing, income, social re-
lationships, health, crime prevention and legal advice, psychological and physical well-being, 
leisure time activities, identity and self-image, among many others. Social reintegration is 
named very frequently as an aim of working with clients. The focus on the relevant goals also 
results from the specific target groups and settings. While crime prevention is an important 
goal when working with clients who have committed offences, for the treatment of drug ad-
dicted mothers or parents a stable parent-child relationship will be among the goals of imme-
diate relevance. This demonstrates that the consumption pattern of clients is one aim among 
many others, and it follows that the success of treatment cannot be decided exclusively or 
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primarily on the basis of drug use. Yet drug use is one of the main characteristics according 
to which therapy approaches can be distinguished. While substitution treatment is aimed at 
changing the consumption pattern in favour of legal and controlled use, detoxification treat-
ment is oriented towards abstinence from (illegal) drugs.  
When talking about the success of treatment it is also necessary to define one's perspective. 
Based on the concept of addiction as a chronic disease which must be seen in its overall 
context, the continuity and the network of various services and facilities play an important 
role. In most cases an isolated care element will not suffice, especially if long-term and sus-
tainable success is to be guaranteed. To name an example, the success of abstinence-
oriented therapy will hardly last if aftercare measures, such as assistance in finding housing 
and work, are inadequate. From this point of view, treatment is only one component in a mo-
del of continuing care ranging from outreach work and low threshold services to social reinte-
gration measures. Moreover it is well-known that abstinence from drugs in most cases can 
only be achieved after several therapies or attempts at therapy. For this reason, the discus-
sion of the success of treatment should distinguish between the micro-level of individual fa-
cilities and services and the macro-level, i. e. the network of help services available to drug 
addicts, which not only includes drug-specific measures but also general health and social 
policy interventions. 
In the view outlined above there is no contradiction between the political and the professional 
definition of success. The existing drug policy strategies also recognise addiction as a 
chronic disease which requires diversified, client-specific measures. Whether treatment can 
be called successful is therefore a matter of identifying the respective objectives of care and 
goals of the drug help system, where abstinence, or controlled use of drugs, is but one as-
pect among many.  
12.2 Evaluation of the treatments 
In the light of the above considerations on the objectives and the concept of success, to de-
termine the success of treatments in Austrian drug help is possible only to a very limited ex-
tent. The evaluation of drug-specific treatments has only started to develop more visibly over 
the last decade. At the beginning of the 1990s there were two evaluation studies on a larger 
scale, both on substitution treatment, both characterised by the comparative novelty of this 
type of treatment and the corresponding challenge of success. Since the mid-1990s a grow-
ing number of research projects in the field of treatment have resulted in evaluation studies 
or monitoring studies on specific issues. In ÖBIG's pilot study cited above (cf. Chapter 3.1) 
one fifth of the 105 examined outpatient services and two thirds of the 13 examined inpatient 
facilities reported they were conducting research projects; evaluation studies were named 
most frequently by both types of facilities (ÖBIG 2001).  
However, it remains difficult to present an overview of the success of the various types of 
treatment or of the entire drug help system. Only a limited number of completed evaluation 
studies are available, as many projects are still running and the comparability of results is re-
stricted (cf. also Chapter 12.3). However, there is hope that the situation will change for the 
better in a few years time; acceptance of evaluation as a quality standard in drug help has 
been growing, and at the same time the first comparative studies have been initiated. One 
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example is the joint evaluation plan of the short-term therapy services Haus am Seespitz (Ty-
rol) and Lukasfeld (Vorarlberg), which has been the basis for a comparative catamnestic 
study (evaluating the final after-treatment reports) carried out since summer 1999.  
In the following section, a summary of the hitherto available research results in the field of 
treatment will be presented. While the focus is on evaluation studies, complementary results 
of monitoring studies on specific issues will also be presented, as they may represent clues 
to the success of treatments or to criteria that might be relevant for success. 
It has already been mentioned that the first evaluation results available in Austria were ob-
tained in the field of substitution treatment in the early 1990s (cf. also ÖBIG 1999). In  
1989/90 Uhl et al. (1992) interviewed a total of 121 patients and 35 experts about their ex-
perience with oral substitution treatment. The clients were asked to compare their life situa-
tion in the three months prior to substitution treatment with that of the three months preced-
ing the interview. The results were mainly positive: the income situation had stabilised, which 
was revealed by marked declines of illegal forms of income acquisition, among other factors. 
The number of reports to the police had decreased, whereas the state of health had im-
proved. In 1990 Rittmannsberger et al. (1994) conducted a study on experiences over the 
first three years of methadone substitution programmes in Upper Austria, which involved 81 
clients. Some positive developments were registered, e. g. increase in gainful employment 
(from 20% to 41%), decline of criminal activity and good compliance of HIV-positive patients 
regarding infection monitoring and treatment. Clients also gave an overall positive assess-
ment of their psychological and physical state and of the therapy programme as a whole. 
Over the past few years a number of monitoring studies and comparative studies involving 
various substitution substances have been published, especially by the University Hospitals 
in Vienna, where the focus has been on the substitution treatment of pregnant addicts (see 
below), and Innsbruck.  
In a comparative study carried out in Innsbruck, clients using methadone, morphine sulphate 
and buprenorphine as substitution substances - 30 of each group - were examined with re-
gard to physical side effects (Opiate Withdrawal Score). For all examined criteria, morphine 
sulphate had the strongest side effects (somatic and general side effects), while buprenor-
phine showed best results especially as to general symptoms (lack of energy, attacks of 
anxiety, depression, etc.) (Giacomuzzi et al. o.J.). In another comparative study focusing on 
the quality of life of 30 clients using methadone and 30 clients using morphine sulphate as 
substitution substances, the Lancashire Quality of Life Profile (LQLP) was applied. Also in 
terms of objective data, the methadone group was found to have an overall better quality of 
life, with marked differences to the morphine sulphate group especially among women. There 
were no marked differences as to parallel consumption of illegal substances. However, the 
significance of the results is limited by the fact that HIV prevalence was markedly higher in 
the morphine sulphate group (33.3% vs. 6.7%) (Giacomuzzi et al. 2001). In a diploma thesis, 
selected items of the Frankfurt Self-Concept Scale were used to investigate the effect of 
substitution with buprenorphine (n = 30) and methadone (n = 23) on self-esteem. It was 
shown that substitution treatment had a stabilising effect, as in both groups the feeling of 
self-esteem was found to have increased over a period of six months after therapy had be-
gun (Dinich 2001). 
Successful treatment 
 66 
In the field of detoxification treatment evaluation results have primarily been obtained in 
the inpatient sector. In 1995/96, the therapy department Lukasfeld (Vorarlberg) effected an 
evaluation based on the comparison of 25 abstinent and 31 relapsed former clients applying 
theAddiction Severity Index (EuropASI), the LQLP and the Frankfurt Self-Concept Scale. It 
turned out that abstinent ex-clients could cope better with their psychosocial problems, they 
showed a higher frustration tolerance and better handled their everyday lives, their jobs and 
the relationship with partners than clients who had relapsed. But also among the abstinent 
group, two years after completing therapy 70% reported they still had depressive symptoms 
requiring psychiatric treatment or psychotherapy (cf. also EDDRA).  
In a catamnestic study carried out by the Anton Proksch Institute (API) 100 clients with poly-
drug consumption patters were examined with special regard to psychiatric co-morbidity. At 
the time of first data collection all clients were undergoing withdrawal therapy, subsequently 
70 patients changed over to long-term therapy in the API, six chose the three-month short-
term therapy, and the remaining clients discontinued either withdrawal or short-term therapy. 
After the initial data collection in 1993/94, where a variety of test methods was used (e. g. 
EuropASI, DSM III-R, Global Assessment Scale), follow-up investigations were carried out 
after one year (n = 60), three years (n = 51) and six years (n = 32) according to EuropASI, 
with additional questions on individual spheres of life. Almost three fourths of the clients had 
personality disorders, 24% even multiple personality disorders (cf. also Chapter 3.3). 36% of 
the clients completed therapy, the others gave up prematurely. Among clients with multiple 
personality disorders, the tendency to drop out of therapy was significantly higher, while the 
clients who completed therapy were significantly older than those dropping out. The follow-up 
investigations revealed significant improvements in all spheres of life for the clients who had 
completed therapy (ASI-Ratings), with a tendency for improvements to continue over the 
years. Among the persons who had given up therapy prematurely there were no significant 
changes. After three years 69% of the clients who had completed therapy were abstinent (vs. 
24% of the clients who had dropped out), after six years, the share had even risen to 87% 
(while that of the clients who had dropped out went down to 17%). None of the clients who 
had completed therapy were ever imprisoned again, while the opposite was the case for one 
third of the clients who had not completed therapy, according to the follow-up investigation 
after 6 years. The author concludes that a treatment scheme with a focus on social and psy-
chotherapy interventions markedly increases the social competence and the subjective satis-
faction of the clients, which results in long-term stability (Wirth 2001).  
Also in the field of long-term therapy, a study is carried out at the therapy department Carina 
in Vorarlberg following the model of Lukasfeld (see above), while a long-term catamnestic 
study is effected by the therapy community Grüner Kreis (cf. also below). The Erlenhof ther-
apy department in Upper Austria has substantially altered its therapy schemes this year (cf. 
Chapter 9.3) and has plans for simultaneous evaluation while implementing the new scheme. 
From these projects, however, no data has been available yet. 
Results have been obtained from studies in the field of long-term treatment in prisons. In the 
therapy department of the prison of Innsbruck, in 1996/97 a total of 40 clients were investi-
gated as to therapy input and therapy outcome under a number of aspects, in particular de-
linquency and drug use. At the time of evaluation 8 clients were still undergoing therapy, 23 
had completed therapy and nine had been dismissed from therapy because they lacked mo-
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tivation. Of the 23 clients who had completed therapy, seven (31%) were abstinent from 
drugs at the time of evaluation, one client was undergoing long-term therapy, three clients 
were receiving substitution treatment, for four clients no information was available. Three of 
the nine dismissed ex-clients had died from overdose in the meantime. 19 (83%) of the 23 
clients who had completed therapy were released on probation before their original term of 
imprisonment was over, four of the same group were reimprisoned because they had again 
committed criminal offences. The authors conclude that addiction therapy in a "closed" envi-
ronment may present an opportunity, while pointing out that most of the abstinent clients 
went into outpatient aftercare and that the existence of aftercare services is essential for sus-
tainable therapy success (Prunnlechner-Neumann et al. 1998 and EDDRA).  
A specific focus of evaluation and monitoring research in Austria is on the treatment of 
drug-addicted mothers or parents and their children. In this context therapy goals not 
only refer to drug-addicted clients but also to their children. Over the last few years, the drug 
addiction outpatient clinic of the Vienna University Hospital has concentrated on examining 
the substitution treatment of pregnant clients, with a pilot project on pregnancy and drugs in 
Vienna (cf. ÖBIG 1999), applying primarily EuropASI and collecting data on the withdrawal 
symptoms of mothers and children (Finnegan Score). In a comparative study of 24 pregnant 
clients using methadone and 24 clients using slow-release morphines as substitution sub-
stances, both groups showed high compliance, a lower consumption of cigarettes and almost 
no gynaecologically relevant problems; most of them had vaginal births of healthy children 
with a satisfactory weight at birth. The parallel consumption of opiates was significantly 
higher in the group of methadone clients (50%) than in the morphine substitution group 
(21%). All the babies suffered from neonatal abstinence syndrome (NAS), with an average 
duration (16 to 21 days) that showed but slight variations (Fischer et al. 1999). Subsequently 
15 pregnant clients treated with buprenorphine as substitution substance were examined. 
They showed good compliance, a low degree of withdrawal symptoms, significant reduction 
of cigarette consumption and very little parallel drug consumption (9% positive opiate sam-
ples, 0% for other substances). No problems occurred during pregnancy, and all the children 
were born healthy. There were no, or rather mild, neonatal abstinence syndromes, only three 
babies had to be treated for a short period (one or two days). In this respect there was no dif-
ference as to the dose of buprenorphine, while the cigarette consumption among mothers 
with NAS-children was significantly higher (Fischer et al. 2000). 
Results have also been obtained from an evaluation pilot project carried out by the 
Rosenhügel Hospital in Vienna, where aftercare services for children have been established 
to minimise development risks. From monitoring research using a great variety of indicators 
(e. g. Neurodevelopment Scales, Ordinal Scales of Psychological Development, PIR-GAS, 
Axis 2) data is available on 110 children in aftercare. On the whole the biological develop-
ment risk of the children in aftercare (premature birth, weight at birth, head size, neurological 
syndromes and pathological spontaneous movements) was found to be low. The majority of 
the children aged 12 months had a normal psychological development, at 24 months retar-
ded development was found especially as to speech imitation. Only a small group of children 
had clinically relevant psychopathological disorders. At the age between three and five years 
a trend towards slightly reduced cognitive performance was registered. Whether the pro-
gramme can reduce the children's risk of developing an addiction will only be found out at a 
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later stage. In general the results obtained so far demonstrate that a comprehensive care 
programme can markedly reduce existing risks (cf. Elstner et al. 2000 and EDDRA).  
The treatment provided in the Parents and Children House of Grüner Kreis (cf. also Chapter 
9.6) is also under evaluation, which consists mainly in psychological testing of the children at 
different stages. First results have shown that the treatment programmes designed for the 
children facilitate improvement in the sense of compensating retarded development 
characteristics. In the course of therapy the children compensated behaviour deficits, while 
existing conspicuous behaviour declined. The relapse quota among formerly addicted 
parents following therapy is low, and their educational competence is strengthened in the 
course of therapy. From a subjective as well as an objective point of view, the quality of the 
relationship is considered to have improved (cf. EDDRA). 
The available data mentioned above neither allow for comprehensive statements on the 
success of treatments provided in Austria nor for a comparison of the different treatment 
approaches. However, summing up the available evaluations it can be stated that the 
examined treatments were successful in improving the quality of life of the clients. In many 
cases it has been possible to promote social reintegration, reduce delinquency and change 
the consumption patterns in the sense of achieving abstinence or stability. This is an impor-
tant contribution to the clients' quality of life and the prevention of health and social harm 
through drug use. Positive results have also been achieved with regard to specific goals, 
such as promoting the development of the children of drug-addicted parents. To conclude it 
should be pointed out once again that the success of treatments can only be viewed in the 
context of drug help as a comprehensive network of drug-related and non-specific services 
(e. g. established doctors, youth help services, etc.). This becomes apparent for instance in 
the high significance of aftercare for the success of drug therapy programmes in the prison at 
Innsbruck (cf. above). In the catamnestic study at the Anton Proksch Institute it was also 
found that a majority of the clients resorted to drug-related treatment and care before and 
after therapy. Therefore the success of treatment in a certain facility cannot be seen as an 
isolated phenomenon, but should rather be related to the entire system.   
12.3 Methodological issues 
The data situation in the field discussed above is still very deficient in Austria. This is not only 
the case with regard to results from (scientific) evaluations, but already starts with the lack of 
data on sociodemographic and addiction-related characteristics of the clients of drug help 
services. Because of this situation statements on the number and characteristics of drug help 
clients or specific changes over time cannot be compared on a nationwide scale (cf. Chapter. 
3.1). This is expected to improve after the key indicator Treatment Demand has been imple-
mented, which is planned. However, this key indicator only represents the clients' character-
istics at the beginning of treatment, so it does not provide evidence on the results and suc-
cess of treatment either.  
As mentioned in the introduction to this chapter, the issue of successful treatment poses a 
number of methodological problems, starting with its exact definition and positioning (see 
above). The selection of samples for highly significant evaluation studies is one major prob-
lem which is hard to solve because of the difficult access to the target group. Therefore some 
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studies used comparisons between clients who completed therapy and clients who discon-
tinued therapy (e. g. API), others have compared groups of abstinent and relapsed clients 
(e.g. Lukasfeld). From a methodological perspective this is unsatisfactory because it can be 
assumed that clients with a favourable background would tend to complete therapy and stay 
abstinent in the long run. Another problem is how to reach ex-clients for long-term catamnes-
tic studies. Again it can be presumed that abstinent and socially integrated clients would be 
more easy to contact than clients who are currently dependent on drugs, so a certain distor-
tion of results must be accounted for. Despite these problems the evaluation studies confirm 
that, at least for a certain group of clients, treatment has the desired effects and can be 
termed successful.  
To complement the studies that are already running at the level of institutions, evaluation re-
search with a view to the entire network of drug help should be intensified in the future. 
Moreover efforts should be made to further develop the methods and instruments of evalua-
tion and harmonise the research designs in order to improve the quality and comparability at 
a European level. In this respect the EMCDDA could play a major role. In addition the exist-
ing studies, which have been quantitatively oriented and have used standardised instru-
ments, should be complemented by explorative and qualitative research, which could yield 
in-depth, insights of greater complexity into the concept of success and related issues in the 
context of treatment.  
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13 Drug users in prison4 
The following presentation focuses on the situation of drug use in those prisons which are in 
the competence of the Federal Ministry of Justice (FMJ). In all provinces there are also police 
prisons affiliated with the Federal Police and in the competence of the Federal Ministry of the 
Interior (FMI). The drug situation in the police prisons, where as a rule, foreigners to be de-
ported and administrative law offenders are detained for a maximum period of six weeks, 
cannot be discussed in detail here (cf. Chapter 5). 
To provide a context for the information presented in the following chapters, a few general 
data on criminal punishment in Austria: The administration of justice as well as the central 
administration of prisons is in the competence of the Federal Ministry of Justice. In principle, 
there are three different types of imprisonment - penal imprisonment, imprisonment on re-
mand and custody in the context of measures other than punishment. The legal framework 
for the execution of penal imprisonment and custody in the context of measures other than 
punishment is provided by the Execution of Sentence Act (ESA), while imprisonment on re-
mand is based on the Code of Criminal Procedure (CCP).  
In Austria there are 29 prisons and 16 affiliated institutions. Parallel to the three types of 
criminal punishment outlined above, there are three kinds of prisons: penal institutions (n = 7) 
for offenders with a term of imprisonment of more than 18 months, criminal court prisons (n = 
17) for prisoners on remand and convicted persons (men and women) with terms of impris-
onment of up to 18 months, special institutions (n = 5) for specific groups, e. g. women, male 
youths - and special establishments for custody in the context of measures other than pun-
ishment. The legal regulations for measures other than punishment, which are determined by 
the courts, are set down in the Penal Code. The egulations that are relevant for the present 
purposes are the articles on delinquents in need of detoxification treatment (alcohol or drug 
addicts) and mentally abnormal delinquents. Institutions for custody in the context of meas-
ures other than punishment have specific treatment and care facilities (Koeck o. J.).  
On the target date 1 July 2001 a total of 6,671 prisoners were detained in Austria - 6,080 
men (91%), 372 women (6%) and 219 youths (aged between 14 and 19 - 3%). For the last 
decade the number of prisoners in Austria has remained constant at approximately 7,000 
annually. Around one third of inmates are on remand, around two thirds are in penal impris-
onment. The average share of imprisoned foreigners is 25 to 30% (Koeck o. J.). 
 
 
 
 
 
 
 
 
 
 
 
4 We would like to express our gratitude to Mr. Walter Kahl (Federal Ministry of Justice) and to the so-
cial scientists Mr. Harald Spirig and Ms. Octavia Ess-Dietz for sharing their knowledge in expert dis-
cussions and providing fundamental information for this Key Issue Chapter. Use of this information in 
the text is referred to as "personal information“ (p. i.). 
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13.1 Epidemiological situation 
Empirical evidence on drug use before imprisonment is contained in an inquiry (represen-
tative of the total prison population) that was carried out in six Austrian prisons in 1999, with 
a total of 263 respondents (69 women, 143 men and 51 male youths). More than one fourth 
of the men, one third of the women and 9% of the male youths indicated IV drug use, imme-
diately before imprisonment in most cases. It is remarkable that the great majority had long 
careers of drug use of up to ten years and had already been in drug therapy. Substitution 
treatments that had started before imprisonment were usually continued in prison. It also 
turned out that 80% of the men among IV users and 90% of the women exclusively used 
their own injecting equipment before imprisonment (European Network 2000). 
As yet there has been no systematic data collection on drug use within prison. On account 
of differing thematic focuses, the findings resulting from individual surveys on drug use in pri-
son are to some extent contradictory, similar to the expert opinions on this issue. According 
to the Federal Ministry of Justice approximately 30% of the prisoners are considered to be 
misusers of drugs (alcohol, pharmaceuticals, illegal drugs, mixed drug use), 10% of which 
are regular or frequent IV users. Other experts assume the share of IV users in prison to be 
in the order of 20%, an estimate which is confirmed by existing analyses on HIV, hepatitis B 
and hepatitis C prevalence (Pont 2000). It is estimated that 50% of all prisoners occasionally 
use drugs in prison. If the problematic use of other psychoactive substances - such as alco-
hol and pharmaceuticals - is included in the considerations, the share of prisoners concerned 
rises to two thirds (Spirig 2001). The high share of misusers (of alcohol and drugs) is partly 
explained by the fact that many acts leading to criminal punishment are connected to drug 
dependence.  
The inquiry among prisoners mentioned above also yields information on drug use during 
imprisonment differentiated according to specific groups (men, women and male youths). 
IV consumption in prison was indicated by 15% of men, 6% of women and 8% of youths 
among the respondents. Slightly below 3% of the men and the women, respectively and 2% 
of the youths said their first IV use occurred in prison (European Network 2000). Because of 
lacking data it is not possible to give a precise quantity of people taking up (IV) drug use in 
prison (Spirig p. i.). No data is available on the prevalence of drug consumption among other 
specific groups, such as on remand prisoners, imprisoned members of minority groups, etc. 
According to experts, the prevailing consumption pattern is poly-drug use - of alcohol, 
pharmaceuticals, cannabis, opiates, etc. (Kahl p. i., Spirig 2001). Aspects influencing the 
consumption pattern are supply and control (e. g. urinalyses). It has been found that in insti-
tutions or departments where urine tests are carried out regularly, cannabis use is compara-
tively rare, while cannabis consumption is high in departments without urine tests (Spirig p. 
i.). It should be added that the consumption of illegal substances (cannabis etc.) or psy-
choactive substances is no conclusive evidence that the consumers are addicted to drugs. 
On the contrary it is reported that cannabis for example is used as a specific form of relaxa-
tion alleviating the conditions of imprisonment.  
The risk behaviour of drug users in prison is considered to be significantly higher than out-
side. According to experts, among the population of Austrian prisons IV consumption with 
needle sharing is the most relevant risk behaviour for the transmission of HIV, HCV and HBV 
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(Pont 2000). This is confirmed by two studies carried out at the low threshold service 
Ganslwirt (Zach et al. 1999; Neubauer 1999; ÖBIG 2000a). Also according to the Austrian 
National Report there is a great number of IV consumers who report that they share injection 
equipment (more than 50% of male IV consumers, 17% of female IV consumers and one out 
of two IV consuming youths; European Network 2000). 
According to recent data on HIV, HBV and HCV prevalence in all prisons5, among the per-
sons imprisoned in 1999 hepatitis B prevalence was 5% and hepatitis C prevalence was 
20%. HIV prevalence was just below 1%. However, for reasons of data protection, the per-
centages correspond to all prisoners and have not been specified for IV drug users (Pont 
2000). While in general the HIV prevalence among Austrian prisoners is considered to be 
low, the prevalence of HCV and HBV is supposed to be high. No data is available on the 
prevalence of other infections (TBC etc.) in prisons.  
The general health status of prisoners is reportedly poor. In the inquiry among prisoners 
cited above approximately one third of the respondents (men, women and youths respec-
tively) said they had been receiving inpatient hospital treatment in the year before imprison-
ment (European Network 2000). Experts have also pointed out the poor state of health of the 
drug-addicted prisoners, e. g. bad teeth, etc. (Kahl p. i., Ess-Dietz p. i., Spirig p. i.).  
Regarding the social and legal consequences of drug use in prison, the general rule is that 
prisoners actually caught with drugs will be reported and the incident will be registered in 
their personal file. In the case of positive urine tests usually no reports are made. Possession 
of alcohol is fined (administrative punishment). In addition, there are social consequences of 
drug use in prison, such as restriction of additional rights (visitors, phone calls, etc.).  
13.2 Availability and supply of drugs in prison 
Contrary to earlier assessments, the fact that illegal substances are consumed in prisons and 
that there is no such thing as a drug-free prison has been generally acknowledged among 
experts (cf. Kahl p. i., Spirig 2001). Cannabis is considered to be the most commonly used il-
legal drug in prison. The ways of access to drugs in prison are described as multi-faceted: 
all contacts with the outside world are potential occasions for smuggling drugs. The most fre-
quently used channels are outside visitors and (daytime or longer) leave from detention. Ac-
cording to the FMJ illegal substances are mainly found, registered and reported in the course 
of searching prison cells or during body searches. No quantitative data is available on the 
frequency of smuggling drugs into prison nor on the amounts seized. Various measures 
have been taken to prevent or reduce the smuggling of illegal substances into the prisons: for 
instance, in almost all prisons inmates are not allowed to receive parcels (containing food 
etc.). In the case of inmates with daytime employment outside the prison and for prisoners 
returning from leave there are routine checks. If there are indications of drug smuggling, this 
also has a negative effect on the mode of visits from outside (visitors sitting at the same table 
as prisoners vs. separation by means of glass plates) . 
 
5 Test frequencies with regard to HIV/HBV and HCV vary greatly between penal prisons and police 
prisons on the one hand and among penal prisons on the other. HCV and HBV data presented here 
is calculated on the basis of all prisons with a test frequency of more than 70%. 
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Regarding the price level of drugs used in prison it should be noted that the substances in 
question are usually procured outside and then smuggled into the prisons. But dealing of ille-
gal substances in prison also occurs, at a price level which is three to four times higher than 
that of drugs bought in the free market (cf. also Chapter 5). In terms of spending power the 
costs of the substances purchased in prison are ten to twenty times higher. This extreme 
disparity in prices is explained by the fact that dealing in closed systems like prisons is much 
more dangerous and difficult. One mode of payment is return services of various types, from 
cell cleaning for co-inmates to sexual services. In many cases payment is effected directly, 
via friends outside prison. Furthermore, a well-functioning structure of barter systems and in-
formal currencies such as tobacco have been reported for the prison setting (Spirig p. i.). 
13.3 Contextual information 
General information on the Austrian prison system has already been presented in the intro-
duction. Regarding structural organisation the principle of decentralisation is followed, 
which means that prisons are general institutions applying various methods. The staff-to-
inmate ratio is 1:2.2, at a staff force of approximately 3,500 (Koeck o. J.). Average costs per 
prisoner and day amount to ATS 1,000 (EURO 73), not including services such as social 
work, therapy or (external) medical care etc.  
Interaction among inmates and between inmates and staff are multi-layered and should be 
interpreted in the context of the legal obligation as well as the internal and external organisa-
tion of prisons. From a sociological perspective, prisons are total institutions characterised by 
powerful hierarchies and defence strategies against outside influences, guided by military 
principles and relationships of covert or open violence. Action guidelines for prison guards 
and prisoners alike are clearly regulated according to penal law. The relationship between 
prisoners and guards can be described as a special type of coercive community, in which 
staff has to perform a double task which is a contradiction in terms: imprisonment and social 
reintegration. In the prison routine staff members fulfil a number of roles and functions at the 
same time (executive officer, contact person, social worker, doctor, etc.; Spirig 2000). As is 
common in closed systems, the development of subcultures and prison hierarchies has been 
observed, in which drug misusers or addicts are attributed a low status. This especially ap-
plies to drug addicts misusing pharmaceuticals in prison, who tend to cause problems related 
to their addiction. Violence, sexual abuse and prostitution especially occur in larger prisons. 
Here the size of cells is a decisive element. Incidents of sexual abuse among inmates are 
hardly ever reported, but rather settled informally, the reason being that victims fear sanc-
tions on the part of the perpetrators (Kahl p. i.). The Federal Ministry of Justice plans to draw 
up a statistic with details on the reports of offences committed by inmates against staff and 
offences committed among inmates. 
It should be added that at present, the Austrian penal system is the object of media coverage 
and political discussion. This was caused by the death of several inmates at the prison of 
Stein (Lower Austria) on the one hand and by the report of the Anti-Torture Committee of the  
Council of Europe published in June 2001 (Council of Europe 2001). Within the framework of 
the current reform of the administration carried out by the Austrian Federal Government a re-
form of the penal system is planned, according to which the institutions and measures of the 
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penal system shall be restructured, the execution of measures shall be integrated and im-
provements of the external and internal health care system shall be made.  
13.4 Demand reduction policy in prison 
The main objectives of drug help in prisons are the treatment of damages and injuries 
resulting from drug use and measures to stabilise health in cases of chronic dependence 
(health maintenance), therapy and psychosocial treatment, demand reduction and prevention 
measures (Bundesministerium für Justiz 2001). Whether drug-addicted delinquents need 
therapy (needs assessment) is decided during examinations at the beginning of imprison-
ment on the basis of the relevant Decrees of the FMJ (e. g. Decree on Oral Substitution 
Treatment) and the drug-specific admission guidelines and care schemes of the respective 
prison (drug-free zone, therapy scheme, etc.). In general the commitment of the prisoners 
concerned also plays a role in needs assessment for therapy measures.  
Efforts have been made to extend the measures of drug-specific prevention, care and treat-
ment. The focuses for drug users and drug addicts among the inmates are as follows:  
Abstinence-oriented treatment: Care and treatment measures for drug-addicted prisoners 
can be initiated by court order, but in most cases they are effected upon voluntary application 
by the prisoners concerned. It should be noted that abstinence continues to be the prevailing 
therapy principle for treating drug-addicted prisoners. Currently the prisons of Vienna/Favori-
ten, Innsbruck, Stein, Feldkirch and Eisenstadt have specific detoxification facilities (Bundes-
ministerium für Justiz 2001). The prison of Vienna/Favoriten is the only institution which spe-
cialises exclusively in the treatment and care for drug-addicted prisoners, with a capacity of 
approximately 110 places and a comprehensive care scheme integrating psychotherapy, me-
dical, psychological, and social work as well as educational aspects. 
Substitution treatment: According to a Decree issued by the Federal Ministry of Justice, 
substitution treatment shall be provided by all Austrian prisons. The decision on applying 
substitution therapy is in the exclusive competence of the prison doctors and is not linked to 
the duration of the term of imprisonment. The main target groups are HIV positive prisoners 
and prisoners with a prominent record of opiate use. In individual cases, prisoners can also 
begin substitution therapy during their term of imprisonment or before they are released 
(Kahl p. i.). Substitution therapy has become a standard part of the treatment range. In most 
cases, methadone is used as substitution substance, with the exception of the prison of 
Stein, where currently the pharmaceutical Mundidol is the main substance used. Substitution 
treatment is especially applied in the prisons of Vienna/Josefstadt, Innsbruck, Eisenstadt and 
Stein (Bundesministerium für Justiz 2001). According to recent data 335 prisoners receive 
substitution treatment, i. e. 5% of all prisoners, which represents a further increase compared 
to previous years (Pont 2000).  
Drug-free zones: Following the positive outcome of the pilot project initiated in 1995 at the 
prison of Hirtenberg (cf. Chapter 13.5 and ÖBIG 2000a), drug-free zones were also estab-
lished at the prisons of Innsbruck, Sonnberg, Vienna/Simmering and Stein, which brings the 
total capacity of places in controlled drug-free areas to 600 (Kahl 2000). It should be pointed 
out that the drug-free zones in the various prisons differ as to their size and their conceptual 
basis (Spirig 2001). Since controlled zones were found to have a positive effect on the prison 
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environment (cf. Chapter 13.5), the establishment of such zones is further promoted. Drug-
free zones are intended as a protected area where no contact with drugs takes place. Pris-
oners are admitted to drug-free zones on a voluntary basis; the system is a combination of 
applying controls (urinalyses, body searches) and granting additional rights (better conditions 
for visits from outside, phone calls, leave from detention).  
Prevention of infections: On account of the high-risk behaviour of IV users in prison (cf. 
13.1.) measures for the prevention of hepatitis B/C and HIV/AIDS infections are of particular 
importance. At the prison of Vienna/Favoriten, a centre for the distribution of material on 
HIV/hepatitis to all other prisons was established. In the course of admission every prisoner 
receives a take-care set containing HIV/AIDS- and hepatitis-related information, condoms, 
etc. Risk-reducing measures are promoted in cooperation with the regional branches of the 
AIDS Assistance Service. Furthermore, according to a Decree of the Federal Ministry of Jus-
tice prisoners shall have free and uncontrolled access to condoms and disinfectants. The 
degree of implementation of this Decree varies from prison to prison (Spirig p. i.). Special 
training for prison guards (training as care-assistant, urinalysis training) is another focus of 
prevention and will be intensified in the future (Kahl 2000). Also, prison doctors have drawn 
up a consensus paper on hepatitis C treatment (Pöhnl 2000). 
On the whole it can be said that all Austrian prisons have established demand reduction 
measures, with a strong variation in the range of activities and underlying concepts. One of 
the deficits that is frequently referred to in expert discussions is the lack of drug-related ser-
vices for women in prison (cf. Chapter 13.6). Apart from the special institution at Vi-
enna/Favoriten, where a department for women with a capacity of 32 places and an external 
work therapy facility (NORA) have been established, there are hardly any drug-related ser-
vices specifically aimed at women prisoners. The prison of Schwarzau (Lower Austria), the 
only women's prison in Austria, has general care facilities, but no drug-specific services. 
Therefore the Federal Ministry of Justice has voiced plans to provide therapy options in ex-
ternal drug help facilities for women prisoners near the end of their prison term. 
Cooperation of prisons with external facilities takes place on many levels. Specific medical 
services which cannot be performed in the prisons are provided by established medical spe-
cialists or in public hospitals. There are also several cooperations with regional drug help fa-
cilities. Therapy and psychosocial care for juvenile prisoners, women prisoners and inmates 
of court prisons is provided in cooperation with external services of drug help facilities. Ac-
cording to ÖBIG's pilot study, 38 outpatient drug help services located in almost all provinces 
have special cooperations with local prisons, which is more than one third of the total of 105 
drug help services included in the study. Another 8 facilities provide care services of a gen-
eral nature for prisoners (ÖBIG 2001). In the prison of Vienna/Favoriten, a project of volun-
tary probation assistance has been initiated with the aim of providing continual support and 
care to prisoners in the months preceding and following their release from detention (cf. also 
EDDRA). Furthermore the services of the Association of Probation Assistance and Social 
Help are available for persons released from detention all over Austria. 
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13.5 Evaluation of drug users treatments in prison 
One focus of the evaluation of drug-related measures in prison is on the analysis and as-
sessment of drug-free zones. As the results of the survey of the prison of Hirtenberg have 
shown, the drug-free zone has been well received both by the prison staff members and by 
the prisoners. It also turned out that the establishment of the drug-free zone resulted in a 
marked reduction of the use of illegal drugs and psycho-pharmaceuticals among prisoners 
(Steinacher 2001, cf. also EDDRA). The great majority of the prisoners said their quality of 
life had substantially improved, especially in the fields of self-determined social interaction, 
health and preparation for release from detention. Among staff members, marked improve-
ments were registered with regard to the quality of their jobs, work environment and job satis-
faction, the latter aspect resulting in less frequent sick-leaves. However, the study also re-
vealed that the drug-free zone primarily benefits non-addicted drug users (prisoners receiv-
ing substitution treatment are not admitted into the drug-free zone) and that negative effects 
on everyday prison life were observed, such as the development of a two-class hierarchy 
among prisoners, with a lower cast of "difficult" prisoners, etc. (Spirig 2000). In the course of 
operation of the drug-free zone at the prison of Innsbruck it turned out that in prisons mainly 
dealing with prisoners on remand, fluctuation is too high for the system of drug-free zones to 
be applicable (Kahl 2000).  
Evaluation results on the treatment and care for drug-addicted prisoners at the prison of Vi-
enna/Favoriten have shown that more than half of the clients were prevented from relapse 
into drug use during the phase of eased restrictions (cf. EDDRA). Recent evaluation results 
on long-term therapy of drug-addicted inmates of the prison of Innsbruck are presented in 
Chapter 12 (cf. also EDDRA). 
A project on risk minimising in the course of rehabilitation of drug-addicted women in the 
prison of Vienna/Favoriten is currently carried out in cooperation with the University of Vi-
enna; results are expected for autumn 2001.  
Currently, the Austrian team of the European Network on HIV/AIDS and Hepatitis Prevention 
in Prisons is carrying out a comparative study of specific prevention activities in Austrian pri-
sons. Results of this study, which evaluates and analyses the health care measures for the 
prevention of HIV and hepatitis in the prisons of Hirtenberg, Innsbruck, Sonnberg, Stein and 
Vienna/Favoriten, are also scheduled for autumn 2001. 
13.6 Methodological issues 
In Austria no quantitative, systematic data collection on the situation of (illegal) drug use in 
prisons is available. Similarly, there are few qualitative findings from this field. Surveys (cf. 
above) have been made in individual prisons, but as a rule their findings cannot be general-
ised to describe the overall situation in Austria's prisons.  
Data is also lacking in the field of drug use differentiated according to specific groups, such 
as women, youths, and foreign prisoners. While the existing data shows that the share of 
women among the total prison population is low, drug-using or drug-addicted women are de-
scribed as a group requiring specific measures. On account of the obvious correlation of de-
linquency and drug problems among youths comprehensive data material would be neces-
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sary to implement specific measures for the target group of young delinquents. The share of 
foreign inmates among the total prison population is high (25% - 30%). Also for this group 
empirical findings are required in order to gain insights into drug use and, as a further step, 
supply adequate services to reduce drug consumption. Finally, as yet very little is known 
about the extent of drug problems and the situation of persons addicted to psychoactive sub-
stances in the police prisons located in almost all provinces.  
For the future, it would be desirable to carry out representative inquiries on a continual basis 
among prisoners and members of the prison administration within the framework of the 
European Network on HIV/AIDS and Hepatitis Prevention in Prisons. Another suggestion, 
concerning the analyses of HIV and hepatitis prevalence that are regularly effected in all 
Austrian prisons, is a specification regarding the group of IV drug use. Furthermore a stron-
ger emphasis on explorative and qualitative research methods in the context of drug use in 
prison is recommended. Detailed epidemiological findings as well as qualitative analyses are 
needed in order to gain more specific insights into the extent, the patterns and the complex 
dynamics of drug use in prisons and accordingly conceive and develop adequate, target-
group specific prevention and care measures. 
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DATABASE 
EDDRA = Exchange on Drug Demand Reduction Action 
Internet-Datenbank der EBDD: http://www.emcdda.org/databases 
 
Austrian Projects in the EDDRA-Database: 
Employment programme WALD 
(H.I.O.B. - Contacting and counselling centre for drug addicts, Vorarlberg) 
Assisted Housing 
(Vienna Social Projects Association, Vienna) 
CARINA - Long term therapy facility  
(Foundation Maria Ebene, Vorarlberg) 
ChEck iT! Scientific Pilot Project Check iT!  
(Vienna Social Projects Association, Wien) 
Drug-free zone at the prison of Hirtenberg 
(prison of Hirtenberg, Lower Austria) 
Drug-free zone at the prison of Innsbruck 
(prison of Innsbruck, Tyrol) 
Drug Out - therapy unit at the prison of Innsbruck 
(prison of Innsbruck, Tyrol) 
Probation assistance for inmates at the prison of Favoriten, Vienna, provided by voluntary 
staff 
(Vienna Association of Probation Assistance and Social Help) 
European Networking in addiction prevention 
(Institute for Addiction Prevention, Upper Austria) 
Fantasy instead of Ecstasy – addiction prevention through peergroup education in a voca-
tional high school at Neumarkt, Salzburg 
(AKZENTE Salzburg – Addiction Prevention Unit, Salzburg) 
Fix und Fertig - Socio-economical company   
(Vienna Social Projects Association, Vienna) 
Training course on addiction prevention in the kindergarten, for kindergarten  
(VIVID – Addiction Prevention Unit, Styria) 
Promote health - prevent addiction - Action programme of the Federal Ministry of Educa-
tion and Cultural Affairs  
H.I.O.B. Help – Information – Orientation – Counselling for Drug Addicts 
(H.I.O.B. – contacting and counselling centre for drug addicts, Vorarlberg) 
Youth counselling service WAGGON  
(TENDER – Association for youths work, Lower Austria) 
Campaign „Empower our children” 
(SUPRO – Addiction Prevention Unit of Vorarlberg, Vorarlberg) 
Lukasfeld – short-term therapy department for persons addicted to illegal drugs 
(Stiftung Maria Ebene, Vorarlberg) 
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Comprehensive care project for substance abusing mothers and their children. 
Sub-programme of the Viennese Pilot Project „Pregnancy and Addiction“.  
(Department of Child and Adolescent Neuropsychiatry, Hospital Rosenhügel, Vienna) 
Needles or Pins – European project to develop innovative projects for social and labour in-
tegration of people with drug related problems – Viennese sub-project 
(Support and counselling centre for drug addicts and their relatives - DIALOG, Vienna) 
Needles or Pins – European project to develop innovative projects for the social and 
professional rehabilitation of people with drug problems - sub-project of Vorarlberg 
(Die Fähre, Vorarlberg) 
SAS - Pupils Searching for Alternative Solutions. A pupil-multiplier-project of primary addic-
tion prevention based on the concept of peer-group education 
(VIVID - Addiction Prevention Centre, Styria) 
Schweizer Haus Hadersdorf – Medical and psychosocial sanatorium 
(Evangelisches Haus Hadersdorf – WOBES: Medizinische, Psychologische und Psychothe-
rapeutische Gesundheits- und Heilstätte „Schweizer Haus Hadersdorf“ (SHH) Ges.m.b.H., 
Wien) 
Toyfree kindergarten. Addiction prevention by promoting life skills  
(ISP – Information Centre for Addiction Prevention of the City of Vienna, Vienna) 
Umbrella–Network–Project Austria - Switzerland: Analysis of problems with HIV, AIDS and 
STDs in European border regions as well as development of co-operative, border-crossing 
prevention methods  
(Institut für Sozialdienste, Vorarlberg) 
URBAN - Wien Gürtel Plus. Secondary addiction prevention for youths in urban areas  
(Drug advisory centre Change, Vienna) 
Vienna Job Exchange – Vienna Job Exchange Association for the vocational integration of 
persons who are addicted to (pharmaceutical) drugs and/or alcohol  
(Vienna Job Exchange, Vienna) 
Wien-Favoriten - Treatment and care of addicted offenders in Vienna Favoriten Prison 
(Vienna Favoriten Prison, Vienna) 
Grüner Kreis: Parents - Child - House. Therapy for Parents and Children at Grüner Kreis 
(Association Grüner Kreis) 
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WEBSITES  
The following pages provide WebSites of facilities working in the addiction and drug field, 
mentioned in the report.  
A detailed list of relevant Internet-addresses concerning addiction and drugs can also be 
found via http://www.oebig. at (working field Drugs / Links). 
AIDS-Hilfe (AIDS-Care) 
http://www.aidshilfe.at 
AKZENTE Salzburg (Drug Prevention Unit Salzburg) 
http://www.akzente.net 
Arbeitsmarktservice Oberösterreich (Public Employment Service, Upper Austria) 
http://www.ams.or.at/ooe 
ARGE Suchtvorbeugung (Working Group Addiction Prevention) 
http://www.praevention.at/projekte/arge.html 
Anton Proksch-Institut 
http://www.api.or.at 
Bundesministerium für Bildung, Wissenschaft und Kultur (Federal Ministry of Eduction, 
Science and Culture) 
http://www.bmbwk.gv.at 
Bundesministerium für Inneres (Federal Ministry of the Interior) 
http://www.bmi.gv.at 
Bundesministerium für Justiz (Federal Ministry of Justice) 
http://www.bmj.gv.at 
Bundesministerium für soziale Sicherheit und Generationen (Federal Ministry for Social 
Security and Generations) 
http://www.bmsg.gv.at 
Carina - Therapiestation (Therapy Facilitiy) 
http://www.mariaebene.at/carina/welcome.htm 
Caritas - Diözese Innsbruck 
http://www.caritas-innsbruck.at 
CheckiT! - Verein Wiener Sozialprojekte (Vienna Social Projects Association) 
http://checkyourdrugs.com   
CONTACT - Spitalsverbindungsdienst (Hospital Liaison services) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-contact.htm 
Cybertown - Internetforum für Prävention (Internetforum for Prevention) 
http://www.cybertown.at 
dialog - Beratungs- und Betreuungszentrum (Counselling and Support Centre for Drug 
Addicts and their Relatives) 
http://www.dialog-on.at  
Drogenambulanz - AKH Wien (Outpatient Drug Department of the General Hospital, 
Vienna) 
http://www.akh-wien.ac.at/drogenambulanz 
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EMCDDA (European Monitoring Centre for Drug and Drug Addiction) 
http://www.emcdda.org 
European Network on HIV/AIDS and Hepatitis Prevention in Prisons 
http://members.aol.com/orspaca/gbp1.htm  
Fachstelle für Suchtvorbeugung NÖ - Gesundheitsforum NÖ (Addiction Prevention Unit 
Lower Austria) 
http://www.fachstelle.at  
Fonds „Gesundes Österreich“ (Healthy Austria Fund) 
http://www.fgoe.org 
Fonds Soziales Wien (Social Vienna Fund) 
http://www.drogenhilfe.at 
Ganslwirt - Verein Wiener Sozialprojekte (Vienna Social Project Association) 
http://www.vws.or.at/ganslwirt/index.html 
GIVE - Servicestelle für Gesundheitsbildung im Österreichischen Jugendrotkreuz (Service 
unit for Healthpromotion at the Austrian Red Cross) 
http://www.give.or.at 
Grüner Kreis 
http://www.gruenerkreis.at 
Haus am Seespitz - Kurzzeittherapie für Drogenabhängige (Short Term Therapy for Drug 
Addicts) 
http://www.jugendweb.at/drogenhandbuch/einrichtung/seespitz.htm 
Institut für Medizinische und Chemische Labordiagnostik der Universität Wien (Institute for 
Medical and Chemical Diagnostics at the Vienna University) 
http://www.univie.ac.at/med-online/A5273/index.html 
Institut für Suchtforschung der Universität Innsbruck mit Sitz am KH Maria Ebene (Institute 
for Addiction Research at the University of Innsbruck - Tyrol) 
http://www.suchtforschung.at 
Institut für Suchtprävention OÖ (Institute for Addiction Prevention Upper Austria) 
http://www.praevention.at      
IZS - Interdisziplinäres Zentrum Suchtforschung, Universität Wien (Interdisciplinary Centre 
for Addiction Research at the Vienna University) 
http://www.univie.ac.at/sucht/ 
Komfüdro - Kommunikationszentrum für DrogenkonsumentInnen (Communication Centre 
for Drug Users) 
http://www.caritas-innsbruck.at/komfuedro.htm 
kontakt&co - Suchtpräventionsstelle Tirol (Addiction Prevention Unit Tyrol) 
http://www.kontaktco.at 
Krankenhaus Rosenhügel (Hospital Rosenhügel, Vienna) 
http://www.health.magwien.gv.at/welt/kavw/nkr/ 
Kriminalpolizeilicher Beratungsdienst Wien (Counselling Centre of the Vienna Police) 
http://www.polizei.gv.at/wien/fixlokal/kriminalpolizeilicher_beratungsd.htm 
Landes-Nervenklinik Wagner Jauregg (Neurological Hospital Wagner Jauregg, Styria) 
http://www.wagner-jauregg.at 
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Ludwig Boltzmann-Institut für Suchtforschung (Ludwig Boltzmann-Institute for Addiction 
Research) 
http://www.api.or.at/lbi/index.htm 
Lukasfeld - Therapiestation (Therapy Department, Vorarlberg) 
http://www.mariaebene.at/Lukasfeld/welcome.htm 
Needles or Pins - dialog 
http://www.dialog-on.at/dialog/channels/standorte/base2_html 
Otto Wagner-Spital - Drogeninstitut (Drug Treatment Centre at the Otto Wagner-Hospital, 
Vienna) 
http://www.drogenhilfe.at/rathilfe/skh/r-s-ows.htm 
Pädagogische Akademie des Bundes in Oberösterreich (Federal Paedagogical Academy, 
Upper Austria) 
http://www.pa-linz.ac.at/ 
pro mente Oberösterreich 
http://www.promenteooe.at/ 
risiko - Institut für Sozial- und Gesundheitspsychologie (Institute for Social- and Health-
Psychology) 
http://www.members.aon.at/isg 
Stiftung Maria Ebene 
http://www.mariaebene.at 
Substanz - Verein für suchtbegleitende Hilfe (Association for Accepting Drug Assistance) 
http://www.substanz.at 
SUPRO - Werkstatt für Suchtprophylaxe (Addiction Prevention Unit, Vorarlberg) 
http://www.supro.at 
Verein für Bewährungshilfe und Soziale Arbeit (Association for Probation assistance and 
Social Help) 
http://www.vbsa.at/ 
VIVID - Fachstelle für Suchtprävention, Steiermark (Addiction Prevention Unit, Styria) 
http://www.checkit.at/vivid 
VWS - Verein Wiener Sozialprojekte (Vienna Social Projects Association) 
http://www.vws.or.at 
Wiener Berufsbörse (Vienna Job Exchange Association) 
http://www.bhakwien13.at/Beruffoerd/default.htm 
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Data source 
Responsible institution 
Type of Date New developments and activities 
Relevant monitoring and information systems at the federal level 
Drug-related deaths - 
special register  
Federal Ministry for Social 
Security and Generations 
(FMSSG) 
Fatalities related to drugs 
directly (overdoses) or indi-
rectly (suicide, AIDS, 
accidents, premature natural 
death, etc.)  
In the course of implementing the key indicator drug-related deaths, 
a comparative survey on the cases included in the special register 
and in the general mortality register was carried out. The cases in 
the two registers are matching to a high extent, which indicates good 
quality of data.  
The preparation of the annual statistics for the year 2000 was 
accompanied by intensive discussions of how to register drug-
related deaths. As a result it was decided to classify causes of death 
in a more detailed way in future, based on the guidelines for special 
registers of the EMCDDA. Simultaneous use of alcohol will also be 
listed separately (cf. below). 
What is still under discussion is inclusion of intoxications with 
psychoactive substances. This year cases where only psycho-
pharmaceuticals were found toxicologically have not been included 
(two cases in total). 
Drug-related deaths- 
general mortality 
register 
Statistics Austria 
Death cases with drug-related 
ICD-Codes for cause of death 
In the course of implementing the key indicator drug-related deaths, 
a comparative survey of the cases included in the special register 
and in the general mortality register was carried out. The cases in 
the two registers are matching to a high extent, which indicates good 
quality of data. 
Substitution treatment 
FMSSG 
Reports on the beginning and 
end of substitution treatment 
by physicians in charge of 
treatment 
In order to improve the situation regarding completeness and quality 
of data it has been considered to involve the provinces more inten-
sively in data collection and routine comparisons of data available at 
federal and provincial levels. This has not been implemented until 
now. 
Drug-specific treatment 
and care 
FMSSG 
Aggregate statistics on clients 
of drug centres announced 
according to Art. 15 of the 
Narcotic Substances Act 
(NSA) 
The annual client statistics, which are available now and have been 
submitted in the form of aggregate data, permit a limited epidemiol-
ogical analysis only. In the context of a working group convoked by 
the FMSSG to discuss the establishment of a nation-wide uniform 
treatment reporting system that will meet EU requirements, a first 
draft of the client protocol was completed in spring 2001 and its 
practical application was tested in spring and summer 2001. Parallel 
to this the discussions of the organisational, financial and legal 
framework of a national treatment reporting system have been 
continued. 
Register of drug users 
reported according to 
the Narcotic Substances 
Act (NSA) 
FMSSG 
Personal- as well as episode-
specific data of all persons 
reported to the FMSSG with 
regard to the regulations of 
Art. 24 NSA (esp. reports to 
the police, legal proceedings, 
convictions and alternatives to 
punishment)  
Activities aimed at improving the technical and organisational basis 
and thus the quality of data of the register have been continued in 
the reporting period and have advanced substantially. 
In addition the FMSSG commissioned the Focal Point to analyse the 
epidemiological information of the data and to submit proposals re-
garding an intensified use of this data in the context of epidemiologi-
cal monitoring. The pertinent results will be available in spring 2002. 
Reports to the police for 
violation of the NSA 
Federal Ministry of the 
Interior (FMI) 
Episode-specific data on all 
reports for violations of the 
NSA registered by federal and 
province police or customs 
authorities (double counting 
cannot be excluded)  
No relevant changes. The online network of all the units involved - 
installed in the beginning of 2000 - seems to work very well. Data 
can now be made available earlier than in the past.  
Seizures of narcotic 
drugs  
FMI 
Number and quantity of 
seizures registered by federal 
and province police or customs 
authorities 
No relevant changes. The online network of all the units involved - 
installed in the beginning of 2000 - seems to work very well. Data 
can now be made available earlier than in the past. 
Convictions under the 
NSA 
Statistics Austria 
Number of convictions under 
the NSA and type of punish-
ment  
Due to lack of resources, at the moment only data referring to 
leading offences is available.  
 
 
96
 
Data source 
Responsible institution 
Type of date New developments and activities 
Relevant monitoring and information systems at the provincial level 
Vienna  
Drug Coordination Office 
of the City of Vienna 
Data on the number of clients 
and services provided by drug 
help centres; drug-related 
deaths; substitution treatment; 
overdoses; ambulance 
services required; population 
surveys 
The Vienna monitoring system collects a variety of data (see type of 
data) and is advanced continually: the working group responsible for 
developing a uniform documentation system has completed a basic 
documentation (data on clients) and now deals with a performance 
documentation. The client questionnaire has been tested in a few 
drug centres since beginning of 2001. Furthermore, in 2001 another 
population survey on attitudes has been organised (with the same 
design as the 1993, 1995, 1997 and 1999 surveys).  
Upper Austria 
Drug Coordination of 
Upper Austria 
Rapid situation assessment 
with general population survey 
and interviews with experts; 
data on the number of clients 
and services provided by the 
drug help centres; drug-related 
deaths; substitution treatment 
In Upper Austria the monitoring system is already collecting a variety 
of data (see type of data). In the context of the rapid situation 
assessment pilot project a variety of data and information were 
compared to assess the drug situation. In addition, a general 
population survey on prevalence of drug use as well as attitudes and 
interviews with experts about trends were carried out.  
Other provinces 
Drug Coordination 
Data on the number of clients 
and services provided by the 
drug help centres; drug-related 
deaths; substitution treatment; 
examinations according to the 
NSA; in part: population 
surveys 
In the other provinces the extent of the monitoring and information 
systems vary. Almost all of them collect data from the regional drug 
help centres, as well as data on substitution treatment and drug-
related deaths. In many provinces the monitoring system is in the 
process of being expanded. All provinces participate in a working 
group convoked by the FMSSG to discuss the establishment of a 
nation-wide uniform treatment reporting system that will meet EU 
requirements. In four provinces (Burgenland, Lower Austria, the 
Tyrol and Vorarlberg) the client protocols were tested during a pilot 
stage in spring and summer 2001. 
 
Drug related deaths: new categories in line with EMCDDA requirements 
The statistical tables on drug-related deaths used in past years have been modified and now follow the documentation sys-
tem suggested by the EMCDDA (cf. Tables A2 to A6). For this year’s statistics drug-related deaths from 1991 to 2000 have 
been reanalysed on the basis of the new definition and in consideration of the current list of narcotics specified in the Narcotic 
Substances Act. 
Based on the EMCDDA classification intoxications leading to the death of the patient have been broken down in the following 
way.  
Intoxication by opiate(s): intoxication resulting from use of one or several opiates but no other narcotic substance, alco-
hol or psychoactive medicines have been found 
Poly-drug intoxication incl. opiate(s): intoxication resulting from use of one or several opiates combined with other nar-
cotic substances, alcohol and/or psychoactive medicines 
(Poly-drug) intoxication by narcotic drug(s) excl. opiates: intoxication resulting from use of one or several narcotic 
drugs but no opiates or intoxication resulting from use of one or several narcotic drugs but no opiates combined with al-
cohol and/or psychoactive medicines 
Intoxication of unknown type: intoxications that cannot be included in the above categories (e.g. in cases when a body 
was found long after death had occurred so testing for specific substances was not possible) 
The question of considering intoxication by psychoactive medicines is still under discussion in Austria. This year cases 
where only psychopharmaceuticals were found toxicologically have not been included in the statistics (two cases in total). 
In cases of indirect drug-related death the groups other diseases, accidents, homicides and unknown cause of death, 
summarised under the heading other causes in the past reports, have now been included. Different to past years the group 
suicides only includes suicides not caused by intoxication.  
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Table A1: Overview of selected studies on drug experience among the Austrian population, published 
between 1996 and 2000 
Study 
(year of publication) 
Area covered, 
year of data  
collection 
(period covered) 
Target group 
(sample) 
Drug types surveyed Percentage of re-
spondents with drug 
experience 
Age group             % 
Schulstudie Kärnten / 
school survey, Carinthia 
(Bohrn/Bohrn 1996) 
Carinthia 
1996 
(lifetime) 
Students in their 7th 
to 12th/13th school 
years 
(n = 1,234) 
Hashish 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–19 
13–19 
13–19 
13–19 
13–19 
7.7
3.2
1.0
0.3
0.3 
NÖ Jugendstudie /  
youth survey, Lower Austria 
(Brunmayr 1997) 
Lower Austria 
1996/97 
(lifetime) 
Students in their 9th 
to 12th/13th school 
years 
(n = 1,300) 
Hashish 
Ecstasy 
Hallucinants 
Cocaine 
Heroin 
15–19 
15–19 
15–19 
15–19 
15–19 
20 
4 
>1 
>1 
>1 
Schulstudie NÖ / 
school survey, Lower Austria 
(Institut für Sozial- und 
Gesundheitspsychologie 
1999) 
Lower Austria 
1997 
(lifetime) 
Students in their 7th  
to 12th school years
(n = 1,899) 
Cannabis 
Ecstasy 
LSD 
Cocaine 
Heroin 
13–18 
13–18 
13–18 
13–18 
13–18 
13.6
3.8
1.7
1.3
0.6 
Linzer Suchmittelstudie /  
drug survey, Linz 
(Institut für Soziologie der  
Universität Linz, undated) 
Linz 
1998 
(lifetime) 
General population 
aged 15 and older 
(n = 394) 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
Cannabis 
15–19 
20–29 
30–39 
40–49 
50 + 
28 
37 
19 
7 
5 
Jugendstudie Tirol  
youth survey, the Tyrol 
(Schüßler et al. 2000) 
Innsbruck 
1999 
(lifetime) 
Youths aged 
14 to 19  
(n = 493) 
Hashish 
Other illegal drugs 
14–19 
14–19 
22 
3 
Wiener Suchtmittelstudie / 
general population drug sur-
vey, Vienna (IFES 2000) 
Vienna 
1999 
(lifetime) 
General population
aged 16 and older 
(n = 600) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Opiates 
0ther illegal drugs  
16+ 
16+ 
16+ 
16+ 
16+ 
16+ 
11 
1 
1 
1–2 
1 
1–2 
Bevölkerungsbefragung 
OÖ / general population 
survey, Upper Austria 
(market 2000) 
Upper Austria 
2000 
(lifetime) 
General population
aged 15 and older 
(n = 1,011) 
Cannabis 
Ecstasy 
Amphetamines 
Cocaine 
Morphine  
LSD 
Smart drugs 
15+ 
15+ 
15+ 
15+ 
15+ 
15+ 
15+ 
21 
4 
1 
4 
1 
3 
1 
Summarised by ÖBIG 
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Table A2: Number of drug-related deaths in Austria by cause of death from 1991 to 2000 
Cause of death 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Intoxication by opiate(s) 29 48 37 63 49 69 39 27 25 18 
Poly-drug intoxication including opiate(s) 29 69 109 105 115 115 92 81 101 147 
(Poly-drug) intoxication by narcotic drug(s) excl. opi-
ates  
10 9 5 4 4 6 5 1 2 2 
Psychoactive medicines 7 2 6 4 8 4 5 8 8 * 
Intoxication of unknown type 3 3 5 1 2 1 0 0 0 0 
  Total/intoxications 78 131 162 177 178 195 141 117 136 167 
AIDS 26 39 47 41 28 23 9 20 11 13 
Other diseases 4 9 12 13 21 5 5 11 9 22 
Suicide (no intoxication) 8 7 4 13 9 2 8 8 12 16 
Accidents, homicides 0 1 1 6 5 5 9 4 3 8 
Unknown cause of death 0 0 0  0 0 0 0 2 3 1 
 Total/indirect drug-related deaths 38 56 64 73 63 35 31 45 38 60 
Total 116 187 226 250 241 230 172 162 174 227 
* = not included for the year 2000 (cf. Annex A) 
Note: The statistical tables on drug-related deaths used in past years have been modified and now follow the documentation system 
suggested by the EMCDDA (cf. Annex A). For this year’s statistics drug-related deaths from 1991 to 2000 have been reana-
lysed on the basis of the new documentation system and in consideration of the current list of narcotics specified in the Nar-
cotic Substances Act. 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
Table A3: Number of drug-related deaths in Austria by province from 1991 to 2000 
Province 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 1991 - 2000 
Burgenland 0 1 1 4 3 2 3 2 0 0 16 
Carinthia 3 4 3 6 4 3 8 5 7 3 46 
Lower Austria 4 6 10 10 11 18 13 11 12 15 110 
Upper Austria 16 20 15 27 24 17 10 14 5 18 166 
Salzburg 1 3 3 5 7 6 12 13 9 7 66 
Styria 1 7 5 5 8 10 13 6 6 12 73 
Tyrol 10 12 28 26 23 18 15 18 21 18 189 
Vorarlberg 19 19 18 20 24 20 7 13 10 10 160 
Vienna 62 115 143 147 137 136 91 80 104 144 1,159 
Total 116 187 226 250 241 230 172 162 174 227 1,985 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
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Table A4: Number of drug-related deaths in Austria by age group and total by gender from 1991 to 
2000 
Age group 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
 abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % abs. % 
19 and younger 2 2 22 12 32 14 34 13 33 14 24 10 20 12 8 5 19 11 25 11 
20–24 22 19 40 21 63 28 55 22 40 16 47 20 38 22 41 25 27 15 41 18 
25–29 36 31 42 23 38 17 42 17 46 19 36 16 26 15 26 16 27 15 40 18 
30–34 39 34 47 25 56 25 65 26 62 26 54 24 33 19 26 16 39 23 39 17 
35–39 13 11 25 13 32 14 42 17 41 17 45 20 30 17 27 17 38 22 36 16 
40 and older 4 3 11 6 5 2 12 5 19 8 24 10 25 15 34 21 24 14 46 20 
Total 116 100 187 100 226 100 250 100 241 100 230 100 172 100 162 100 174 100 227 100 
Women 24 21 33 18 39 17 40 16 45 19 36 16 29 17 24 15 48 28 44 19 
Men 92 79 154 82 187 83 210 84 196 81 194 84 143 83 138 85 126 72 183 81 
abs. = absolute figures 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
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Table A5: Distribution of drug-related deaths in Austria by cause of death and age in 2000 
Age group 
Cause of death 
<15 15–19 20–24 25–29 30–34 35–39 40–44 45–49 >49 Total 
One opiate 0 2 3 4 1 1 2 0 0 13 
Several opiates 0 1 2 2 0 0 0 0 0 5 
+ alcohol 0 2 4 4 4 1 3 1 0 19 
+ psychoactive 
medicines 0 3 3 2 1 2 0 1 0 12 
Opiates 
+ alcohol & psycho-
active medicines 0 1 3 2 0 3 1 0 0 10 
Narcotic drug(s) only 0 2 6 4 3 5 4 0 0 24 
ND + alcohol 0 0 2 5 2 5 2 0 1 17 
ND + psychoactive 
medicines 0 4 7 5 6 5 4 1 0 32 
Opiates 
and other 
narcotic 
drugs  ND + alcohol & psycho-
active medicines 0 2 4 2 10 6 7 2 0 33 
Narcotic drug(s) only 0 2 0 0 0 0 0 0 0 2 
ND + alcohol 0 0 0 0 0 0 0 0 0 0 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + alcohol & psy-
choactive medicines 0 0 0 0 0 0 0 0 0 0 
Total intoxications 0 19 34 30 27 28 23 5 1 167 
In
to
xi
ca
tio
ns
 
of these men 0 13 25 28 22 22 17 4 1 132 
AIDS 0 0 0 2 5 0 3 3 0 13 
Other diseases 0 2 1 4 2 6 3 4 0 22 
Suicides (no intoxication) 0 1 5 4 2 2 1 1 0 16 
Accidents, homicides  0 3 1 0 3 0 1 0 0 8 
Unknown cause of death 0 0 0 0 0 0 1 0 0 1 
Total of indirect drug related deaths  0 6 7 10 12 8 9 8 0 60 I
nd
ire
ct
 d
ru
g-
 
re
la
te
d 
de
at
hs
 
of these men 0 4 6 8 7 12 7 7 0 51 
Total 0 25 41 40 39 36 32 13 1 227 
ND = narcotic drug(s) 
Note: The statistical tables on drug-related deaths used in past years have been modified and now follow the documentation system 
suggested by the EMCDDA (cf. Annex A). For this year’s statistics drug-related deaths from 1991 to 2000 have been reana-
lysed on the basis of the new definition and in consideration of the current list of narcotics specified in the Narcotic Substances 
Act. 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
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Table A6: Distribution of drug-related deaths in Austria by cause of death and province in 2000 
Province 
Cause of death 
B C LA UA S St T VB V A 
One opiate 0 0 1 0 0 0 1 1 10 13 
Several opiates 0 0 1 0 0 0 1 0 3 5 
+ alcohol 0 0 0 0 0 1 0 0 18 19 
+ psychoactive 
medicines 0 0 0 1 1 1 2 1 6 12 
Opiates 
+ alcohol & psycho-
active medicines 0 0 0 3 2 0 0 0 5 10 
Narcotic drug(s) only 0 0 1 0 1 3 1 0 18 24 
ND + alcohol 0 0 3 0 0 1 1 1 11 17 
ND + psychoactive 
medicines 0 2 2 2 0 2 4 0 20 32 
Opiates and 
other narcotic 
drugs  
ND + alcohol & psy-
cho-active medicines 0 0 2 5 2 3 1 2 18 33 
Narcotic drug(s) only 0 0 1 0 0 0 0 0 1 2 
ND + alcohol 0 0 0 0 0 0 0 0 0 0 
ND + psychoactive 
medicines 0 0 0 0 0 0 0 0 0 0 
Narcotic 
drugs excl. 
opiates 
ND + alcohol & psy-
choactive medicines 0 0 0 0 0 0 0 0 0 0 
In
to
xi
ca
tio
ns
 
Total/intoxications  2 11 11 6 11 11 5 110 167 
AIDS 0 0 0 6 0 1 2 0 4 13 
Other diseases 0 0 3 1 0 0 1 1 16 22 
Suicides (no intoxication) 0 0 1 0 0 0 4 1 10 16 
Accidents, homicides  0 1 0 0 1 0 0 3 3 8 
Unknown cause of death 0 0 0 0 0 0 0 0 1 1 Ind
ire
ct
 d
ru
g-
 
re
la
te
d 
de
at
hs
 
Total/indirect drug-related deaths  0 1 4 7 1 1 7 5 34 60 
Total 0 3 15 18 7 12 18 10 144 227 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, St = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: The statistical tables on drug-related deaths used in past years have been modified and now follow the documentation system 
suggested by the EMCDDA (cf. Annex A). For this year’s statistics drug-related deaths from 1991 to 2000 have been reana-
lysed on the basis of the new definition and in consideration of the current list of narcotics specified in the Narcotic Substances 
Act. 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
Table A7: Development of AIDS cases in Austria by risk situation from 1991 to 2000 
Risk situation 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Homo-/bisexual contact 74 77 90 71 71 59 25 28 26 12 
Intravenous drug use 56 57 59 42 39 25 22 24 23 17 
Heterosexual contact 27 30 30 27 34 21 16 24 29 26 
Other cause / unknown 42 27 54 27 62 34 35 20 17 21 
Total 199 191 233 167 206 139 98 96 95 76 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
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Table A8: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by first offenders and repeat offenders and 
development from 1991 to 2000 
Reports 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Total number of reports 5,392 7,805 10,915 12,623 13,093 16,196 17,868 17,141 17,597 18,125 
First offenders 2,185 3,616 4,788 5,281 5,521 8,322 9,278 8,672 9,868 9,343 
Repeat offenders 2,918 3,893 5,882 7,117 7,313 7,511 8,325 8,228 7,463 8,296 
Difference between sum of individual province figures and total figure = unknown offenders 
Since 1998: all reports, not only narcotic drugs but also psychotropic substances 
Note: on 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
Table A9: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by province from 1991 to 2000 
Province 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Burgenland 309 368 332 343 669 694 759 707 603 843 
Carinthia 260 355 334 524 534 1,280 961 1,076 1,208 1,088 
Lower Austria 767 1,055 1,216 1,772 1,655 1,550 2,686 2,519 2,389 2,624 
Upper Austria 564 936 992 1,133 1,405 1,941 2,256 2,334 1,946 1,887 
Salzburg 250 268 504 436 355 962 855 1,053 840 718 
Styria 419 340 458 739 851 1,093 1,125 973 1,367 1,305 
Tyrol 468 842 1,483 1,798 1,382 2,268 2,204 2,212 2,152 2,687 
Vorarlberg 405 748 973 888 1,082 1,040 933 1,144 1,848 1,183 
Vienna 1,950 2,893 4,623 4,990 5,160 5,368 6,089 4,606 4,858 5,233 
Total 5,392 7,805 10,915 12,623 13,093 16,196 17,868 16,624 17,211 17,568 
Difference between sum of individual province figures and total figure = reports not attributable to province 
1998/1999/2000: for the purpose of comparison only reports related to drugs have been considered. 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
Table A10: Distribution of reports to the police for violations of the Narcotic Drugs Act/ 
Narcotic Substances Act in Austria by drug type from 1991 to 2000 
Drug type 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Cannabis 4,132 5,889 7,913 9,552 9,845 14,456 16,124 16,376 17,236 17,001
Heroin and opiates 1,527 2,803 4,340 4,394 4,386 3,727 3,434 2,850 2,524 2,413
Cocaine 643 819 1,267 1,404 1,603 1,912 2,764 2,103 2,608 2,494
LSD 149 200 296 234 315 640 893 736 532 477
Ecstasy - - - 116 496 1,375 1,942 1,411 1,517 2,337
Amphetamines - -  103 81 342 1,068 - - 1,041
Psychotropic substances        802 750 780
Other drugs 182 222 226 306 302 430 850 - - -
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the figures differ from the total number of reports. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
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Table A11: Distribution of reports to the police for violations of the Narcotic Substances Act in Austria 
by drug type and province in 2000 
Drug type B C LA UA S ST T VB V Total 
Cannabis 1,107 1,279 2,730 2,071 775 1,777 2,967 1,234 3,061 17,001 
Heroin und opiates 50 37 318 106 95 137 156 114 1,400 2,413 
Cocaine 34 83 375 171 72 152 237 222 1,148 2,494 
LSD 6 37 159 78 12 54 28 67 36 477 
Ecstasy 45 256 593 295 93 229 350 257 219 2,337 
Psychotropic substances 0 10 74 18 6 63 35 3 571 780 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, St = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: Because of data broken down by type of drug one report to the police may have been listed under several headings, therefore 
the figures differ from the total number of reports. At present it is not possible to break down reports related to amphetamines 
according to province.  
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
Table A12: Convictions under the Narcotic Drugs Act/Narcotic Substances Act and total number of 
convictions in Austria from 1991 to 2000 
Year Total number of convictions Convictions under Convictions under Convictions in Austria 
 under the NDA/NSA Art. 12 NDA/ 
Art. 28 NSA 
Art. 16 NDA/ 
Art. 27 NSA 
total number under the NDA/NSA 
(percentage) 
1991 1,469 503 947 75,155 2.0 
1992 1,720 617 1,074 74,419 2.3 
1993 2,683 952 1,700 74,937 3.6 
1994 3,275 1,230 2,010 69,458 4.7 
1995 3,261 1,124 2,102 69,779 4.7 
1996 3,454 1,027 2,382 66,980 5.2 
1997 3,797 1,036 2,717 65,040 5.8 
1998 3,327 1,041 2,207 63,864 5.2 
1999 3,359 1,022 2,230 61,954 5.4 
2000 3,240 933 2,245 41,624 7.8 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistics Austria (Criminal Court Statistics) 
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Table A13: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act in Austria by age, 
gender and reason for conviction in 2000  
Reason for conviction  14–19 years 20–24 years 25–30 years 31–35 years >35 years Total 
NDA/NSA total men 569 1,013 506 341 435 2,864 
 women 95 111 54 52 64 376 
Art. 12 NDA / Art. 28 NSA men 120 246 154 118 192 830 
 women 19 27 10 17 30 103 
Art. 16 NDA / Art. 27 NSA men 449 760 343 217 214 1,983 
 women 75 81 43 33 30 262 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions un-
der the NDA, or the NSA, respectively, are covered.  
Source: Statistic Austria (Criminal Court Statistics) 
Table A14: Final convictions under the Narcotic Drugs Act/Narcotic Substances Act, according to 
youths and adults, reason for conviction and form of punishment in 2000  
Reason for conviction  Fine Prison sentence Other 
punishment1 
Total 
   Probation No probation Partial probation   
NDA/NSA total youths 144 160 22 56 135 517 
 adults 962 778 692 255 36 2,723 
Art. 12 NDA / Art. 28 NSA 
(felonies) 
youths 
adults 
7 
21 
48
196 
11 
445 
40 
164 
0 
1 
106
827 
Art. 16 NDA / Art. 27 NSA 
(misdemeanours) 
youths 
adults 
137 
927 
112
561 
11 
226 
16 
88 
135 
32 
411
1,834 
Youths = persons younger than 19 at the time of the offence 
NDA = Narcotic Drugs Act 
NSA = Narcotic Substances Act 
On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. 
Art. 12 NDA / Art. 28 NSA = trafficking, possession, etc. of large quantities of narcotic drugs (commercial trafficking) 
Art. 16 NDA / Art. 27 NSA = trafficking, possession, etc. of small quantities of narcotic drugs 
1 Other punishment: partial probation (Art. 43 A (2) CC), referrals to institutions (Arts. 21 (1), 21 (2), 22 and 23 CC), no additional 
punishment (Art. 40 CC) and, though only in the case of youths, conviction with punishment reserved 
(Art. 13 JCA) and conviction without punishment (Art. 12 JCA) 
Note: These figures only refer to the leading offence, i.e. the offence with the highest range of punishment, so not all convictions 
under the NDA, or the NSA, respectively, are covered. 
Source: Statistics Austria (Criminal Court Statistics) 
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Table A15: Development of application of alternatives to punishment in Austria from 1994 to 2000 
Withdrawal of report /  
dismissal of proceedings 
1994 1995 1996 1997 1998 1999 2000 
Total 3,446 4,395 5,248 5,817 7,468 7,030 8,098 
Art. 35 NSA (withdrawal of report) - - - - 6,699 6,360 7,088 
of these: Art. 35 (4) NSA (cannabis) - - - - 1,432 1,355 1,411 
Art. 37 NSA (dismissal of proceedings) - - - - 769 670 1,010 
Art. 35 NSA = temporary withdrawal of the report to the police by the public prosecutor 
Art. 35 (4) NSA = temporary withdrawal of the report to the police in the case of small quantities of cannabis for personal use 
Art. 37 NSA = temporary dismissal of proceedings by the court 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act. A specification of the kind of alterna-
tive to punishment can be given for the period since 1998 only. 
Source: FMSSG (BMSG, Abt. VIII/B/12) 
Table A16: Number of seizures of narcotic drugs/substances in Austria from 1991 to 2000 
Narcotic drugs/substances 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Cannabis 1,485 2,334 2,953 3,510 3,757 4,838 4,957 4,683 5,079 4,833 
Heroin 435 859 1,289 1,225 1,298 1,110 861 654 452 478 
Cocaine 158 235 332 376 421 525 651 531 519 554 
Amphetamines 4 14 26 103 43 136 221 - - 141 
LSD 30 51 58 50 80 102 113 61 56 42 
Ecstasy - - - 51 153 254 253 135 215 330 
Psychotropic substances        14 74 65 
Psychotropic medicines        521 517 501 
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, including since then also psychotro-
pic substances.  
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
Table A17: Seizures of narcotic drugs/substances in Austria by quantity from 1991 to 2000 
Narcotic drugs/substances 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 
Cannabis (kg) 12,166 248 546 394 697 517 912 1,336 451 1,806
Heroin (kg) 102.8 78.2 104.8 80.2 47.0 81.3 102 118 78 230
Cocaine (kg) 84.4 58.1 83.9 52.6 55.3 72.7 87 99 63 20
Amphetamines (kg) 0.3 0.4 0.3 0.7 1.6 3.7 7.9 - - 1
LSD (doses) 906 3,847 28,201 1,543 2,602 4,166 5,243 2,494 2,811 865
Ecstasy (doses) - - - 3,003 31,338 25,118 23,522 114,677 31,129 162,093
Psychotropic substances (kg) - - - - - - - 0.128 4.004 1.294
Psychotropic medicines (doses) - - - - - - - 82,018 36,437 38,507
- = not evaluated separately or not specified 
Note: On 1 January 1998 the Narcotic Drugs Act was replaced by the Narcotic Substances Act, including since then also psychotro-
pic substances. 
Source: FMI (BMI - Jahresberichte über die Suchtgiftkriminalität in Österreich) 
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Table A18: Ingredients of samples bought as ecstasy or speed and analysed by the ChEck iT! project 
at rave parties, from 1997 to 2000 
Samples bought as ecstasy  Samples bought as speed  
Ingredients 
1997/1998 1999 2000 1997/1998 1999 2000 
MDMA 31% 78% 86% 3% 12% 8% 
MDE 3% 0% 4% 1% 0% 0% 
MDA 3% 1% 1% 1% 0% 0% 
MBDB 0% 0% 1% 0% 0% 0% 
Amphetamine 16% 9% 1% 55% 57% 67% 
Metamphetamine 4% 1% 1% 3% 9% 3% 
Other ingredients 43% 11% 6% 37% 22% 22% 
Note: In 1997/1998 a total of 370 samples were analysed; 1999: 239 samples; 2000: 453 samples. The majority of the samples were 
bought as ecstasy (= MDMA) or speed (= amphetamine). 
Source: Kriener et al. 1999 and VWS 2001e; calculation by ÖBIG  
Table A19: Number of outpatient drug centres in Austria by types of service provided and type of 
facility in 2000  
Type of service provided Counselling/care/treatment centres Total number of 
centres1 
(n=105) 
 ≥ 40 hours per week 
(n=38) 
< 40 hours per week 
(n=54) 
Low threshold 
services / out-
reach work (n=11) 
 
 abs. % abs. % abs. % abs. % 
Care for clients undergoing obligatory 
treatment 30 79 33 61 0 0 64 61 
Medical treatment and counselling  29 76 28 52 3 27 61 58 
Medical services in the context of 
substitution treatment  19 50 5 9 0 0 25 24 
Psychotherapeutic treatment and care  27 71 20 37 0 0 48 46 
Psychosocial counselling and care 34 90 41 76 9 82 86 82 
Psychological counselling and care 26 68 23 43 0 0 49 47 
Specific counselling (legal advice, debts, job, 
training)  21 55 7 13 3 27 31 30 
Outreach services 28 74 19 35 10 91 57 54 
Harm reduction 26 68 19 35 11 100 57 54 
Social (re)integration 28 74 27 50 10 91 66 63 
Work with relatives and acquaintances 35 92 47 87 5 46 88 84 
Primary/secondary prevention 30 79 31 57 4 36 65 62 
1) Two centres have not been included in any category 
The shadowed columns give absolute numbers of indications, followed by percentages related to the total number of centres in the 
individual categories. 
Source: ÖBIG 2001 - calculations by ÖBIG (May to September 2000) 
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Table A20: Number of inpatient drug facilities in Austria by types of service provided in 2000  
Specific 
services 
Occasional 
services 
No services Type of service provided 
abs. % abs. % abs. % 
Care for clients undergoing obligatory treatment  7 54 2 15 4 31 
Medical treatment and counselling  11 85 0 0 2 15 
Medical services in the context of substitution treatment  6 46 1 8 6 46 
Psychotherapeutic treatment and care  8 62 2 15 3 23 
Psychosocial counselling and care 11 85 1 8 1 8 
Psychological counselling and care 9 69 1 8 3 23 
Specific counselling (legal advice, debts, job, training)  7 54 1 8 5 39 
Leisure time and daily routine activities 10 77 1 8 2 15 
Services for education and further training 5 39 1 8 7 54 
Contacting of clients (outreach work) 7 54 0 0 6 46 
Aftercare 7 54 1 8 5 39 
Work with relatives and acquaintances 7 54 4 31 2 15 
Primary/secondary prevention 4 31 2 15 7 54 
Specific services: Services of centres specialised for one or more of the services listed in the corresponding categories. 
Occasional services: Services by centres that do not regularly provide any of the services listed in the corresponding categories but 
provide such services occasionally. 
No services: Centres that do not provide any of the services listed in the corresponding category. 
The shadowed columns give absolute numbers of indications, followed by percentages related to the total number of inpatient cen-
tres. 
Source: ÖBIG 2001 - calculations by ÖBIG (May to September 2000) 
Table A21: Number of persons currently registered for substitution treatment in Austria by first 
treatment/continued treatment and province in 2000 
Treatment B C LA UA S St T VB V A* 
Continued treatments 20 65 274 272 209 120 207 331 2,558 4,071 
First treatments 2 29 65 59 99 70 10 68 412 822 
Total 22 94 339 331 308 190 217 399 2,970 4,893 
B = Burgenland, C = Carinthia, LA = Lower Austria, UA = Upper Austria, S = Salzburg, St = Styria, T = Tyrol, VB = Vorarlberg, 
V = Vienna, A = Austria 
Note: Continued treatments are treatments started before the respective year or repeated treatments of persons having undergone 
substitution treatment before. First treatments are treatments of persons who have never been undergoing substitution treat-
ment before. 
* The total number of substitution treatments in Austria is higher than the sum of the substitution treatments by provinces since re-
cords of the provinces are incomplete in some cases.  
Source: FMSSG (BMSG, Abt. VIII/B/12); calculations by ÖBIG 
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Table A22: Austrian population statistics by age group and gender in 2000 
Age group Men Women Total 
  0 to less than   5 years 213,157 202,477 415,634 
  5 to less than 10 years 241,367 229,715 471,082 
10 to less than 15 years 239,499 227,199 466,698 
15 to less than 20 years 247,814 236,791 484,605 
20 to less than 25 years 237,849 230,968 468,817 
25 to less than 30 years 284,646 285,435 570,081 
30 to less than 35 years 356,957 344,788 701,745 
35 to less than 40 years 365,325 347,555 712,880 
40 to less than 45 years 312,880 301,170 614,050 
45 to less than 50 years 262,964 258,604 521,568 
50 to less than 55 years 250,230 247,964 498,194 
55 to less than 60 years 242,150 250,792 492,942 
60 to less than 65 years 201,939 216,456 418,395 
65 to less than 70 years 158,033 185,953 343,986 
70 to less than 75 years 138,905 192,008 330,913 
75 to less than 80 years 98,225 194,364 292,589 
80 to less than 85 years 42,553 95,806 138,359 
85 to less than 90 years 28,835 77,675 106,510 
90 to less than 95 years 7,778 26,767 34,545 
95 and older 1,693 5,692 7,385 
Total 3,932,799 4,158,179 8,090,978 
  0 to less than 15 years 694,023 659,391 1,353,414 
15 to less than 30 years 770,309 753,194 1,523,503 
30 to less than 45 years 1,035,162 993,513 2,028,675 
45 to less than 60 years 755,344 757,360 1,512,704 
60 to less than 75 years 498,877 594,417 1,093,294 
75 and older 179,084 400,304 579,388 
Total 3,932,799 4,158,179 8,090,978 
 
Source: Statistics Austria, calculations by ÖBIG 
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AMS Public Employment Service 
ARBÖ Auto-, Motor- und Radfahrerbund Österreichs 
ATS Austrian Schillings 
CC Criminal Code 
EDDRA Exchange on Drug Demand Reduction Action 
EDPW European Drug Prevention Week 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
EU European Union 
FMAFEW Federal Ministry of Agriculture, Forestry, Environment and Water Management  
(BMLFUW) 
FMD Federal Ministry of Defence (BMLV) 
FMESC Federal Ministry of Education, Science and Culture (BMBWK) 
FMF Federal Ministry of Finance (BMF) 
FMFA Federal Ministry for Foreign Affairs (BMA) 
FMI Federal Ministry of the Interior (BMI) 
FMJ Federal Ministry of Justice (BMJ) 
FMSSG Federal Ministry for Social Security and Generations (BMSG) 
FMTIT Federal Ministry for Transport, Innovation and Technology (BMVIT) 
HAF Healthy Austria Fund (FGÖ) 
IFES Institute for Empirical Research 
JCA Juvenile Court Act (JGG) 
MDMA methylenedioxymethamphetamine 
NDA Narcotic Drugs Act (SGG) 
NSA Narcotic Substances Act (SMG) 
ÖBIG Austrian Health Institute 
PMA paramethoxyamphetamine 
REITOX European Information Network on Drugs and Drug Addiction 
(Réseau Européen d’Information sur les Drogues et les Toxicomanies) 
UNDCP United Nations International Drug Control Programme 
VSF Vienna Social Fund (FSW) 
VWS Vienna Social Projects Association 
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